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ABSTRACT 
 
Post-exercise blood flow restriction (BFR) is a novel training method which, through 
alterations to the haemodynamic, metabolic and hypoxic stimulus, could augment skeletal 
muscle adaptation in endurance trained individuals. The studies described in this thesis 
investigated the combined effect of post-exercise BFR and interval training on angiogenic and 
mitochondrial biogenic molecular and adaptive responses and high-intensity endurance 
performance. It was initially demonstrated that a very strong correlation exists between critical 
power (CP), an important parameter of endurance performance, and indices of skeletal muscle 
capillarity (r = 0.94), implying that skeletal muscle capillarity is an important determinant of 
CP (Chapter 3). Chapter 4 investigated the efficacy of combining post-exercise BFR with 4 
weeks of sprint interval training (SIT) (4-7 x 30 s maximal bouts) in trained individuals. SIT 
increased CP by ~3.5% in trained individuals, but the addition of BFR did not enhance this 
further. In contrast, neither skeletal muscle capillarity or mitochondrial protein content 
increased following SIT with or without BFR. However, there was a trend (P = 0.06) for an 
increase in proliferating endothelial cells after four weeks of SIT only with post-exercise BFR, 
tentatively suggesting that post-exercise BFR could elicit an enhanced angiogenic response 
when undertaken with a greater training duration and/or volume. This was investigated in 
Chapter 6 in which the time course of transient transcriptional changes during two weeks of 
post-exercise BFR combined with a higher volume high intensity interval training (HIIT) 
modality was examined. BFR did not enhance the transient increases in VEGF, PGC-1α of 
HIF-1α mRNA following HIIT during two-weeks of training and did not increase VEGF 
protein content. There was however, an increase in resting eNOS mRNA after two weeks only 
when HIIT was combined with post-exercise BFR, suggesting BFR elicited an increased shear 
stress stimulus. There was no increase in mitochondrial protein content or citrate synthase 
activity following 2 weeks of HIIT with or without post-exercise BFR. Collectively the 
findings from these studies imply that post-exercise BFR does not increase mitochondrial 
content, but although there was no increase in skeletal muscle capillarity, there were 
suggestions that post-exercise BFR could elicit an enhanced angiogenic stimulus when 
undertaken with higher training volumes and could subsequently increase performance.  
Key words: Blood flow restriction, angiogenesis, mitochondrial biogenesis, critical power 
interval training, trained individuals.  
ii 
 
ACKNOWLEDGEMENTS 
 
This thesis has only been made possible with the considerable help and support of a number of 
individuals.  
Firstly, I would like to thank my supervisor Dr Richard Ferguson for his guidance and support 
throughout my PhD studies and for trying to get me to see the glass half-full. His advice and 
encouragement have been invaluable and the work we have undertaken, alongside the 
opportunities he has provided me with, have only fuelled my interest in the world of research. 
I also must thank him for conducting the many muscle biopsies that were involved throughout 
this thesis.  
I would also like to thank Dr Neil Martin and Dr Mark Turner for training me in the skills 
required and assisting with undertaking the skeletal muscle analysis. I am very grateful for their 
expertise, patience and continued support through the many problems I encountered during the 
analysis phases. I must also extend my gratitude to Dr Stephen Bailey for his expertise in setting 
the gas exchange thresholds and for his insightful discussions around the critical power 
concept. I would also like to express my gratefulness to Dr Carolin Stangier for her support 
and friendship through periods of the data collection and participant recruitment, as well as to 
all the undergraduate and postgraduate students from Loughborough University who assisted 
with aspects of the data collection. 
This thesis simply would not have been possible without the commitment and cooperation of 
all the participants who volunteered to undertake the studies, the majority of which involved 
putting themselves through uncomfortable training sessions and consenting to multiple muscle 
biopsies. I am extremely grateful to all of them.  
To my friends in the PhD office in the NCSEM, thank you for the many laughs we have had 
together that made the time I spent at Loughborough so enjoyable. I am sure these friendships 
will continue for years to come.  
Finally, Toby, thank you for your endless support and encouragement throughout this time. 
And to my Mum and Dad, words cannot express how grateful I am for your continued support 
in everything I do that has allowed me to get to where I am today.   
  
iii 
 
PUBLICATIONS 
 
The publications that have arisen from this thesis are as follows: 
 
Journal articles: 
Mitchell EA, Martin NRW, Bailey SJ & Ferguson RA (2018). Critical power is positively 
related to skeletal muscle capillarity and type I muscle fibers in endurance trained 
individuals. J Appl Physiol 125, 737–745. 
 
Mitchell EA, Martin NRW, Turner MC, Taylor CW & Ferguson RA (2019). The combined 
effect of sprint interval training and postexercise blood flow restriction on critical power, 
capillary growth and mitochondrial proteins in trained cyclists. J Appl Physiol 126, 51–
59. 
 
Conference presentations: 
Mitchell EA, Martin NRW, Turner MC, Taylor CW & Ferguson RA. The combined effect of 
sprint interval training and blood flow restriction on critical power, capillary growth and 
mitochondrial proteins in trained cyclists.  European College of Sport Science Annual 
Congress. 2018, Dublin, Ireland. 
 
Mitchell EA, Ibeggazene S, Leftwich R, Smith T, Frisch X, Rees-Clark S & Ferguson RA. 
Combined effects of blood flow restriction and sprint interval training on the power-
duration relationship in trained individuals. BASES Annual Conference. 2016, 
Nottingham, UK. 
 
  
iv 
 
TABLE OF CONTENTS 
 
ABSTRACT……………………………………………………………………………………i 
ACKNOWLEDGEMENTS………………………………………………………………...…ii 
PUBLICATIONS…………………………………………………………………………..…iii 
LIST OF FIGURES…………………………………………………………………………..vii 
LIST OF TABLES…………………………………………………………………………….xi 
LIST OF ABBREVIATIONS………………………………………………………………..xii 
CHAPTER 1 – INTRODUCTION……………………………………….…………………....1 
CHAPTER 2 – LITERATURE REVIEW……………………………………………….…….4 
2.1 Peripheral adaptations to endurance training……………………………..…4 
2.2 Mechanisms of the adaptive response to endurance training…………………...7 
2.3 Reduced plasticity of the trained muscle……………………………………23 
2.4 Training with blood flow restriction (BFR)…………………………………..26 
2.5 Physiological signals from BFR…………………………………………...28 
2.6 Post-exercise BFR………………………...………………………………….32 
2.7  The critical power concept………………………………………………….33 
2.8 Summary and aims……………………………………………………………35 
CHAPTER 3 – CRITICAL POWER IS POSITIVELY RELATED TO SKELETAL MUSCLE 
CAPILLARITY AND TYPE I MUSCLE FIBRES IN ENDURANCE TRAINED 
INDIVIDUALS……………………………………………………………………………....37 
3.1 Abstract………………………………………………………………..…… ..38 
3.2 New and noteworthy………………...………………………………………..38 
3.3 Introduction……………………………………………………….….………39 
3.4 Methods…………………………………………………………………..…..42 
3.5 Results…………………………………………………..……………………46 
3.6 Discussion…………………………………………………………..………..52 
v 
 
CHAPTER 4 – THE COMBINED EFFECT OF SPRINT INTERVAL TRAINING AND 
POST-EXERCISE BLOOD FLOW RESTRICTION ON CRITICAL POWER, CAPILLARY 
GROWTH AND MITOCHONDRIAL PROTEINS IN TRAINED CYCLISTS …………….57 
4.1 Abstract …………………………………………………………………....…58 
4.2 New and noteworthy……………………………………………………….…58 
4.3   Introduction……………………………………………………………..……59 
4.4 Methods……………………………………………………………..………..61 
4.5 Results……………………………………………………………………..…67 
4.6 Discussion………………………………………………………………..…..75  
CHAPTER 5 – THE EFFECT OF COMBINED SPRINT INTERVAL TRAINING AND 
POST-EXERCISE BLOOD FLOW RESTRICTION ON SKELETAL MUSCLE 
OXYGENATION…………………………………………………………………………….79 
5.1 Introduction………………………………………………………………..…79 
5.2 Methods……………………………………………………………………....81 
5.3 Results……………………………………………………………………..…83 
5.4 Discussion…………………………………………………………………....87  
CHAPTER 6 – TIME COURSE OF THE TRANSCRIPTIONAL, TRANSLATIONAL AND 
PHENOTYPIC RESPONSE TO HIGH INTENSITY INTERVAL TRAINING COMBINED 
WITH POST EXERCISE BLOOD FLOW RESTRICTION…………………………..…….90 
6.1 Introduction……………………………………………………….….………91    
6.2 Methods………………………………………………………………..……..93 
6.3 Results……………………………………………………………………......99 
6.4 Discussion…………………………………………….…...………………..106 
CHAPTER 7 – GENERAL DISCUSSION……………………..………………………..…111 
7.1 Summary…………………………………………………………..……….. 111 
7.2 Critical power……………………………………………………………….112 
7.3 Angiogenic potential of post-exercise BFR………………………………..115 
7.4 Mitochondrial biogenic potential of post-exercise BFR…………………..120 
7.5 The effect of post-exercise BFR on endurance performance………………..121 
7.6 Limitations………………………………………………………………… .122 
7.7 Conclusions and future directions…………………………………………...124 
 
vi 
 
CHAPTER 8 – SKELETAL MUSCLE ANALYSIS METHOD DEVELOPMENT………..126 
8.1 Immunohistochemical protocol optimisations………………………………126 
8.2 Immunohistochemical optimised protocol…………………………………..136 
8.3 Western blot protocol optimisations……………………………………..….138 
8.4 Western blot optimised protocol…………………………………….………144 
REFERENCES…………………………………………………………………….………..146 
 
 
  
vii 
 
LIST OF FIGURES 
 
Figure 2.1. Schematic of the key components of the known signalling pathways likely eliciting 
exercise-induced angiogenesis and mitochondrial biogenesis (Adapted from Egan & Zierath, 
2013)………………………………………………………………………………………….. 8 
 
Figure 2.2. Schematic of the blunted molecular response with continued training. Adapted 
from Perry et al. (2010), with data specific to PGC-1α mRNA and protein content and CS 
activity………………………………………………………………………………………..24 
 
Figure 2.3. Hypothesised effects of blood flow restriction (BFR) (demonstrated by red arrows) 
on the signalling pathways of angiogenesis and mitochondrial biogenesis…………………...28 
 
Figure 3.1. Representative images of immuno-histochemical staining of muscle samples from 
two participants; A) CP = 207 W, V̇O2peak = 3.93 l.min-1, capillary to fiber ratio = 1.90; B) CP 
= 353 W, V̇O2peak = 5.38 l.min-1, capillary to fiber ratio = 3.40. Type I fibers = red, type II fibers 
= blue, and capillaries = green. Scale Bar = 50 μm…………………………………….……...47 
 
Figure 3.2. Correlations between CP and: A) % proportion of type I fibers, B) % proportion of 
type II fibers, C) CSA of type I fibers, D) CSA of type II fibers, E) capillary density, F) capillary 
to fiber ratio, G) capillary contacts around type I fibers, H) capillary contacts around type II 
fibers……………………………………………………………………………………….…48 
 
Figure 3.3. Correlations between W' and: A) % proportion of type I fibers, B) % proportion of 
type II fibers, C) CSA of type I fibers, D) CSA of type II fibers, E) capillary density, F) capillary 
to fiber ratio, G) capillary contacts around type I fibers, H) capillary contacts around type II 
fibers……………………………………………………………………………………….…49 
 
Figure 4.1. Individual responses of V̇O2max (A), MAP (B), CP (C), Wʹ (D), PPO (E) and MPO 
(F) before and after control (CON) and blood flow restriction (BFR) training interventions…69 
 
 
viii 
 
Figure 4.2. Muscle capillaries before and after control (CON) and blood-flow restriction (BFR) 
training interventions. A) Representative images of muscle capillaries stained with CD-31 
(green) and type II fibres (blue). Scale Bar = 50 μm. B) Individual responses of capillary density 
and capillary to fibre ratio. Data are CON n = 7; BFR n = 9…………………………………...71 
 
Figure 4.3. Presence of proliferating endothelial cells before and after control (CON) and 
blood-flow restriction (BFR) training interventions. A) Representative image of Ki-67 (red) 
positive endothelial cell (green). Scale Bar =50 μm. B) Individual responses of Ki-67 positive 
endothelial cells per fibre. Data are CON n = 6; BFR n = 9. One bar for BFR is hidden as data 
are pre =0.00 and post = 0.00…………………………………………………………………72 
 
Figure 4.4. Content of CS (A), COX II (B) and COX IV (C) protein before and after control 
(CON) and blood flow restriction (BFR) training interventions. Values are expressed as fold 
changes relative to pre-training values. Bars represent the mean and lines represent individual 
responses. Data are CON n = 7; BFR n = 7……………………………………………………74 
 
Figure 5.1. O2Hb in RF (A) and VL (B), HHb in RF (C) and VL (D) and TOI in RF (E) and 
VL (F) during control (CON) (open circles) and blood flow restriction (BFR) (closed circles) 
sprint interval training sessions. * denotes significantly different to CON, P < 0.05……….....84 
 
Figure 5.2. O2Hb in RF (A) and VL (B), HHb in RF (C) and VL (D) and TOI in RF (E) and 
VL (F) during a single sprint and recovery period in CON (red), BFR120 (green), BFR160 
(purple) and BFR2 (blue) sprint interval training sessions……………………………………86 
 
Figure 6.1. Schematic of training schedule and muscle biopsy timings………………………93 
 
Figure 6.2. mRNA expression of VEGF (A), PGC-1α (B), HIF-1α (C) and eNOS (D) pre and 
3 hours post training sessions 1, 4 and 7 in control (CON) (open circles) and blood flow 
restriction (BFR) (closed circles). Values are expressed as fold changes relative to pre-training 
values. Data are mean ± SD. aP < 0.05 vs CON, bP < 0.05 vs pre, cP < 0.05 vs 4th 3 hr, dP < 
0.10 vs 1st 3 hr pre, eP < 0.10 vs 4th pre……………………………………………………100 
 
 
 
ix 
 
Figure 6.3. Protein content of VEGF (A), COXII (B), COXIV (C) and CS (D) in control (CON) 
(open circles) and blood flow restriction (BFR) (closed circles) training interventions. Values 
are expressed as fold changes relative to pre-training values. Data are mean ± SD………….101 
 
Figure 6.4. Citrate synthase (CS) activity in control (CON) (open circles) and blood flow 
restriction (BFR) (closed circles) training interventions. Markers with thick dashed lines 
represent means and thin dotted lines represent individual responses……………………….102 
 
Figure 6.5. HR during exercise (A) and recovery (B) during control (CON) (open circles) and 
blood flow restriction (BFR) (closed circles) training interventions. Data are mean ± SD. aP < 
0.05 vs CON, bP < 0.10 vs CON, 
cP < 0.05 vs 1, dP < 0.10 vs 1, eP < 0.05 vs 2, fP < 0.10 vs 
2……………………………………………………………………………………………..104 
 
Figure 6.6. RPE during control (CON) (open circles) and blood flow restriction (BFR) (closed 
circles) training interventions. Data are mean ± SD. cP < 0.05 vs 1, dP < 0.10 vs 1, eP < 0.05 vs 
2, fP < 0.10 vs 2, gP < 0.05 vs 3, hP < 0.10 vs 3, iP < 0.10 vs 5………………………………..105 
 
Figure 8.1. CD31 staining. A) Primary antibody concentration 1 in 250 and secondary 1 in 
1000. B) Primary antibody 1 in 100 and secondary antibody 1 in 500……………………….127 
 
Figure 8.2. CD31 (pink) & MHC I (green) staining. A) Fixed with acetone for 5 min. B) Fixed 
with acetone for 30 s and P-formaldehyde for 2 min. C) Fixed with P-formaldehyde for 10 
min…………………………………………………………………………………………..128 
 
Figure 8.3. CD31 staining (red). Primary antibody concentration: A) 1 in 100; B) 1 in 250; C) 
1 in 500……………………………………………………………………………………...129 
 
Figure 8.4. A) CD31 (green) new primary antibody incubated overnight, exposure time = 878 
ms B) CD31 (red) original primary antibody incubated overnight, exposure time = 1584 ms C) 
CD31 (green) new primary antibody incubated for 1 hour, exposure time = 623 ms………...130 
 
Figure 8.5. CD31 staining (green). Primary antibody concentration: A) 1 in 50 B) 1 in 100 C) 
1 in 250………………………………………………………………………………….…..131 
 
x 
 
Figure 8.6. CD31 staining (green). Secondary antibody concentration: A) 1 in 250 B) 1 in 500 
C) 1 in 1000………………………………………………………………………………….132 
 
Figure 8.7. MHC II staining (red). Primary antibody concentration: A) 1 in 1000 B) 1 in 
2000…………………………………………………………………………………………133 
 
Figure 8.8. MHC II staining (red). Secondary antibody concentration: A) 1 in 250 B) 1 in 500 
C) 1 in 1000………………………………………………………………………………….134 
 
Figure 8.9. No primary antibody controls: A) Alexa Fluor 488 Mouse antibody B) Alexa Fluor 
594 Rabbit antibody. Exposure time ~600ms……………………………………………….134 
 
Figure 8.10. Western blots for (left to right) CS, COXII and COXIV with 15 ug loaded on the 
left-hand lanes and 30 ug loaded on the right-hand lanes……………………………………138 
 
Figure 8.11. Western blots for VEGF. Top) blocked in 5% BSA, bottom) blocked in 5% milk. 
Left-hand lane 60 μg protein loaded and right-hand lane 30 μg protein loaded…………...…139 
 
Figure 8.12. Western blots for VEGF at a primary antibody concentration of (left to right) 1 in 
1000, 1 in 2000 and 1 in 4000………………………………………………………………..140 
 
Figure 8.13. Western blots for VEGF. A) left hand lane 30 μg, right hand lane 60 μg. Exposure: 
initial time of 10 s for total of 12000 s. B) left-hand lane primary antibody concentration of 1 
in 500 and right-hand lane 1 in 1000. Exposure: initial time 30 s for 3600 s…………………140 
 
Figure 8.14. Western blots for PGC-1α A) left hand lane 60 μg, right hand lane 30 μg, with 
antibodies diluted at 1 in 1000 in 3% milk. B) left-hand lane primary antibody concentration 
of 1 in 1000 and right-hand lane 1 in 2000 with antibodies diluted in 5% milk…………..…..141 
 
Figure 8.15. Western blot for PGC-1α A) left lane muscle sample, right lane positive control. 
B) left lane current Merck monoclonal antibody, right lane Abcam polyclonal antibody…...142 
 
Figure 8.16. A) Western blot for PGC-1α on experimental samples across the training period 
from Chapter 6. B) Western blot for mTOR (~289 kDa)…………………………………….143 
xi 
 
LIST OF TABLES 
 
Table 3.1. Parameters of performance and skeletal muscle morphology……………………..43 
 
Table 3.2. Parameter estimates of the power-duration relationship…………………………..46 
 
Table 3.3. Correlations between V̇O2peak and MAP and markers of skeletal muscle 
capillarization and muscle fiber composition…………………………………………………51 
 
Table 4.1. Physiological and performance variables before and after control (CON) and blood-
flow restriction (BFR) training interventions…………………………………………………68 
 
Table 4.2. Capillarisation and muscle morphology before and after control (CON) and blood- 
flow restriction (BFR) training interventions…………………………………………………73 
 
Table 6.1. Primers used for real-time RT-PCR analyses…………………………………….97 
 
Table 6.2. Performance variables before and after control (CON) and blood-flow restriction 
(BFR) training interventions………………………………………………………………...103 
 
Table 8.1. Molecular weights and primary antibody solutions for the proteins of interest…..145 
 
Table 8.2. Exposure times for the proteins of interest……………………………………….145 
  
xii 
 
LIST OF ABBREVIATIONS 
 
AMP   Adenosine monophosphate 
AMPK   5' AMP-activated protein kinase 
ATP   Adenosine Triphosphate 
BFR   Blood flow restriction 
BSA   Bovine serum albumin 
CaMKII  Ca2+/Calmodulin-dependent kinase II 
CC type I  Capillary contacts around type I fibres 
CC type II  Capillary contacts around type II fibres 
CON   Control 
COXII   Cytochrome c oxidase subunit II 
COXIV  Cytochrome c oxidase subunit IV 
CP   Critical power 
CS   Citrate synthase 
CSA   Cross sectional area 
eNOS   Endothelial nitric oxide synthase 
FXYD1  Phospholemman-1 
GET   Gas exchange threshold 
HDAC4  Histone deacetylase-4 
HHb   Deoxyhaemoglobin 
HIF-1α  Hypoxia inducible factor-1 alpha 
HIIT   High intensity interval training 
HR   Heart rate 
MAP   Maximal aerobic power 
MEF2   Myocyte enhancer factor-2  
MHC   Myosin heavy chain 
MMP   Matrix metalloproteinase 
MPO   Mean power output 
mRNA   Messenger RNA 
mtDNA  Mitochondrial DNA 
NIRS   Near-infrared spectroscopy 
NO   Nitric oxide 
xiii 
 
NOS   Nitric oxide synthase 
NRF   Nuclear respiratory factor 
O2Hb   Oxyhaemoglobin 
p38 MAPK  p38 mitogen-activated protein kinase 
PBS   Phosphate buffered saline 
PCr   Phosphocreatine 
PGC-1α  Peroxisome proliferator-activated receptor-γ coactivator 1α 
PPO   Peak power output 
RF   Rectus femoris 
RM   Repetition maximum 
RPII   RNA polymerase II 
RPE   Rating of perceived exertion 
ROS   Reactive oxygen species 
RT-PCR  Reverse transcription polymerase chain reaction 
SD   Standard deviation 
SIT   Sprint interval training 
TBST   Tris buffered saline with tween  
Tfam   Mitochondrial transcription factor 
TOI   Tissue oxygenation index 
Type I fibre %  %proportion of type I fibres 
Type II fibre %  %proportion of type II fibres 
VEGF   Vascular endothelial growth factor 
VEGFR  Vascular endothelial growth factor receptor 
VL   Vastus lateralis 
V̇O2   Oxygen uptake 
V̇O2max  Maximal oxygen uptake 
V̇O2peak  Peak oxygen uptake 
Wʹ   Curvature constant 
 
 
1 
 
CHAPTER 1 
INTRODUCTION 
 
 
Skeletal muscle demonstrates remarkable plasticity in its adaptive remodelling and functional 
response to a range of physiological stimuli (Hoppeler, 2016). These include: hypoxia 
(Hoppeler et al. 2008), disuse (Bodine, 2013), nutritional modulations (Hawley et al. 2011) 
and not least endurance training (Holloszy et al 1977; Saltin et al. 1977). The adaptations 
elicited are specific to the stimuli imposed, allowing the individual better defence against future 
disturbances to homeostasis (Coffey & Hawley, 2007; Egan & Zierath, 2013). Specifically, 
endurance training elicits adaptations supporting oxygen delivery and utilisation, such as 
increased capillary supply and mitochondria (Andersen & Henriksson, 1977; Klausen et al. 
1981; Holloszy et al. 1977; Holloszy & Coyle, 1984). These adaptations are critical for 
optimising oxidative capacity and demonstrate close correlations with parameters of endurance 
performance (Flueck, 2010; Iaia et al. 2011; Saltin et al. 1977; Tonkonogi & Shalin, 1997).   
At the periphery multiple physiological and metabolic signals are induced during endurance 
exercise, such as mechanical stretch, calcium release and changes in the adenosine 
monophosphate (AMP) to adenosine triphosphate (ATP) ratio, that activate a cascade of 
molecular pathways (Coffey & Hawley, 2007; Hoppeler, 2016). These pathways elicit transient 
increases in the transcription of genes and translocation of proteins involved in skeletal muscle 
adaptation (Hoier et al. 2012; 2013b; Little et al. 2010a; Perry et al. 2010). The cumulative 
effect of these transient responses elicits a gradual increase in protein content and phenotypic 
remodelling, ultimately leading to functional performance enhancements (Egan & Zierath, 
2013; Hoppeler 2016; Perry et al. 2010).  
It is generally considered that further adaptations are more difficult to elicit in endurance 
trained individuals, who through years of training already possess highly adapted physiology, 
including capillary to fibre ratios and oxidative enzyme activities double that of untrained 
individuals (Hermansen & Wachtlova, 1971; Ingjer, 1979; Saltin et al. 1977; Tonkonogi & 
Sahlin, 1997). Indeed, as training progresses there is an attenuation in the magnitude of 
performance improvements (Hoppeler et al. 1985) alongside diminished increases in oxidative 
enzymes and capillary supply (Saltin et al. 1977). Moreover, training methods demonstrated to 
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elicit potent increases in oxidative capacity in untrained individuals, do not induce these 
adaptions in endurance trained athletes (Weston et al. 1997). This blunting of the adaptive 
scope is reflected at the molecular level. As individuals become accustomed to a specific 
exercise bout there is a blunting of the acute angiogenic and mitochondrial biogenic 
transcriptional response (Hoier et al. 2012; Perry et al. 2010; Richardson et al. 2000; Schmutz 
et al. 2006). Accordingly, an inverse relationship exists between mitochondrial content and the 
expressional response of mitochondrial and angiogenic transcripts (Flueck, 2010). The 
challenge for the endurance athlete therefore, is to identify training methods that are able to 
overcome this blunted response and promote continued adaptation. 
Blood flow restriction (BFR) achieved through the application of inflatable cuffs proximal to 
the working muscle, is a potential strategy to enhance the endurance training stimulus in trained 
individuals. The use of BFR has received extensive focus in the literature as tool to augment 
the adaptative response to low-load resistance training and has been demonstrated to be an 
effective method to enhance strength and hypertrophic adaptations (Pope et al. 2013; Scott et 
al. 2015; Slysz et al. 2016). In contrast, the use of BFR during endurance training has received 
little attention and is currently an underexplored training method. Some studies have 
highlighted the potential of BFR, observing enhancements to maximal oxygen uptake (V̇O2max) 
and exercise capacity when combined with ‘low’-intensity training (Abe et al. 2010a; de 
Oliviera et al. 2016; Park et al. 2010; Paton et al. 2017). Moreover, the application of BFR can 
increase multiple primary contractile stimuli including: shear stress (Takarada et al. 2000; 
Paiva et al. 2016), skeletal muscle hypoxia (Karabulut et al. 2011; Tanimoto et al. 2005), 
metabolic stress (Takarada et al. 2000; Suga et al. 2009; 2012) and oxidative stress 
(Christiansen et al. 2018), all of which are important stimuli of angiogenesis (Egginton, 2009) 
and/or mitochondrial biogenesis (Hood, 2009; Ljubicic et al. 2010). Indeed, the addition of 
BFR to low-intensity exercise can increase the acute transcriptional response of several key 
angiogenic and mitochondrial biogenic genes (Christiansen et al. 2018; Ferguson et al. 2018; 
Larkin et al. 2012). 
For individuals to be able to tolerate a combined stimulus, the application of BFR during 
exercise requires a reduction in training intensity. Accordingly, current studies have only 
investigated the use of BFR during low-intensity (≤40% VO2max) continuous (Abe et al. 2010a; 
Park et al. 2010) or reduced intensity interval type training (de Oliveira et al. 2016; Paton et 
al. 2017). This model of BFR training may have applications during specific circumstances 
such as periods of rehabilitation following injury when high loads are contraindicated. 
3 
 
However, the maintenance of a high training intensity is critical to optimise adaptations and 
endurance performance in athletes (Laursen et al. 2002; 2005; Mujika, 2010), suggesting a 
limited application of these ‘reduced’ intensity protocols during pre-competition training.  
In an alternative approach a recent investigation provided preliminary support for the potency 
of post-exercise BFR. Whereby the BFR stimulus is applied as an additional stimulus in the 
recovery intervals during an interval training program, without requiring a reduction in the 
training intensity (Taylor et al. 2016a). This study combined post-exercise BFR with a classic 
sprint interval training (SIT) program. 20 trained cyclists undertook 4 weeks of SIT either alone 
or with 2 min of post-exercise BFR during the recovery intervals. They observed a potent 
increase in V̇O2max of 4.5% after just 4 weeks in the BFR group, with no change following SIT 
alone. However, despite preliminary signalling data supporting the angiogenic potential of the 
combined stimulus, the effect on skeletal muscle adaptation and endurance performance have 
yet to be established. 
In the context outlined above, this thesis herein outlines a series of experiments designed to 
further examine the potential of post-exercise BFR as an endurance training tool for trained 
individuals. The series of experiments investigated responses from the molecular to the whole-
body level to assess the potential of post-exercise BFR to overcome the blunted molecular 
response in the trained state, augment skeletal muscle adaptations favourable to performance 
and ultimately enhance endurance performance.  
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CHAPTER 2  
LITERATURE REVIEW 
 
 
The performance of endurance training, either involving continuous low intensity sustained 
efforts or high intensity intervals interspersed with periods of recovery, elicits central and 
peripheral adaptations when performed for sufficient durations and intensities. The adaptations 
elicited enhance delivery and utilisation of oxygen and substrates and ultimately enhance an 
individual’s ability to defend homeostasis and resist fatigue (Andersen & Henriksson, 1977; 
Egan & Zierath, 2013; Ekblom et al. 1968; Holloszy et al. 1977; Holloszy & Coyle 1984). 
Thereby, enabling the individual to maintain a higher power output or speed for a given 
duration. 
 
2.1 PERIPHERAL ADAPTATIONS TO ENDURANCE TRAINING 
Multiple peripheral adaptations are elicited by endurance training that are advantageous for 
endurance performance, including: mitochondrial biogenesis (Holloszy, 1967), angiogenesis 
(Anderssen & Henrikssen, 1977; Klausen et al. 1981; Jensen et al., 2004a), muscle fibre type 
conversion from type IIx to IIa (Bamman et al. 2007; Fitzsimons et al. 1990), increased muscle 
glycogen content (Greiwe et al. 1999; Hickner et al. 1997) and alterations to substrate 
metabolism at submaximal workloads (Holloszy & Coyle, 1984; Saltin et al. 1977). This 
review, however, will focus upon angiogenesis and mitochondrial biogenesis.  
August Krogh’s pioneering work first recognised the capillary bed to be the critical site of 
exchange for oxygen between the vasculature and the working skeletal muscle (Krogh, 1919a; 
1919b). It is now acknowledged that a greater capillary bed enhances respiratory gas and 
substrate and metabolite exchange and consequently the capillary-muscle interface is 
considered as a potential limiting factor for aerobic exercise (Egginton, 2009; Prior et al. 2004). 
Accordingly, muscle capillarity has been implied as an important determinant of endurance 
performance (Coyle, 1995; Joyner & Coyle, 2008). Endurance trained individuals have 
consistently been reported to possess skeletal muscle with enhanced capillary supplies, with 
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capillary to fibre ratios up to double that of untrained individuals (Brodal et al. 1977; 
Hermansen & Wachtlova, 1971; Ingjer, 1979; Saltin et al. 1977). 
Studies have provided evidence for the importance of the capillary bed to aerobic function and 
endurance performance. Indeed, the number of capillaries surrounding each muscle fibre has 
been shown to be proportional to the oxidative activity of that fibre (Romanul, 1964) and a 
close correlation has also been observed between the number of capillaries per fibre of the 
vastus lateralis and cycling V̇O2max (Saltin et al. 1977). Moreover, Coyle et al. (1988) observed 
a correlation of r = 0.74 between capillary density and time to exhaustion during exercise at 
88% of V̇O2max and Iaia et al. (2011) reported positive correlations between capillary density 
and capillary to fibre ratio with time to task failure during performance times of ~1-20 minutes.  
A high capillary supply is key to enhancing oxygen extraction. Oxygen extraction is a function 
of muscle oxygen diffusion capacity and muscle blood flow (Roca et al. 1992; Wagner, 1992), 
the former of which is primarily determined by the number of red blood cells in contact with 
the contracting skeletal muscle fibres (Federspiel & Popel, 1986). This is therefore, facilitated 
by a high capillary network, given that the majority of capillaries are believed to support red 
blood cell flux (Poole et al. 2013). Furthermore, capillary supply also facilitates the removal 
of fatigue inducing muscle metabolites, therefore sustaining exercise tolerance (Joyner & 
Coyle, 2008). Capillarity is correlated to blood lactate accumulation and pH during and upon 
completion of an exercise bout (Iaia et al. 2011; Tesch & Wright 1983). Iaia et al. (2011) 
further demonstrated a positive correlation between capillary density and the mean net rate of 
plasma potassium (K+) accumulation, suggesting an increased transfer of K+ from the 
extracellular space to the circulation. This would delay extracellular accumulation of K+, which 
has been implicated to contribute to skeletal muscle fatigue and limiting high intensity exercise 
performance (Allen et al. 2008; McKenna et al. 2008).  
Capillary supply is typically expressed as: capillary density (the number of capillaries per mm-
2), capillary to fibre ratio (the number of capillaries divided by the number of fibres) and 
capillary contacts (the number of capillaries in contact with each fibre), to give an overall 
picture of skeletal muscle capillarity. It is important to note that capillary density is limited as 
a marker of capillarity to determine the extent of exercise-induced angiogenesis as it is also a 
function of muscle fibre cross sectional area (CSA), which is similarly modulated in response 
to training (Olfert et al. 2016). Furthermore, capillary to fibre ratio may be of more importance 
to enhancing oxygen extraction than capillary density. Hepple et al. (2000) demonstrated that 
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a decrease in capillary density through short-term immobilization, which left capillary to fibre 
ratio unchanged, did not increase muscle oxygen diffusing capacity. This is further supported 
by observations that a group of endurance trained individuals possessed higher capillary to 
fiber ratios but had similar capillary densities as a group of untrained individuals (Hermansen 
& Wachtlova, 1971). 
Endurance training is also well known to elicit increases in mitochondrial content and 
mitochondrial function (Holloszy, 1967; Holloszy et al. 1977; Hood, 2001; Bishop et al. 2014). 
Trained individuals have consistently been shown to have higher markers of mitochondrial 
protein content, enzyme activity and higher mitochondrial functions than untrained individuals 
(Befroy et al. 2008; Hoppeler, 1986; Larsen et al. 2009; Mogensen et al. 2006; Saltin et al. 
1977), with elite level athletes possessing even higher values (Jacobs & Lundby, 2013). 
Mitochondria are a crucial component of skeletal muscle and have several key functions 
including cell apoptosis, cell signalling and are often referenced as the ‘power houses’ of the 
cell as the fundamental organelle of ATP production, the energy currency of living organisms 
(Hood, 2001). Within mitochondria ATP resynthesis occurs during the reactions of the Krebs 
cycle in the matrix and the electron transport chain at the inner mitochondrial membrane. Given 
the pivotal role of the mitochondria in providing ATP, it is not surprising adaptations to the 
mitochondria have been associated with endurance performance. Studies have demonstrated a 
close correlation between markers of mitochondrial density and V̇O2max (Flueck, 2010; Jacobs 
& Lundby, 2013; Tonkonogi & Sahlin, 1997). Jacobs et al. (2011) further observed that 
mitochondrial function, as assessed by mitochondrial respiration, accounted for 47% of the 
variance in the performance of a 26 km time trial in a group of well-trained cyclists (V̇O2max = 
70.5 ± 5.6 ml.min-1.kg-1).   
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2.2 MECHANISMS OF THE ADAPTIVE RESPONSE TO ENDURANCE TRAINING 
Skeletal muscle demonstrates remarkable plasticity in response to exercise. The molecular 
mechanisms that induce the adaptive response of angiogenesis and mitochondrial biogenesis 
involve a gradual modification of protein content and enzyme activity as a result of the 
activation of specific signalling pathways (Egan & Zierath, 2013). Following an acute bout of 
exercise in response to primary physiological and metabolic signals (such as mechanical stretch, 
calcium release, changes in AMP:ATP ratios, production of reactive oxygen species (ROS) etc; 
Coffey and Hawley, 2007) there is a transient increase in gene transcription of selected genes 
(Gustafsson et al. 1999; Perry et al. 2010; Pilegaard et al. 2000; 2003), alterations to protein 
stability and subcellular localisation of transcription factors (Ameln et al. 2005; Hoier et al. 
2013b; Little et al. 2010a). With continued training these repeated transient changes lead to the 
changes in protein content and phenotypic remodelling demonstrated with training (Egan et al. 
2013; Perry et al. 2010). An overview of the key signalling pathways for angiogenesis and 
mitochondrial biogenesis is displayed in Figure 2.1. 
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Figure 2.1. Schematic of the key components of the known signalling pathways likely eliciting 
exercise-induced angiogenesis and mitochondrial biogenesis (Adapted from Egan & Zierath, 
2013). 
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Angiogenesis 
Angiogenesis is the process of growth of new capillaries from an existing capillary bed 
(Egginton, 2011). Whilst in animals angiogenesis has been reported to occur in as little as four 
days with continuous low frequency electrical stimulation (Hudlicka 1998), with exercise 
training in humans the process appears to take longer, with significant changes in capillarity 
being reported only after 4-5 weeks of training (Andersen & Henriksson, 1977; Jensen, et al. 
2004a). This process is tightly regulated by a combination of pro- (e.g. Vascular endothelial 
growth factor (VEGF), endothelial nitric oxide synthase (eNOS), matrix metalloproteinases 
(MMP), angiopoietin-2) and anti-angiogenic factors (e.g. angiopoietin-1, tissue inhibitors of 
metalloproteinases, angiostatin), which appear to both be required for well controlled 
angiogenesis (Egginton, 2009; Hoier et al. 2012; Olfert & Birot, 2011).  
Exercise-induced angiogenesis occurs through two processes: sprouting angiogenesis and 
intussusception. Sprouting angiogenesis refers to the process in which activated endothelial 
cells branch out from an existing capillary (Prior et al. 2004). Here, following the initial 
proteolytic breakage of the basement membrane, typically quiescent endothelial cells extend 
laterally from a capillary through the extracellular matrix to form abluminal sprouts (Egginton, 
2009; Hoier & Hellsten, 2014). These sprouts then elongate and develop lumen, before re-
entering the capillary bed by joining with existing vessels or other sprouts (Egginton, 2009; 
Prior et al. 2004). This newly formed capillary is initially leaky but becomes functional when 
it is invested by pericytes and the basement membrane is reconstructed (Hoier & Hellsten, 
2014). Intussusception, also referred to as longitudinal splitting, is a luminal process where 
opposing endothelial cells extend into the lumen of the capillary and make contact dividing the 
vessel in two (Hoier & Hellsten, 2014, Prior et al. 2004). The inter-endothelial pillar-like 
structure is stabilised through the depositing of collagen by pericytes and/or myofibroblasts, 
forming a new capillary in the same direction as the parent vessel (Hoier & Hellsten, 2014). 
This process appears to be more efficient than sprouting angiogenesis, requiring less 
endothelial cell proliferation and the capillary is also not functionally compromised during the 
process (Egginton, 2009; Hoier & Hellsten, 2014).     
VEGF is well recognised as the most central pro-angiogenic factor in skeletal muscle (Neufeld, 
et al. 1999; Olfert et al. 2010; 2016; Wagner et al. 2006). VEGF exerts its effects through 
endothelial cell specific receptor tyrosine kinases, vascular endothelial growth factor receptor 
-1 (VEGFR-1) and VEGFR-2, of which VEGFR-2 appears to be the most important (Neufeld 
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et al. 1999). The binding of VEGF to its receptors is known to stimulate the proliferation and 
migration of endothelial cells, promote endothelial cell survival and differentiation and induce 
capillary permeability (Egginton, 2009). Studies on rodents have elucidated the importance of 
the role of VEGF for exercise-induced angiogenesis. Early evidence observed VEGFR 
blockade partially inhibited the training induced increase in capillarisation in exercising rats 
(Lloyd et al. 2005). More recent studies have demonstrated that muscle specific VEGF 
knockout in mice markedly reduces basal skeletal muscle capillary supply (Olfert et al. 2009) 
and skeletal myocyte-specific VEGF gene-deletion abolishes exercise induced angiogenesis 
(Delavar et al. 2014; Olfert et al. 2010), providing evidence that VEGF is essential for exercise 
induced-angiogenesis.  
Increased expression of VEGF messenger RNA (mRNA) has been reported following an acute 
bout of a range of exercise modalities including; single (Gustaffson et al. 1999; Richardson et 
al. 1999) and two legged knee extensor exercise (Hiscock et al. 2003; Jensen et al. 2004b), 
submaximal cycling exercise (Gavin et al. 2004; Hoier et al. 2012; Hoier et al. 2013b; Rullman 
et al. 2007; Ryan et al. 2006) and both high intensity interval training (HIIT) (Hoier et al. 
2013a) and sprint interval training (SIT) (Taylor et al. 2016a; 2016b). The increased expression 
of VEGF mRNA has been demonstrated between zero and six hours after the completion of 
exercise, with levels returning to baseline within 20 – 24 hours (Hiscock et al. 2003; Jensen et 
al. 2004b), and is attenuated following a period of training (Hoier et al. 2012; Jensen et al. 
2004b; Richardson et al. 2000). In comparison to mRNA expression the muscle VEGF protein 
response to an acute bout of exercise and period of training has not been well elucidated. Varied 
results have been observed following an acute bout of submaximal continuous cycling with 
reports showing a decrease (Gavin et al. 2004) or no change in protein levels immediately 
(Rullman et al. 2007) and up to two hours post exercise (Hoier et al. 2013b), whereas, other 
studies have demonstrated an increase in protein levels 2-4 hours post exercise (Rullman et al. 
2007; Ryan et al. 2006). It could therefore be speculated that an increase in content of VEGF 
protein typically takes longer. However, in humans no increase in basal VEGF protein content 
have been reported following 4-8 weeks of either continuous or HIIT (Gliemann et al. 2015; 
Hoier et al. 2012; Hoier et al. 2013a). Nevertheless, Gustafsson et al. (2002) did identify an 
increase in VEGF protein following short term (10 days) one legged knee extensor exercise. 
Therefore, VEGF protein levels may be upregulated in the early phase of a training period 
before returning to baseline as training continues, as has been reported in rodents (Olenich et 
al. 2013).  
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In addition to the transcriptional response, during and immediately after exercise there is also 
an increase of VEGF protein content in interstitial fluid (Hellesten et al. 2008; Hoffner et al. 
2003; Hoier et al. 2010; 2012; 2013b). For muscle derived VEGF to stimulate angiogenesis, 
secretion into the interstitial fluid is required (Olfert et al. 2016). In human skeletal muscle 
there is localisation of VEGF in small vesicles located in subsarcolemmal regions and between 
the contractile elements (Hoier et al. 2013b). Following an exercise bout, there is an increase 
in these VEGF-containing vesicles close the sarcolemma. This suggests that muscle contraction 
stimulates these vesicles to redistribute to the sarcolemma and to secrete VEGF into the 
extracellular fluid (Hoier et al. 2013b). Muscle interstitial fluid obtained during exercise 
induces a several-fold greater rate of endothelial cell proliferation in vitro than that obtained 
during rest (Hoffner et al. 2003; Hoier et al. 2010; Hoier et al. 2013a). VEGF appears to 
contribute to the proliferative effect, since the extent of this effect is paralleled by the content 
of VEGF protein (Hoffner et al. 2003; Hoier et al. 2013a). With the increase in VEGF 
transcription occurring only after exercise, it appears that VEGF synthesis is not required for 
secretion and therefore, the transcriptional response following an exercise bout may play a 
primary role in replenishing lost stores (Hoier & Hellesten, 2014) 
Physiological signals for angiogenesis 
Several primary signals are considered to stimulate exercise induced angiogenesis, these 
include mechanical factors: shear stress and mechanical stretch of the tissue and reduced 
oxygen tension/increased metabolic activity (i.e. hypoxia) (Egginton, 2009). In an exercise 
model it is, however, hard to discriminate between these signals given that all are increased 
during exercise (Hoier & Hellsten, 2014).  
Shear stress 
Shear stress is the tangential frictional force exerted on the luminal side of endothelial cells as 
blood flows along their surface (Prior et al. 2004). Therefore, increased velocity of blood flow, 
as occurs during exercise, increases shear stress (Hudlicka & Brown, 2009). To study the 
effects of shear stress upon angiogenesis in vivo investigations have administered vasodilators, 
such as the α1-adrenergic receptor blocker prazosin, or have undertaken chronic electrical 
stimulation in rodent models, which increase shear stress approximately three- and two-fold 
respectively (Hudlicka et al. 2006; Ziada et al. 1989). Utilising these models shear stress has 
been observed to induce increases in the expression of angiogenic factors, including VEGF, 
(Hudlicka et al. 2006; Milkiewicz et al. 2001; 2005; Rivilis et al. 2002) as well increase skeletal 
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muscle capillary supply (Rivilis et al. 2002; Williams et al. 2006; Ziada et al. 1989; Zhou et 
al. 1998).  
Both nitric oxide (NO) and eNOS expression are increased in response to shear stress and are 
considered as important mediators of shear-induced angiogenesis (Baum et al. 2004; Egginton 
et al. 2016; Hudlicka & Brown, 2009). NO is thought to play an important role in mediating 
VEGF (Egginton, 2009). Indeed, it has been demonstrated that the administration of the nitric 
oxide synthase (NOS) inhibitor L-MNNA in rats, which blocked the activity of eNOS, 
supressed the increased expression of VEGF and VEGFR-2 and abolished early endothelial 
cell proliferation and the increased capillary to fibre ratio observed in chronic electrically 
stimulated muscle (Milkiewicz et al. 2005). Furthermore, the increase in capillary supply 
evident in wild-type mice treated with prazosin for 14 days was abolished in eNOS knockout 
mice (Baum et al. 2004).  
Studies in humans on the impact of shear stress for angiogenesis are limited. However, an 
increase eNOS protein has been demonstrated following 4 weeks of continuous aerobic training 
(Hoier et al. 2012) and after six weeks of SIT (Cocks et al. 2013). Moreover, studies have 
utilised a passive movement model of the lower leg, which increases blood flow to the muscle 
without a significant impact upon muscle activity and metabolism. An acute bout of passive 
exercise has been demonstrated to promote an angiogenic response, inducing an increase in 
interstitial VEGF protein concentration and a greater proliferative effect of interstitial fluid 
(Hellsten et al. 2008; Hoier et al. 2010) and moreover, 4 weeks of passive training elicited an 
increase in capillary contacts and proliferating endothelial cells (Hoier et al. 2010).  
Mechanical Stretch 
During muscle contraction the sarcomere length of skeletal muscle fibres is altered, and tensile 
forces act upon the tissue. The role of this mechanical stretch in angiogenesis has been 
confirmed by rodent and cells models. Stretch of endothelial cells in cell cultures elicited an 
upregulation of both VEGF mRNA and protein content and also increased endothelial cell 
migration and tube formation (Zheng et al. 2001). In accordance, rat muscles which were 
stretch-stimulated for 2 weeks also demonstrated increased VEGF protein content, endothelial 
cell proliferation and capillary to fibre ratios (Rivilis et al. 2002). Angiogenesis induced by 
mechanical stretch appears to occur via sprouting angiogenesis (Pior et al. 2004). Structural 
analysis revealed that the progressive increase in capillary to fibre ratio in stretch induced rat 
muscle was accompanied by abluminal sprouts and basement membrane breakage (Egginton 
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et al. 2001). Furthermore, models of mechanical stretch have also demonstrated elevated 
activity of MMP2 and MT1-MMP (Rivilis et al. 2002; Prior et al. 2004). Matrix MMPs act to 
modify the extracellular matrix and degradation of the basement membrane and are therefore 
important regulators of sprouting angiogenesis (Prior et al. 2004; Egginton, 2009; Haas et al. 
2000; Hoier & Hellsten, 2014). Indeed, the inhibition of MMPs during a muscle stimulation 
model was observed to abolish endothelial cell migration (Haas et al. 2000).  Given the 
difficulty in isolating muscle stretch in humans, with even passive movement models also 
increasing shear stress, limited evidence exists for the role of mechanical stretch for exercise 
induced angiogenesis in humans, however, an acute bout of exercise has been demonstrated to 
increase mRNA and protein levels of MMP-9 (Hoier et al. 2012; Rullman et al. 2007). 
Reduced oxygen tension/increased metabolic activity 
The regulation of angiogenesis by reduced oxygen tension, arising from either decreased 
oxygen supply or high levels of oxygen utilisation, is important to match the cardio-pulmonary-
vascular oxygen supply to metabolic demand in local tissue (Hirota & Semenza, 2006). 
Hypoxia is considered to be one of the more potent angiogenic stimuli which appears to act 
primarily through the upregulation of VEGF (Egginton, 2009). Indeed, endothelial cell 
migration and increased VEGF mRNA are induced under exposure to hypoxic conditions, a 
response which is reversed upon return to normoxic conditions (Shweiki et al. 1992; Toffoli et 
al. 2009). The angiogenic response to reduced oxygen tension is likely mediated by the increase 
in hypoxia inducible factor-1 (HIF-1), in particular its subunit HIF-1α (Ameln et al. 2005; 
Toffoli et al. 2009). It has been demonstrated that when HIF-1α was inhibited, the increase in 
endothelial cell migration recorded in hypoxia was completely prevented (Toffoli et al. 2009). 
HIF-1α is highly sensitive to oxygen levels and increases exponentially as cellular oxygen 
concentration is reduced (Jiang et al. 1996). Upon activation in hypoxic conditions HIF-1α 
translocates to the nucleus where it then activates the expression of multiple gene targets by 
binding to DNA within the hypoxia response element (Ameln et al. 2005; Ke & Costa, 2006; 
Toffoli et al. 2009), with VEGF shown to be one of these target genes (Forsythe et al. 1996).  
Ameln et al. (2005) first reported an increase in multiple factors of the HIF-1 angiogenic 
pathway in response to an acute exercise bout undertaken under normal oxygen delivery 
conditions in humans. They demonstrated that HIF-1α protein content increased immediately 
after 45 minutes of one-legged knee extension by 83%, which remained elevated for 6 hours, 
and also observed increased myonuclear staining of HIF-1α following exercise. Moreover, they 
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reported an increase in VEGF mRNA expression. However, HIF-1α mRNA levels were not 
increased at any time point following exercise. This is consistent with other investigations, 
demonstrating no increase in HIF-1α mRNA following 45-minutes of one-legged knee 
extension (Gustafsson et al. 1999) or SIT (Taylor et al. 2016a). In contrast Lundby et al. (2006) 
did report an increase in HIF-1α mRNA expression but this occurred only after 6 hours 
following a 3 hour two-legged knee extension exercise protocol. Therefore, it appears that 
under conditions of normal oxygen supply the early HIF-1α upregulation in response to 
exercise is not due to increased transcription.    
Chronic hypoxia does not appear to promote angiogenesis in humans, with increases in 
capillary density only reported alongside decreased muscle fibre CSA (Hoppeler et al. 1990; 
Lundby et al. 2004). However, undertaking training sessions in hypoxic conditions can induce 
increases in capillarisation. In the study of Desplanches et al. (1993) participants undertook 3 
weeks of continuous cycling exercise at the same relative intensity of ~75% V̇O2max under 
either normoxic or hypoxic (FIO2 = 10-12.7%) conditions. They reported a significant increase 
in capillary to fibre ratio following training in hypoxic conditions only. Furthermore, Geiser et 
al. (2001) also observed an increase in capillary supply following 6 weeks of continuous 
cycling training for 30 minutes at ~80% V̇O2max undertaken in hypoxia, whereas there was no 
change after the same training regime performed in normoxia.  
Role of PGC-1α 
More recently, in addition to its role as a master regulator of mitochondrial biogenesis (see 
below), peroxisome proliferator-activated receptor-γ coactivator 1-α (PGC-1α) has been 
established as an important pro-angiogenic factor (Arany et al. 2008; Chinsomboon et al. 2009; 
Geng et al. 2010; Leick et al. 2009; Tadaishi et al. 2011). Overexpression of PGC-1α has been 
observed to elicit increases in VEGF mRNA and VEGF protein secretion in cell cultures 
(Arany et al. 2008) and increase the basal capillary network in transgenic mice (Arany et al. 
2008; Tadasihi et al. 2011). Further evidence for the importance of PGC-1α has been 
established from PGC-1α knockout mice. Leick et al. (2009) observed that the increase in 
VEGF mRNA and protein content following an acute exercise bout and five weeks of exercise 
training, respectively, was eliminated in PGC-1α knockout mice. Furthermore, the exercise 
induced increase in capillary supply with wheel running is abolished in knockout mice 
(Chinsomboon et al. 2009; Geng et al. 2010). Interestingly it was also observed that there was 
no difference in the capillary supply when mice did not undertake any wheel running, 
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demonstrating that PGC-1α is specifically involved in the angiogenic response to exercise 
(Chinsomboon et al. 2009). Fentz et al. (2015) also later investigated the effect of upstream 5' 
AMP-activated protein kinase (AMPK) knockout on VEGF signalling. They observed that the 
increased expression of VEGF mRNA in wild-type mice following an acute bout of exercise 
was abolished in AMPK knockout mice. Therefore, also implicating the importance of the 
AMPK signalling pathway in exercise induced angiogenesis. 
Exercise modality and angiogenesis 
A range of exercise training modalities are known to induce angiogenesis, including continuous 
moderate intensity exercise (Andersen & Henriksson, 1977; Cocks et al. 2013; Hoier et al. 
2012; Hoier et al. 2013a; Klausen et al. 1981), HITT (Frandsen et al. 2000; Jensen et al. 2004a) 
and SIT (Bonafiglia et al. 2017; Cocks et al. 2013). Current data however, supports the 
importance of training volume over training intensity to promote angiogenesis in trained 
individuals (Gliemann et al. 2016). Hoier et al. (2013a) reported that four weeks of continuous 
moderate intensity (65% of V̇O2max) cycling exercise promoted an increase in capillary supply 
in previously untrained healthy participants. Following this initial preconditioning period, the 
participants then undertook four weeks of HIIT (~117% V̇O2max), which did not induce any 
additional increases in skeletal muscle capillarity. Furthermore, they demonstrated that an acute 
session of the HIIT elicited a lower increase in muscle interstitial VEGF protein concentration, 
and the interstitial fluid produced a lower proliferative effect than acute moderate intensity 
exercise (2.5- vs 6-fold increase compared to rest). Moreover, Gliemann et al. (2015) 
demonstrated that when trained runners replaced two of three weekly endurance training 
sessions with 10-20-30 HIIT training (which briefly involves one-minute intervals of 30, 20 
and 10 s at an intensity of ~30, 60 and 90-100% of maximal running speed), thereby reducing 
their total training volume for a period of 8 weeks, muscle VEGF protein concentration was 
decreased by 22% and there was no increase in capillarisation.  
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Mitochondrial biogenesis 
It is well-known that regular endurance training, at a sufficient intensity and frequency, can 
induce an increase in mitochondrial content in less than a week (Egan et al. 2013; Perry et al. 
2010) and increases can range from ~50-100% within 6 weeks (Hood, 2001). The process by 
which there is an increase in the mitochondrial reticulum is referred to as mitochondrial 
biogenesis (Hood, 2009). The increase in mitochondria does not happen de novo, rather new 
proteins are recruited into the organelle, which subsequently divides by fission (Ryan & 
Hoogenraad, 2007). Although the majority of DNA is located within the nucleus, mitochondria 
also possess multiple copies of their own circular DNA, typically referred to as mitochondrial 
DNA (mtDNA). mtDNA codes for 13 proteins, 22 transfer RNA and 2 ribosomal RNA which 
are essential for protein synthesis within the mitochondria. Therefore, mitochondrial biogenesis 
requires the coordination of both nuclear and mitochondrial genomes (Hood et al. 2006; Hood, 
2001). In addition to an increase in mitochondrial content, mitochondrial biogenesis can also 
be associated with a change in mitochondrial function (Bishop et al. 2014) i.e. the ability of 
the mitochondria to maintain cellular energetic homeostasis (Johnson et al. 2013), which is 
also an important determinant for endurance performance (Jacobs et al. 2011).  
At the molecular level the process of exercise-induced mitochondrial biogenesis is initiated by 
perturbations to homeostasis at the onset of activity, including; increased AMP:ATP ratio, 
mechanical stretch, calcium release and production of ROS (Coffey & Hawley, 2007; Hood, 
2009). These putative signals subsequently activate kinases (such as AMPK, p38 mitogen-
activated protein kinases (p38 MAPK) and Ca2+/Calmodulin-dependent kinases II (CaMKII) 
which in turn phosphorylate downstream targets such as transcription factors or transcriptional 
coactivators which are involved in the regulation of DNA transcription (Hood, 2009). These 
events trigger a transient increase in mRNA of these sensor enzymes and downstream proteins 
(Hood et al. 2006; Ljubicic et al. 2010). Translation then occurs, and the subsequent precursor 
proteins formed are imported into the mitochondria (Hood, 2001; Ljubicic et al. 2010). These 
proteins undergo post translational modifications and become functionally active and act as 
metabolic enzymes (such as those of the Krebs cycle), form part of electron transport chain 
complexes or serve as transcription factors for mtDNA-encoded proteins (Hood, 2009). 
mtDNA transcription and translation subsequently increases, and the resulting mitochondrial 
encoded proteins combine with nuclear derived proteins to form multi-subunit complexes of 
the electron transport chain (Hood, 2009). 
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PGC-1α is considered as the ‘master regulator’ of mitochondrial biogenesis (Wu et al. 1999; 
Puigserver & Spiegelman, 2003). PGC-1α is a transcriptional coactivator, it therefore lacks the 
ability to bind to DNA, but acts by binding to and co-activating DNA binding transcription 
factors (Ljubicic et al. 2010). Of importance to mitochondrial biogenesis is the interaction of 
PGC-1α with the nuclear respiratory factors NRF-1 and NRF-2 (Hood, 2009), which mediate 
the expression of multiple nuclear encoded proteins, including cytochrome c components of 
the electron transport chain complexes and mitochondrial import machinery (Hood, 2009; 
Ljubicic et al. 2010). The nuclear respiratory factors, in particular NRF-1, also activate 
transcription factors of mtDNA, such as mitochondrial transcription factor (Tfam) (Virbasius 
& Scarpulla, 1994; Wu et al. 1999). Tfam is a nuclear encoded protein which, upon import into 
the mitochondria, binds to the D-loop region of mtDNA and upregulates mtDNA transcription 
and replication (Hood et al. 2006; Ljubicic et al. 2010). Through this NRF-1: Tfam axis PGC-
1α thus also activates mtDNA transcription. In addition, PGC-1α has also been demonstrated 
to translocate into mitochondria (Safdar et al. 2011; Smith et al. 2013) and form a complex 
with Tfam in the mtDNA D-loop region (Safdar et al. 2011) suggesting that PGC-1α may also 
play a more direct role in upregulating the mitochondrial genome. Therefore, through these 
mechanisms PGC-1α is able to coordinate both nuclear and mitochondrial gene expression.   
The potency of PGC-1α to induce mitochondrial biogenesis has been demonstrated by PGC-
1α overexpression in cells and transgenic mice. For example, overexpression of PGC-1α in 
myotubes from C2C12 muscle cells increased the mRNA content of electron transport proteins 
cytochrome c oxidase subunits II (COXII) and IV (COXIV) and cytochrome c and transcription 
factors NRF-1 and Tfam and increased mitochondrial density by 57% (Wu et al. 1999). 
Transgenic mice expressing upregulated skeletal muscle PGC-1α, also have enhanced exercise 
capacity, mtDNA and citrate synthase (CS) activity than wild-type mice (Lin et al. 2002; Calvo 
et al. 2008). Furthermore, PGC-1α knockout mice possess reduced mitochondrial enzyme 
content, mitochondrial densities, exercise capacity and V̇O2max than their wild-type 
counterparts (Adhihetty et al. 2009; Leick et al. 2008; Leone et al. 2005). Although the 
evidence above clearly highlights the importance of PGC-1α for regulating and optimising 
mitochondrial adaptations, there appears to be some redundancy in the pathways and PGC-1α 
is not essential for exercise induced mitochondrial biogenesis. Indeed, PGC-1α knockout mice 
still demonstrated training induced increases in mRNA and protein content of mitochondrial 
enzymes (Leick et al. 2008) and mitochondrial content (Adhihetty et al. 2009; Rowe et al. 
2012).  
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PGC-1α mRNA expression is upregulated in response to multiple training modalities; studies 
have reported increased expression following two-legged knee extension exercise (Pilegaard 
et al. 2003), continuous exercise (Bartlett et al. 2012; Coffey et al. 2006; Egan et al. 2010; 
Mathai et al. 2008; Pilegaard et al. 2005), HIIT (Bartlett et al. 2012; Nordsborg et al. 2010; 
Perry et al. 2010) and SIT (Gibala et al. 2009; Little et al. 2011; Niklas et al. 2010; Taylor et 
al. 2016a). Taylor et al. (2016b) even observed that just 2 minutes of ‘all-out’ continuous 
cycling was sufficient to elicit an increase in PGC-1α mRNA after 3 hours by 5.5. fold. PGC-
1α mRNA levels appear to peak between 2 and 5 hours post exercise and return to baseline 
within 24 hours (Little et al. 2011; Mathai et al. 2008; Nordsborg et al. 2010 Pilegaard et al. 
2003; 2005). Current evidence suggests PGC-1α mRNA may be increased in an intensity 
dependent manner (Egan et al. 2010; Popov et al. 2014), at least at submaximal intensities; 
Edgett et al. (2013) compared work matched HIIT at 73%, 100% and 133% of peak work rate 
and observed the greatest increase in PGC-1α mRNA at 100%, leading them to conclude that 
supramaximal exercise may not elicit any additional increases. Although typically unchanged 
within in the first hours following an acute exercise bout (Bartlett et al. 2012; Gibala et al. 
2009; Little et al. 2010a; Little et al. 2011; Perry et al. 2010), increases in protein content of 
~20-60% have consistently been reported 24 hours following an acute bout of exercise (Egan 
et al. 2013; Little et al. 2011; Mathai et al. 2008; Perry et al. 2010). PGC-1α protein has also 
been demonstrated to translocate to the cell nucleus and to subsarcolemmal mitochondria 
following an acute exercise bout (Little et al. 2010a; Little et al. 2011; Smith et al. 2013). It 
has been suggested that it is this rapid activation and translocation of PGC-1α, as opposed to 
increased protein content, that enables the initial rapid stimulation of mitochondrial biogenesis 
(Little et al. 2010a; Wright et al. 2007b). This is supported by the observation that several 
mitochondrial constituents were increased prior to any changes in PGC-1α protein content 
(Wright et al. 2007b).  
In addition to the acute response, PGC-1α protein content has been reported to increase by ~16 
to 90% following 12 days to 6 weeks of training, ranging from continuous exercise to SIT 
(Burgomaster et al. 2008; Egan et al. 2013; Granata et al. 2016; Gurd et al. 2010; Perry et al. 
2010; Russell et al. 2003; Stepto et al. 2012). Some studies have not observed changes in PGC-
1α protein content following an endurance training period (Edgett et al. 2016; Granata et al. 
2016; Little et al. 2010b; Vincent et al. 2015). This variation in response is likely attributable 
at least in part to the training methodologies selected. For example, Granata et al. (2016) 
investigated the effect of 3 different training modalities; including sub-lactate threshold 
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continuous cycling, HIIT and SIT. They observed an increase in PGC-1α protein content only 
following SIT, suggesting training intensity may be an important factor. However, 
Burgomaster et al. (2008) reported a similar increase in PGC-1α protein following both SIT 
and continuous cycling exercise at 65% V̇O2max. This continuous exercise was undertaken at a 
similar exercise intensity as that in the study of Granata et al. (2016) but was continued for 
longer (40-60 min vs 20-36 min), it could therefore be suggested that volume of training in 
both the continuous and HIIT groups (which were matched for total work done) in the study of 
Granata et al. (2016) were too low to induce an increase in PGC-1α protein content.  
Physiological signals of mitochondrial biogenesis 
As mentioned above multiple perturbations to homeostasis in response to muscular contraction 
have been evidenced to activate signalling cascades which initiate mitochondrial biogenesis. 
AMP:ATP Ratio and AMPK 
Any cellular stress which either sufficiently raises ATP consumption or reduces ATP re-
synthesis, e.g. muscle contraction at the onset of exercise, results in an increase in the 
AMP:ATP ratio (Coffey & Hawley, 2007). This is detected by a increase in AMPK, which is 
often referred to as an energy sensing enzyme (Hood, 2009). AMPK is activated in three ways: 
through allosteric activation, increasing the binding of upstream kinases and increased 
phosphorylation by inhibiting the dephosphorylation of the 172-threonine residue (Thr172), 
whilst high concentrations of ATP reduces this activation (Hardie et al. 2004a; 2004b). AMPK 
activation and phosphorylation are increased immediately following exercise in an intensity-
dependent manner (Egan et al. 2010; Wojtaszewski et al. 2000), returning within minutes to 
near resting values (Rasmussen et al. 1998). In addition to regulating many of the acute 
metabolic responses that occur in response to a bout of exercise, AMPK also plays a role in 
stimulating mitochondrial biogenesis by altering gene expression and transcriptional regulation 
largely through the activation of PGC-1α (Canto & Auwerx, 2010). AMPK enhances PGC-1α 
promotor activity (Irrcher et al. 2008) and activates PGC-1α through the direct phosphorylation 
of PGC-1α at threonine-177 and serine-538 (Jager et al. 2007). In support of the role of AMPK 
activation for mitochondrial biogenesis, studies have observed that the direct activation of 
AMPK in rodent models leads to an increase in cytochrome-c protein content, NRF-1 DNA 
binding and mitochondrial densities (Bergeron et al. 2001; Zong et al. 2002). These increases 
and an increase in PGC-1α mRNA expression were not evident when the same treatment was 
undertaken upon mice with dominant negative AMPK (Zong et al. 2002).  
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ROS and p38 MAPK 
During exercise ROS are produced from mitochondria, where a small fraction of oxygen 
undergoes a one-electron reduction (Ljubicic et al. 2010) and from non-mitochondrial sources, 
which include xanthine oxidases and NADPH oxidases (Merry & Ristow, 2016). Although 
significant focus has been placed around tissue damage resulting from ROS production, a 
growing body of literature has emerged supporting the role of ROS in activating signalling 
pathways involved in mitochondrial biogenesis (Camera et al. 2016; Hood, 2009). For example, 
chemically induced increases in ROS in myoblasts lead to increased PGC-1α promoter activity 
and mRNA, a response which is blocked with the addition of antioxidants (Irrcher et al. 2009). 
Although a direct link between ROS production during exercise and mitochondrial biogenic 
response has yet to be made in human skeletal muscle (Petrick et al. 2018), it has been 
demonstrated that antioxidant supplementation can interfere with key mitochondrial signalling 
intermediates including p38 MAPK and AMPK in rodents (Merry & Rostow, 2016; Wadley et 
al. 2013) and can attenuate the increase in PGC-1α mRNA and protein and COXIV protein 
following a period of training in humans (Paulsen et al. 2014; Ristow et al 2009). p38 MAPK 
appears to play a role in linking cellular ROS levels and skeletal muscle mitochondrial 
biogenesis, with phosphorylation of p38 MAPK increased in response to ROS (Egan & Zierath, 
2013; Powers et al. 2010). p38 MAPK is an important signalling protein in PGC-1α regulated 
mitochondrial biogenesis. In cell cultures p38 MAPK induces PGC-1α transcription (Akimoto 
et al. 2005) through direct phosphorylation (Puigserver et al. 2001). Increases in 
phosphorylation of p38 MAPK alongside increased PGC-1α mRNA and PGC-1α nuclear 
abundance have also been reported following an acute exercise bout in humans (Bartlett et al. 
2012; Little et al. 2010a; Little et al. 2011).  In addition to p38 MAPK, AMPK has further been 
implicated in regulating the effect of ROS given that AMPK activation and phosphorylation 
were increased in cell cultures following treatment with ROS. This increase in AMPK may be 
elicited due to the ROS induced decrease in ATP levels (Irrcher et al. 2009).   
Calcium Release and CAMKII 
Neural activation of skeletal muscle elicits an action potential which leads to the transient 
release of Ca2+ from the sarcoplasmic reticulum (Coffey & Hawley, 2007). These calcium 
oscillations during muscle contraction appear to act as a potent primary signal which can be 
translated into a transcriptional response leading to mitochondrial biogenesis. This is evidenced 
by studies utilising cultured myocytes, which have demonstrated that elevated Ca2+ leads to 
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increased expression of mRNA and protein content of mitochondrial enzymes and key 
mitochondrial biogenesis transcription factors such as PGC-1α, Tfam, NRF-1 and NRF-2 (Chin,  
2005; Ojuka et al. 2002). At the onset of elevations in intracellular Ca2+ calmodulin (CaM), an 
intermediate binding protein, binds with Ca2+ (Chin, 2005), this complex then acts on 
downstream targets which includes the Ca2+/CaM-dependent phosphatase calcineurin and a 
family of CaM dependent kinases (CaMK’s) (Chin, 2010), of which CaMKII is the dominant 
isoform in skeletal muscle (Rose et al. 2006). On elevation of Ca2+, the Ca2+/calmodulin 
complex binds with CaMKII which initiates intramolecular autophosphorylation, this results 
in the maintenance of the increase in the kinase activity when Ca2+ returns to basal levels (Chin, 
2005). CaMKII appears to elicit mitochondrial biogenesis in part via the upregulation of PGC-
1α through the phosphorylation of p38 MAPK; the inhibition of CaMKII and p38 MAPK 
blocked the increased expression of key transcription factors (PGC-1α, Tfam, NRF-1 and NRF-
2) and PGC-1α and COXI respectively, induced by raising Ca2+ (Wright et al. 2007a). 
Furthermore, CaMKII can also act to upregulate mitochondrial biogenesis by dissociating 
myocyte enhancer factor-2 (MEF2) from histone deacetylase-4 (HDAC4), allowing MEF2 to 
undertake its transcriptional activities on downstream targets, which includes PGC-1α (Chin, 
2005; Liu et al. 2005; Egan & Zierath, 2013).  
Exercise modality and mitochondrial biogenesis 
Multiple training modalities have been shown to induce increases in a range of markers of 
mitochondrial content (Hoppeler et al. 1985; Gibala et al. 2006; Perry et al. 2010; Shepherd et 
al. 2013). Granata et al. (2018) compiled data from available cycling training studies that 
assessed CS activity (a valid marker of mitochondrial content) to investigate the effect of 
intensity and training volume on the magnitude of adaptations. They reported that there was no 
relationship between relative exercise training intensity and CS activity. In agreement with this, 
studies directly comparing SIT to continuous cycle training at ~65% V̇O2max reported similar 
increases in the maximal activity of COX and protein content of COX and COX subunits II 
and IV (Gibala et al. 2006; Shepherd et al. 2013). Granata et al. (2018) did however observe a 
correlation of r = 0.59 between changes in CS activity and training volumes and when studies 
employing SIT (which demonstrated large variability in changes in CS) were removed this 
correlation was increased to r = 0.71. This led the authors to conclude that training volume was 
an important determinant of training induced increases in mitochondrial content when relative 
exercise intensities are ≤ 100% of maximal aerobic power (MAP). Although fewer studies were 
available, they did report relative training intensity to be an important determinant of training 
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induced increases in mitochondrial function, with the highest magnitude of increases occurring 
when at least one third of training was undertaken at an intensity higher than 90% MAP. 
Interestingly, however, they did report a reduced increase in mitochondrial function when SIT 
was undertaken alone, leading to the suggestion that this could be attributed to the significantly 
reduced training volume.  
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2.3 REDUCED PLASTICITY OF THE TRAINED MUSCLE 
So far, this literature review has outlined skeletal muscle angiogenesis and mitochondrial 
biogenesis as peripheral adaptations that are key to optimising endurance performance, and has 
overviewed the key signalling and molecular pathways eliciting these adaptations. Despite the 
adaptability of skeletal muscle described above, it is generally accepted that eliciting further 
adaptations in well-trained individuals, who through continued years of high volumes of 
training possess well adapted physiology for competition, becomes challenging.  
Early research established the reduced plasticity of trained individuals. Hoppler et al. (1985) 
demonstrated that the magnitude of increases in maximal power individuals could maintain for 
30 minutes gradually decreased as training progressed during a six-week period. Moreover, 
Saltin et al. (1977) combined data from longitudinal and cross-sectional studies to demonstrate 
that the large increases elicited during the first few weeks of endurance training in both V̇O2max, 
and skeletal muscle adaptations, including capillarity and oxidative enzymes, are progressively 
attenuated as training continues for several months. More recently HIIT, which is a potent 
method to enhance both oxidative and glycolytic enzyme activity in untrained and 
recreationally active individuals (Laursen & Jenkins, 2002), was demonstrated not to increase 
the activity of CS or phosphofructokinase in trained cyclists who had a V̇O2max greater than 60 
ml.min-1.kg-1 (Weston et al. 1997). Furthermore, a body of literature exists demonstrating that 
an increase in traditional endurance training volume alone appears to be insufficient to further 
enhance aerobic performance or associated physiological determinants in endurance trained 
individuals (Costill et al. 1988; Daniels et al. 1978; Londeree, 1997).  
This blunting of the adaptive scope in trained individuals is also reflected at the molecular 
level. The expression of the mitochondrial transcript in response to an acute exercise bout was 
observed to be blunted following six weeks of endurance training in untrained individuals 
(Schmutz et al. 2006). Moreover, just 10 days of endurance training in previously sedentary 
individuals was enough to abolish a ~10-fold increase in AMPK activity during 120 min of 
cycling at ~66% V̇O2max (McConell et al. 2005). Perry et al. (2010) later investigated the time 
course of the mitochondrial signalling response over 14 days of a HIIT protocol in 
recreationally active individuals. They observed a continual reduction in the magnitude of 
PGC-1α mRNA following each subsequent training session, despite an increase in the absolute 
training intensity (Fig. 2.2). Whilst PGC-1α protein content was increased relative to the pre-
training value throughout the training period, this peaked following 10 days and although not 
24 
 
significantly different slightly decreased after 15 days of training. A blunted molecular 
response has also been observed in angiogenic factors, with the transient expression of VEGF 
mRNA following an acute exercise bout reduced after a period of 4-8 weeks of endurance 
training (Richardson et al. 2000; Hoier et al. 2012).  
 
 
Figure 2.2. Schematic of the blunted molecular response with continued training. Adapted 
from Perry et al. (2010), with data specific to PGC-1α mRNA and protein content and CS 
activity.  
 
In accordance with the blunted molecular response, structural constraints may impose 
limitations on the myocellular adaptive responses. This is supported by the inverse relationship 
observed between mitochondrial content and the expressional response of mitochondrial and 
angiogenic transcripts; specifically, inverse relationships have been observed between 
mitochondrial content and basal levels of phosphorylation of MAPKs including p38 MAPK 
(Flueck, 2010). As such individuals with the highest mitochondrial densities display 
diminished regulation of functionally implicated gene transcripts during recovery from an 
exercise stimulus (Flueck, 2010). This has also been demonstrated in a desensitisation of 
trained individuals to primary training signals; highly trained endurance athletes were observed 
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to display a smaller increase in shear stress-dependent blood flow in comparison with 
habitually active individuals in response to passive movement (Hellsten et al. 2015).  
Therefore, this body of literature highlights the need to identify effective novel training 
methods for trained athletes, who are well-accustomed to high volumes of training over a range 
of exercise intensities, that are able to augment the primary signals elicited in response to 
exercise outlined in the previous section, and overcome the blunted molecular response. 
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2.4 TRAINING WITH BLOOD FLOW RESTRICTION (BFR) 
BFR has emerged in recent literature as a popular intervention to manipulate the training 
stimulus and potentially enhance performance. This training strategy is typically achieved 
through the application of an inflatable cuff (Abe et al. 2006), tourniquet (Shinohara et al. 
1998) or elastic banding (Loenneke et al. 2010) proximal to the working muscle, restricting 
blood flow into and occluding blood flow out of the muscle (Takano et al. 2005).  
Commonly, the application of BFR has been applied during low load (< 50% of one repetition 
maximum [RM]) resistance exercise. In order to elicit strength gains and promote hypertrophy, 
it is generally recommended that resistance exercise with loads of at least 60% of 1-RM are 
required (ACSM, 2009; Kraemer & Ratamess, 2004). However, it has been consistently 
demonstrated that the addition of BFR to low load resistance exercise can; induce strength 
gains (Madarame et al. 2008; Moore et al. 2004; Patterson & Ferguson, 2010; Takarada et al. 
2000, 2002; Yamanaka et al. 2012) promote hypertrophy (Manimmanakorn et al. 2013; 
Takarada et al. 2000; 2002) and increase muscle endurance (Manimmanakorn et al. 2013; 
Takarada et al. 2002). The use of this training modality has typically been advocated for 
populations where high mechanical loads may not be feasible or contraindicated, including the 
frail and elderly (Abe et al. 2010b; Patterson & Ferguson, 2010) and rehabilitation patients 
(Leonneke et al. 2013), however, its efficacy has also been supported for athletes with a history 
of resistance training (Takarada et al. 2002).  
BFR in endurance training 
In addition to its use within resistance exercise, research has also started to explore the use of 
BFR to enhance the adaptations achieved through aerobic training. Early studies utilised 
pressure chambers during one-legged cycling exercise (Kaijser et al. 1990; Sundberg et al. 
1993). In these studies participants undertook four training sessions a week, for a period of four 
weeks at an intensity of ~50% V̇O2max for 45 minutes. One leg was trained under normal 
atmospheric conditions, and the other with a pressure set to 50 mmHg above atmospheric 
pressure, inducing a moderate BFR of ~20%. They reported a greater increase in exercise 
capacity, V̇O2max and CS activity in the leg trained under BFR in comparison to the leg trained 
with a normal blood supply (Kaijser et al. 1990; Sundberg et al. 1993).  
More recent studies have investigated the potential of BFR, achieved through the application 
of inflatable cuffs during endurance-type exercise. These studies have provided support that 
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BFR can enhance endurance adaptations to submaximal exercise training in recreationally 
active individuals. Indeed, investigations have demonstrated that the addition of BFR at a 
pressure of 160-210 mmHg during low intensity cycling or walk training (~40% V̇O2max) can 
induce increases in V̇O2max and exercise capacity, which were not observed after the same 
intensity of training performed alone (Abe et al. 2010a; Park et al. 2010). This was even 
observed when BFR exercise was maintained for only 15 minutes compared to 45 minutes in 
the exercise alone condition (Abe et al. 2010a). Paton et al (2017) reported similar findings 
during HIIT, whereby BFR was applied during repeated 30 s efforts at 80% of peak running 
velocity and induced small but potentially worthwhile greater improvements in V̇O2max and 
exercise capacity than exercise alone. Furthermore, de Oliveira et al (2016) demonstrated that 
the addition of BFR during low intensity interval cycle exercise (30% of peak power) induced 
similar improvements in the onset of blood lactate accumulation, V̇O2max and peak power as 
the same protocol performed at 95-110% of peak power under normal blood flow conditions. 
In contrast, other studies have found that BFR applied during both low intensity cycle training 
and HIIT induced no benefits to aerobic parameters (Keramidas et al. 2012; Kim et al. 2016). 
The lack of effect could, however, be attributable to the methodology employed whereby 
Keramidas et al. (2012) utilised a pressure of 90 mmHg above atmospheric pressure, resulting 
in a pressure <110 mmHg, which is well below the 160-210 mmHg utilised in the 
aforementioned studies. Furthermore, Kim et al. (2016) utilised heart rate reserve to set the 
intensity for their investigation, the control group exercised at 60-70% and the BFR at 30% of 
heart rate reserve. Due to the increased heart rate with the application of BFR, this resulted in 
the BFR group exercising at a lower relative intensity as demonstrated by a reduced RPE 
compared to the control group. Therefore, these studies may not have elicited a sufficient 
training/restriction stimulus to induce adaptations.  
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2.5 PHYSIOLOGICAL SIGNALS FROM BFR 
As summarised in Figure 2.3, BFR could be hypothesised to elicit both angiogenesis and 
mitochondrial biogenesis through the manipulation of multiple primary training signals and the 
activation of the downstream signalling pathways.  
 
Figure 2.3. Hypothesised effects of blood flow restriction (BFR) (demonstrated by red arrows) 
on the signalling pathways of angiogenesis and mitochondrial biogenesis 
 
Haemodynamic Response –shear stress 
The compression of blood vessels induced by the application of BFR, results in a distorted 
haemodynamic profile immediately distal to the area of compression with the induction of 
reciprocating shear stress (Chiu & Chien, 2011). At rest, the application of BFR by an inflatable 
cuff increases retrograde shear rate in the absence of changes to antegrade shear rate (Credeur 
et al. 2010; Jenkins et al. 2013; Thijssen et al. 2009), which increases in a dose-dependent 
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response to the level of pressure applied (Thijssen et al. 2009). Although this isolated increase 
in retrograde shear rate has been shown to impair endothelial function (Thijssen et al. 2009), 
the increase in retrograde shear rate evident during BFR combined with low load exercise is 
also accompanied by an increase in antegrade shear rate (Credeur et al. 2010). This oscillatory 
pattern of increased antegrade and retrograde flow has been suggested to elicit increased shear 
stress-mediated endothelial NO production (Green et al. 2005).  
Furthermore, upon cuff deflation following low intensity BFR exercise vessels are further 
exposed to reactive hyperaemia, with post-exercise blood flow shown to be higher than that of 
low intensity exercise undertaken alone (Paiva et al. 2016; Takarada et al. 2000). This response 
has been demonstrated from pressures as low as 100 mmHg and an increase in blood flow can 
be maintained up to one-hour post deflation (Gundermann et al. 2012; Takarada et al. 2000). 
Therefore, this suggests the induction of a sustained shear stimulus following BFR exercise.   
Muscle oxygenation 
The application of BFR reduces muscle oxygen saturation in a dose-response manner with the 
level of restriction pressure applied at rest (Karabulut et al. 2011). Accordingly, multiple 
studies have observed reduced muscle oxygenation during low load resistance exercise or low 
intensity cycling combined with BFR to levels equal to, or even lower than that achieved during 
higher load intensity exercise under normal blood flow conditions (Corvino et al. 2017; Downs 
et al. 2014; Ganesan et al. 2015; Tanimoto et al. 2005). For example, Downs et al. (2014) 
observed that leg press exercise performed to task failure at 20% and 80% of 1-RM reduced 
thigh muscle oxygen saturation by 35% and 20% respectively, when BFR was applied during 
the same exercise at 20% of 1-RM muscle oxygen saturation was reduced by approximately 
50%. This state of hypoxia is also sustained during the rest intervals if the restriction is 
maintained (Downs et al. 2014; Ganesan et al. 2015). 
Consequently, studies have assessed the effect of BFR upon the acute transcriptional response 
of HIF-1α mRNA. HIF-1α mRNA has been demonstrated to be upregulated following an acute 
bout of low load (20-40% 1 rep max) knee extensions when combined with BFR, with no 
change in HIF-1α mRNA when exercise was performed alone (Ferguson et al. 2018; Larkin et 
al. 2012) Similarly, Taylor et al. (2016a) reported an increase in HIF-1α mRNA 3 hours after 
a single session of SIT only when BFR was undertaken during the recovery intervals. 
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Metabolic stress 
BFR can also increase the metabolic stress imposed by an exercise bout. Indeed, increased 
lactate accumulation has been observed when BFR was added to low load resistance exercise 
(20-40% 1RM) in comparison to the same exercise undertaken alone (Fujita et al. 2007; Poton 
& Polito, 2015; Takano et al. 2005; Takarada et al. 2000). Further investigations have also 
demonstrated greater decreases in pH and phosphocreatine (PCr) and increase in Pi with the 
addition of BFR (Suga et al. 2009; 2012). These increased metabolic perturbations have further 
been demonstrated to be to the same magnitude as induced by higher load exercise (65-80% 
1RM) (Neto et al. 2017; Poton & Polito, 2015; Reeves et al. 2006; Suga et al. 2012). Under 
such conditions it could be hypothesised that there would be an increase in AMPK and its 
associated downstream signalling.     
ROS 
Both exposure to hypoxia (Clanton, 2007) and reperfusion (Granger and Kvietys, 2015) can 
increase ROS. On this basis it could therefore by hypothesised that BFR would provide a 
sufficient stimulus to increase ROS and enhance the associated downstream mitochondrial 
biogenic signalling. In support of this hypothesis Christiansen et al. (2018) observed that the 
addition of BFR during the work periods of a HIIT running protocol, where BFR was removed 
during the rest phases to allow multiple instances of reperfusion, elicited increases in HSP27 
protein, and catalase and HSP70 mRNA, markers of the occurrence of oxidative stress. The 
addition of BFR also led to the increased expression of mRNA of PGC-1α isoforms PGC-1α1 
and PGC-1α4 which was associated with the markers of oxidative stress.  
Current signalling evidence 
In support of the above hypothesised mechanisms several studies have reported enhanced acute 
angiogenic and mitochondrial signalling responses when BFR was undertaken during a range 
of exercise modalities. Within the study of Larkin et al. (2012) participants undertook 2 
sessions of unilateral knee extensions at 40% of 1-RM with and without BFR at a pressure of 
220 mmHg. They observed the addition of BFR enhanced mRNA expressions of VEGF, 
VEGFR-2, HIF-1α, nNOS and iNOS at 2 and 4 hours post exercise. In a similar design 
Ferguson et al. (2018) additionally observed enhanced mRNA expression of PGC-1α and 
eNOS when BFR at 110 mmHg was added to bilateral knee extension performed at 20% of 
1RM. Furthermore, Taylor et al. (2016a) demonstrated enhanced HIF-1α mRNA expression 
31 
 
following a typical SIT session only when combined with post-exercise BFR, however, they 
did not report any enhancements in either PGC-1α, VEGF or eNOS mRNA expression 3 hours 
post-exercise with the addition of BFR. Christiansen et al. (2018) further investigated the 
addition of BFR to intermittent running training, undertaken at an intensity of 105% of the 
lactate threshold. They observed that BFR enhanced mRNA expression of PGC-1α and also 
the Na+, K+-ATPase complex subunit ancillary protein phospholemman-1 (FXYD1). In an 
interesting design, participants also undertook an additional trial under hypoxic conditions, 
whereby the level of muscle hypoxia, as assessed by near-infrared spectroscopy, was matched 
to the BFR condition. In this group there was no increase in either PGC-1α or FXYD1 
signalling, suggesting that this enhanced signalling was not related to hypoxia or CaMKII 
signalling. However, the enhanced signalling with BFR was associated with fibre type-specific 
AMPK downstream signalling and markers of oxidative stress.  
Moreover, the angiogenic potential of the addition of BFR to low load resistance training has 
further been inferred with studies reporting increased calf filtration capacity, an indirect 
measure of capillarisation following 4-6 weeks of training (Evans et al. 2010; Hunt et al. 2013).  
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2.6 POST-EXERCISE BFR 
The ability of BFR to manipulate the training stimulus to submaximal intensity exercise could 
have useful applications during periods of rehabilitation and to control the training load of 
athletes. Nevertheless, maintaining a high training intensity is important to optimise 
adaptations and endurance performance in trained individuals (Laursen et al. 2002; 2005; 
Mujika, 2010) and therefore the application of BFR as an additional stimulus whilst 
maintaining the ‘typical’ intensity of training protocols is arguably of more interest to well-
trained endurance athletes. In a novel approach Taylor et al. (2016a) investigated the use of 
post-exercise BFR during a typical SIT program, with the aim to add a BFR stimulus in the 
absence of a reduction in training intensity. 20 trained cyclists undertook 4 weeks of 
progressive SIT, involving two sessions a week of 4-7 maximal 30 s sprints interspersed with 
4.5 min recovery, either alone or with post-exercise BFR. In the control group the cyclists 
remained stationary on the bike during the recovery period. In the BFR group participants 
dismounted the bike and lay in a semi-supine position on a couch and BFR was rapidly applied 
for 2 min at ~130 mmHg, which was ascertained as the highest tolerable pressure. After the 4 
weeks of training there was a potent increase in V̇O2max of 4.5% in the trained cyclists (V̇O2max 
= 61.2 ± 4.0 ml.min-1.kg-1) in the BFR group, whereas there was no change in the control group. 
However, there was no change in MAP or performance during a 15 km time trial. Although 
further investigation is required to establish if post-exercise BFR can elicit improvements in 
exercise performance, this study clearly highlights the potential potency of post-exercise BFR 
as an additional training stimulus for endurance athletes.   
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2.7 THE CRITICAL POWER CONCEPT 
The critical power (CP) concept was first introduced by Monod and Scherrer (1965) and was 
used to describe the hyperbolic relationship between work rate and time to exhaustion in a 
single muscle group. They determined two parameters that would denote this hyperbolic 
relationship; the power asymptote, CP and a finite amount of work which can be completed 
above CP, i.e. the curvature constant, which was later termed Wꞌ (Equation 1). This concept 
has later been demonstrated to apply during whole body exercise including cycling (Moritani 
et al. 1981), running (Hughson et al. 1984) and swimming (Wakayoshi et al. 1992). Together, 
CP and Wꞌ describe cycling performance within the severe-intensity domain (equation 1) and 
are therefore important performance parameters (Vanhatalo et al. 2011a).  
t = W’ / (P – CP)  (1) 
CP was originally proposed to represent the power associated with the highest rate of aerobic 
energy supply that can be sustained for a prolonged time in the absence of fatigue (Monod & 
Scherrer, 1965; Moritani et al. 1981), typically around 30 min (Brickley et al. 2002). CP has 
subsequently been established as the demarcation between the heavy- and severe-intensity 
exercise domains (Jones et al. 2008; Poole et al. 1988; Whipp, 1996). Below CP, i.e. within 
the heavy-intensity exercise domain, V̇O2, intramuscular substrates (PCr) and metabolites (e.g. 
Pi and H+) achieve submaximal steady state values. In contrast during severe-intensity exercise, 
i.e. above CP, pulmonary V̇O2, intramuscular substrates and metabolites fail to reach a steady 
state and continue to increase/decrease until they attain their respective maxima/minma and 
task failure ensues (Jones et al. 2008; Poole et al. 1988; Vanhatalo et al. 2016). CP is therefore 
considered to reflect the greatest sustainable rate of oxidative metabolism in the absence of a 
progressive loss of muscle metabolic homeostasis (Jones et al. 2010).  
CP has been well established to be a parameter of aerobic function. For example, CP has been 
observed to be negatively correlated with the fundamental time constant of the oxygen uptake 
response to constant load exercise in the severe intensity domain (Murgatroyd et al. 2011) and 
positively correlated with type I fibre proportion (Vanhatalo et al. 2016). CP is also sensitive 
to alterations in oxygen delivery; CP is increased in hyperoxia (Vanhatalo et al. 2010) and 
decreased in hypoxia (Dekerle et al. 2012; Simpson et al. 2015) and with the application of 
BFR (Broxterman et al. 2015). Furthermore, CP is increased following both continuous 
(Gaesser & Wilson, 1988; Jenkins & Quigley, 1992) and HIIT (Gaesser & Wilson, 1988; Poole 
et al. 1990; Vanhatalo et al. 2008), which are known to increase both oxidative capacity 
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(Burgomaster et al. 2008) and capillary supply (Andersen & Henriksson, 1977; Jensen et al. 
2004a).  
In comparison to CP the physiological underpinnings of Wʹ are less clear.  Classically Wʹ was 
considered to represent a fixed anaerobic energy store, representing energy derived from high-
energy phosphates and anaerobic glycolysis and a small contribution from aerobic stores of 
myoglobin and haemoglobin-bound O2 stores (Moritani et al. 1981; Fukuba & Whipp, 1999; 
Morton, 2006). However, this has been challenged by the observation that Wꞌ is reduced under 
conditions of hyperoxia (Vanhatalo et al. 2010). Instead Wꞌ may be linked to the development 
of the V̇O2 slow component, with strong positive correlations observed between Wʹ and the 
V̇O2 slow component (Murgatroyd et al. 2011; Vanhatalo et al. 2011b), and the attainment of 
critical levels of intramuscular pH, PCr and Pi, with consistent ‘critical’ values demonstrated 
at the point of task failure in the severe-intensity domain irrespective of the work rate or the 
inspired O2 fraction (Vanhatalo et al. 2010). Furthermore, a recent study demonstrating a 
positive correlation between Wʹ and gross thigh volume and maximum torque production of 
the knee extensors, suggests that there may be a neuromuscular contribution to the mechanistic 
underpinning of Wʹ (Kordi et al. 2018).    
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2.8 SUMMARY AND AIMS 
This literature review has outlined the ability of skeletal muscle to adapt to the demands elicited 
from a specific exercise bout and has highlighted the importance of optimising adaptations to 
skeletal muscle capillarity and the mitochondria for enhancing endurance performance in 
trained individuals. However, it has also identified the reduced adaptive scope of this 
population. Whereby the acute molecular signalling response of both angiogenic and 
mitochondrial biogenic factors are attenuated as individuals become accustomed to an exercise 
stimulus and subsequently structural and functional adaptations are diminished. The review 
further highlighted the potential for post-exercise BFR as a training tool to overcome these 
attenuated responses and given the current lack of research clearly identified the need for 
further investigation. Finally, this literature review described the CP concept as an important 
performance model and with CP likely being an important parameter of aerobic function, it 
would be expected for CP to be sensitive to peripheral adaptations favouring endurance 
performance. In light of the above, the primary aims of the experimental chapters of this thesis 
were as follows: 
Chapter 3:  
To establish if there is a relationship between the parameters of the power-duration relationship 
and indices of skeletal muscle capillarity and muscle fibre morphology in trained cyclists, 
which would imply them as determinants of CP and/or Wʹ. It was hypothesised that CP would 
be positively correlated to skeletal muscle capillarity and the proportion and CSA of type I 
fibres, whereas Wʹ would not be associated with fibre type composition or capillarity. 
Chapter 4: 
To determine if 4 weeks of SIT combined with post-exercise BFR would increase the 
parameters of the CP concept, and therefore severe-intensity performance, skeletal muscle 
capillarity and mitochondrial protein content more than SIT alone in trained cyclists. It was 
hypothesised that the addition of post-exercise BFR to SIT would enhance CP, angiogenesis 
and mitochondrial protein content. 
Chapter 5: 
Firstly, to establish the level of skeletal muscle oxygenation during SIT with and without post-
exercise BFR and secondly, to investigate if different BFR protocols altered the skeletal muscle 
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oxygenation response. It was hypothesised that post-exercise BFR would reduce skeletal 
muscle oxygenation during the recovery period and that a higher restriction period would 
decrease this further.  
Chapter 6: 
To investigate if post-exercise BFR would enhance and better maintain the magnitude of 
transient transcriptional responses of key angiogenic and mitochondrial biogenic genes and 
increase the translational and phenotypic response to two weeks of higher volume HIIT. It was 
hypothesised that post-exercise BFR would increase and maintain the attenuating acute 
transcriptional response of angiogenic and mitochondrial biogenic genes (VEGF, PGC-1α, 
HIF-1α and eNOS) and enhance VEGF protein content and CS activity.     
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CHAPTER 3 
CRITICAL POWER IS POSITIVELY RELATED TO SKELETAL 
MUSCLE CAPILLARITY AND TYPE I MUSCLE FIBRES IN 
ENDURANCE TRAINED INDIVIDUALS 
 
 
The study presented in this experimental chapter has been published and has the following 
citation: 
Mitchell EA, Martin NRW, Bailey SJ, Ferguson RA (2018). Critical power is positively related 
to skeletal muscle capillarity and type I muscle fibers in endurance-trained individuals. J Appl 
Physiol 125: 737–745. 
This chapter presents the published manuscript.  
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3.1 ABSTRACT 
The asymptote (CP) and curvature constant (W′) of the hyperbolic power-duration relationship 
can predict performance within the severe-intensity exercise domain. However, the extent 
which these parameters relate to skeletal muscle morphology is less clear, particularly in 
endurance trained individuals who, relative to their lesser trained counterparts, possess skeletal 
muscles that can support high levels of oxygen transport and oxidative capacity i.e. elevated 
type I fiber proportion and CSA and capillarity. Fourteen endurance trained males performed 
a maximal incremental test to determine peak oxygen uptake (V̇O2peak; 63.2 ± 4.1 ml.min-1.kg-
1), maximal aerobic power (MAP) (406 ± 63 W), and 3-5 constant load tests to task failure for 
the determination of CP (303 ± 52 W) and W' (17.0 ± 3.0 kJ). Skeletal muscle biopsies were 
obtained from the vastus lateralis and analyzed for % fiber type proportion, CSA and indices 
of capillarity. CP was positively correlated with the % proportion (r = 0.79; P = 0.001) and 
CSA (r = 0.73; P = 0.003) of type I fibers, capillary to fiber ratio (r = 0.88; P < 0.001) and 
capillary contacts around type I fibers (r = 0.94; P < 0.001) and type II fibers (r = 0.68; P = 
0.008). W' was not correlated with any morphological variables. These data reveal a strong 
positive association between CP and skeletal muscle capillarity. Our findings further support 
the assertion that CP is an important parameter of aerobic function.  
 
3.2 NEW AND NOTEWORTHY 
This investigation demonstrated very strong positive correlations between CP and skeletal 
muscle capillarity, particularly around type I fibers, and type I fiber composition. These 
correlations were demonstrated in endurance trained individuals expected to possess well-
adapted skeletal muscles, such as high levels of oxygen transport structures and high oxidative 
capacities, supporting the view that CP is an important parameter of aerobic function. In 
contrast, the curvature constant Wʹ was not associated with fiber type composition or 
capillarity.  
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3.3 INTRODUCTION 
The hyperbolic relationship between time to exhaustion and power output during high-intensity 
exercise is defined by a power asymptote, CP, and curvature constant, W′ (Monod & Scherrer, 
1965; Morton, 2006; Poole et al. 1988). Together, these parameters determine exercise 
performance capabilities within the severe-intensity exercise domain (Jones et al. 2010; 
Vanhatalo et al. 2011a) or alternatively termed the very-heavy intensity domain (Whipp, 1996). 
These parameters are, therefore, of significance to athletes, coaches and exercise physiologists 
interested in fatigue development and its underpinning mechanisms (Burnley et al. 2012; Jones 
et al. 2010; Poole et al. 2016; Vanhatalo et al. 2010; Vanhatalo et al. 2011b). It is well 
established that CP demarcates the heavy and severe exercise intensity domains (Jones et al. 
2008; Poole et al. 1988; Whipp, 1996). During heavy-intensity exercise, pulmonary V̇O2 and 
intramuscular substrates (e.g. phosphocreatine (PCr)) and metabolites (e.g. Pi and H+) achieve 
sub-maximal steady-state values. In contrast, during severe-intensity exercise, i.e. above CP, 
pulmonary V̇O2, and intramuscular substrates and metabolites continue to increase/decrease 
until their respective maxima/minima are obtained and task failure occurs (Jones et al. 2008; 
Poole et al. 1988; Vanhatalo et al. 2016). CP is, therefore, considered to reflect the greatest 
sustainable rate of oxidative metabolism in the absence of a progressive loss of muscle 
metabolic homeostasis, and is an important determinant of endurance exercise performance 
(Jones et al. 2010).  
Whilst the relationship between CP and the broad parameters of aerobic function, such as 
oxygen delivery and V̇O2 kinetics, have been well established (Dekerle et al. 2012; Murgatroyd 
et al. 2011; Vanhatalo et al. 2010; Whipp, 1996), the association between CP and aspects of 
skeletal muscle morphology is not fully understood. Vanhatalo et al. (2016) previously 
reported a positive relationship between CP and the proportion of type I muscle fibers in 
recreationally active individuals. Since type I skeletal muscle fibers possess a superior 
phenotype for oxidative metabolism and enhanced fatigue resistance compared to type II fibers 
(for review see Schiaffino and Reggiani, 2011), this observation is compatible with the 
interpretation that CP is principally a parameter of oxidative metabolism. Another aspect of 
skeletal muscle morphology that will influence oxidative metabolism and fatigue resistance is 
capillarity (Joyner & Coyle, 2008). Muscle capillarity is an important determinant of oxygen 
extraction which itself is a function of the muscle oxygen diffusion capacity and muscle blood 
flow (Roca et al. 1992; Wagner, 1992). The former is primarily determined by the number of 
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red blood cells that are in contact with the contracting skeletal muscle fibers (Federspiel & 
Popel, 1986) which is facilitated by a high capillary network and the likelihood that most 
capillaries support red blood cell flux (Poole et al. 2013). Taken together, therefore, it seems 
logical, that CP would be related to skeletal muscle capillary supply. Iaia et al. (2011) have 
previously demonstrated a positive relationship between capillary supply and time to task 
failure over a performance range of ~1-20 minutes. Although this study did not partition the 
exercise intensity domains as defined by CP, these exercise durations would be expected to fall 
close to or within the severe intensity domain. Therefore, the correlation between time to task 
failure, over a range that spans the severe-intensity exercise domain, and skeletal muscle 
capillarity could be linked to the CP, but the relationship between skeletal muscle capillarity 
and CP has yet to be assessed.      
Compared to CP, the physiological understanding of W' is less clear. Classically, W' was 
considered to represent a fixed anaerobic energy store (Morton, 2006). However, more recent 
observations have challenged this interpretation since W' appears to be sensitive to changes in 
oxygen delivery (Vanhatalo et al. 2010). Instead, W' appears to be linked to the development 
of the V̇O2 slow component, and the attainment of critical levels of intramuscular pH, PCr and 
Pi (Jones et al. 2008; Vanhatalo et al. 2011b), both of which are dependent on muscle fiber 
composition (Krustrup et al. 2004; Pringle et al. 2003). Moreover, as exercise intensity exceeds 
CP and the utilization of W' ensues, muscle blood flow is preferentially distributed to type II 
muscle fibers (Copp et al. 2010) suggesting a potential dependence of W′ utilization on type II 
skeletal muscle fiber recruitment and perfusion. However, Vanhatalo et al. (2016) did not 
report any relationship between the magnitude of W' and the proportion of type II fibers in 
recreationally active individuals. 
It has long been established that endurance trained individuals possess well-adapted skeletal 
muscles with a significantly greater capillary supply (Hermansen & Wachtlova, 1971; Ingjer, 
1979; Saltin et al. 1977) and oxidative capacity (Costill et al. 1976; Saltin et al. 1977) compared 
to untrained individuals. This permits athletes to achieve high levels of oxygen extraction and, 
consequently, very high values of leg V̇O2 (>600 ml.min-1.kg-1) have been observed 
(Richardson et al. 1993). Therefore, the expected high level of oxidative capacity and oxygen 
transport structures in endurance trained athletes suggest this population would achieve greater 
values of CP. Indeed, CP typically occurs at 80-90% of V̇O2max in athletes compared to 70-
80% of V̇O2max in healthy young individuals (Poole et al. 2016). However, despite findings of 
a higher CP and skeletal muscle capillarity and type I fiber percentage in athletes, a direct 
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relationship between capillary supply and muscle fiber composition and CP in endurance 
trained individuals has yet to be established.  
Therefore, the aim of the current study was to assess the relationship between parameters of 
the power-duration relationship (CP and W′) and indices of capillarity and muscle fiber 
morphology in endurance trained individuals. It was hypothesized that CP would be positively 
related to indices of skeletal muscle capillarity and the proportion and cross-sectional area of 
type I skeletal muscle fibers.  
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3.4 METHODS 
Participants 
Fourteen healthy males (Table 3.1) volunteered to take part in the study. Participants were 
competitive cyclists or triathletes and had to achieve the inclusion criteria of V̇O2peak 
approximately 60 ml·min-1kg-1. All completed health and muscle biopsy screening 
questionnaires prior to participation to mitigate for contraindications to maximal exercise and 
muscle biopsy procedures. Participants did not have a history of neuromuscular, hematological 
or musculoskeletal abnormalities and were not using pharmacological treatments during the 
study period. All experimental procedures were approved by the Loughborough University 
Ethics Approvals (Human Participants) Sub-Committee and conformed in all respects with the 
Declaration of Helsinki. Participants were fully informed of the risks and discomforts 
associated with all experimental trials before providing written, informed consent. 
Experimental protocol 
Participants attended the laboratory on five to seven occasions over a period of approximately 
10 days. V̇O2peak was initially tested to ensure participants attained the appropriate inclusion 
criteria. Following a minimum of 48 hours a muscle biopsy was then obtained. After a further 
48 hours participants undertook a series of 3-5 constant load tests to the limit of tolerance, each 
separated by a minimum of 24 hours, to determine CP and W'.  
All performance tests were conducted upon an electronically braked cycle ergometer (Lode 
Excalibur Sport, Lode B.V. Gronigen, The Netherlands). Ergometer saddle and handlebar 
dimensions were recorded for each participant during preliminary testing and remained 
standardized for the remainder of the testing period. Participants were instructed to maintain a 
normal diet during the testing period and refrain from ingesting alcohol and caffeine during the 
48 h preceding testing. All tests were conducted in constant laboratory ambient conditions (19-
21°C, 40-50% humidity). 
Performance measures 
V̇O2peak and maximal aerobic power 
Participants performed an incremental test to exhaustion to establish V̇O2peak and MAP. 
Participants began cycling, at a freely chosen, constant pedal cadence for 1 min at 50 W, after 
which power increased 25 W every 60 s until volitional exhaustion or when cadence fell 10% 
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below the chosen cadence for more than 5 s, despite strong verbal encouragement. Pulmonary 
gas exchange was measured continuously throughout exercise (Cortex MetaLyzer 3B, Leipzig, 
Germany). V̇O2peak and MAP were defined as the highest V̇O2 and power output achieved for 
a 30 and 60 s period during the test, respectively. 
 
Table 3.1. Parameters of performance and skeletal muscle morphology 
 
 Mean ± SD Range 
Participant characteristics   
     Age (yr) 25 ± 6 20 – 41 
     Height (m) 1.82 ± 0.06 1.70 – 1.95 
     Mass (kg) 76.5 ± 9.0 64.2 – 90.4 
Performance parameters   
     V̇̇̇̇ O2peak (ml.min-1.kg-1)  63.2 ± 4.1 58.7 – 72.2 
     V̇̇ O2peak (l.min-1) 4.86 ± 0.68 3.93 – 5.86 
     MAP (W) 406 ± 63 295 – 485 
     CP (W) 303 ± 52 207 – 376 
     W′ (kJ) 17.0 ± 3.0 13.9 – 22.9 
Skeletal muscle morphology   
     Type I fiber % 56.6 ± 11.9 41.2 – 83.9 
     Type II fiber % 43.4 ± 11.9 16.1 – 58.8 
     CSA fiber type I (μm-2) 5937 ± 1333 3835 – 8568 
     CSA fiber type II (μm-2) 5967 ± 1294 4024 - 7997 
     Capillary density (cap.mm-2) 424 ± 55 314 – 489 
     Capillary to fiber ratio 2.84 ± 0.63 1.90 – 4.22 
     CC type I 6.9 ± 1.4 4.8 – 9.4 
     CC type II 6.1 ± 1.1 4.6 – 8.4 
     Sharing index type I 2.43 ± 0.16 2.20 – 2.64 
     Sharing index type II 2.19 ± 0.24  1.74 – 2.62 
Abbreviations: CC type I, capillary contacts around type I fibers; CC type II, capillary contacts 
around type II fibers; CP, critical power; CSA fiber type I, cross sectional area of type I fibers; 
CSA fiber type II, cross sectional area of type II fibers; MAP, maximal aerobic power; Sharing 
index type I, sharing index of type I fibers; Sharing index type II, sharing index of type II fibers; 
Type I fiber %, % proportion of type I fibers; Type II fiber %, % proportion of type II fibers %; 
V̇̇ O2peak, peak oxygen uptake; W', curvature constant. 
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CP and W' 
Participants performed a minimum of 3 constant-load tests that were continued until the limit 
of tolerance at between 75-100% of MAP, the sequence of which was randomized. These were 
designed to elicit exhaustion within 2- to 15-min (Poole et al. 1988). Each test was preceded 
with an initial warm-up at 50 W for 5 min. Time to exhaustion (t) was recorded to the nearest 
second and was taken as either volitional exhaustion or when pedal cadence fell 10% below 
the freely chosen cadence for more than 5 s, despite strong verbal encouragement. No feedback 
regarding the power output or times achieved were provided, however participants were 
permitted to view pedal cadence throughout. To enhance the accuracy of parameter estimates, 
when the standard error (SE) of CP was >5% and W' >10% an additional test was performed 
(Hill & Smith, 1994). 
The parameters of the power-duration relationship, CP and W', were calculated using the 
inverse linear model (equation 1), the linear work-time model (equation 2) and the hyperbolic 
model (equation 3). The equation associated with the lowest combined standard error was 
selected and used for all further analysis. 
 P = W' . (1/t) + CP  (1) 
W = CP . t + Wˈ  (2) 
 t = W' / (P – CP)  (3) 
Muscle sampling and analysis 
Muscle biopsies were obtained from the lateral portion of the vastus lateralis muscle under 
local anaesthesia (1% lidocaine) using the percutaneous needle biopsy technique with suction. 
Muscle samples were immediately embedded in mounting medium (Tissue-Tek OCT 
Compound, Sakura Finetek Europe, The Netherlands) and frozen in liquid-cooled isopentane. 
All samples were then stored at -80°C until analysis.  
Immuno-histochemistry 
Transverse serial sections (8 μm) were obtained using a cryotome and placed onto poly L-
lysine coated glass slides. Sections were fixed for 10 min in 3.7% formaldehyde at room 
temperature and blocked with phosphate buffered saline (PBS) containing 2% bovine serum 
albumin (BSA) and 5% goat serum for 1 h at room temperature. Serial muscle sections were 
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then incubated with either primary antibodies for CD-31 (ab119339, abcam, Cambridge, UK) 
diluted 1:100 and MHC II (ab91506, abcam, Cambridge, UK) diluted 1:1000 in PBS-2% BSA 
or MHC I (A4.951, DSHB, Iowa, USA) diluted 1:500 in PBS-2% BSA for 1 h at room 
temperature. Sections were then incubated for 2 h at room temperature with the appropriate 
secondary antibodies; goat anti-mouse Alexa Fluor 488, (CD-31, MHC I) and goat anti-rabbit 
Alexa Fluor 594 (MHC II) diluted 1:500 in PBS-2% BSA.  Following incubation cover slips 
were mounted with fluoromount aqueous mounting medium (F4680, Sigma-Aldrich, Dorset, 
UK). Specificity of staining was assessed with no primary antibody negative controls. 
Images were captured using a fluorescence microscope (Leica DM2500) at 20x magnification. 
A minimum of 7 images were taken from across the entire cross-sectional area of the sample 
to avoid bias towards smaller fibers, with at least 6 cryo-sections per participant analyzed. The 
number of fibers counted equated to nearly 200 per participant (type I = 93 ± 18 and type II; 
80 ± 33). Images analysis was undertaken using Fiji (ImageJ) software and the investigator was 
blinded to the participant code of each sample. Only transverse fibers were included in the 
analysis which was assessed primarily by the presumption of circularity. Any fibers which were 
clearly oblique or not transverse to the long axis of the fiber were excluded from analysis. 
Cross-sectional area (CSA) of fibers was assessed by manually drawing around the perimeter 
of each fiber and was calculated as the cumulative area of each fiber type divided by the number 
of fibers analyzed. Although absolute fiber size may be over-estimated due to fiber swelling 
during thawing of frozen sections, this should be consistent between participants. Fiber type 
composition was expressed as a percentage of the number of fibers of each type relative to the 
total number of fibers counted. Capillarity was expressed as; capillary density, capillary to fiber 
ratio, number of capillaries in contact with type I (CC type I) and type II fibers (CC type II) 
and sharing index of type I and type II fibers (calculated as CC/capillary-to-fiber ratio).  
Coefficients of variation for intra-rater reliability of image analysis were: % fiber type 
composition = 2.4%; fiber CSA = 2.2%; capillary density = 2.2%; capillary to fiber ratio = 
1.7% and capillary contacts = 1.7%. 
Statistics 
Data were initially checked for normality using Shapiro-Wilk tests and relationships were 
analyzed using the Pearson’s product-moment correlation coefficient. Data are displayed as 
mean ± SD unless otherwise stated. Significance was accepted at P ≤ 0.05 and a statistical trend 
as P ≤ 0.10. 
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3.5 RESULTS 
The parameter estimates of the power-duration relationship for all three equations are displayed 
in Table 3.2. The linear inverse relationship produced the lowest combined standard error for 
CP and W' and was therefore used for further analyses. The ranges of times-to-exhaustion for 
the shortest and longest trials were 127 – 218 s and 512 – 1050 s, respectively. Power-duration 
relationship parameters were established from; 3 trials n = 8, 4 trials n = 5, and 5 trials n = 1. 
Representative images for immuno-histochemical staining are displayed in Figure 3.1 
Performance and skeletal muscle morphology characteristics are displayed in Table 3.1. 
 
Table 3.2. Parameter estimates of the power-duration relationship 
 
CP correlates 
CP was positively correlated with the % proportion of type I fibers, and inversely correlated 
with the % proportion of type II fibers. The correlation remained when type I fibers were 
expressed as CSA but was eliminated when type II fibers were expressed as CSA (Fig. 3.2). 
CP was positively correlated with capillary to fiber ratio and CC type I and CC type II. There 
was a modest (non-significant, P = 0.07) correlation between CP and capillary density (Fig 
3.2). CP was negatively correlated with the sharing index of type II fibers (r = -0.69, P = 0.006), 
but was not correlated with the sharing index of type I fibers (r = -0.16, P = 0.59). 
W′ correlates 
There were no correlations between W' and any measures of fiber type composition and 
capillarity (Fig 3.3).  
 CP (W) CP SE (%) Wˈ (kJ) Wˈ SE (%) R2 
Inverse model 303 ± 52 1.8 ± 1.0 17.0 ± 3.0 8.9 ± 5.2 0.982 ± 0.019 
Work-time model 302 ± 52 1.8 ± 1.0 17.4 ± 2.3 14.5 ± 8.5 0.999 ± 0.001 
Hyperbolic model 299 ± 52 1.8 ± 1.3 19.0 ± 3.0 16.8 ± 10.1 - 
Abbreviations: CP, critical power; SE, standard error; Wˈ, curvature constant.   
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Figure 3.1. Representative images of immuno-histochemical staining of muscle samples from 
two participants; A) CP = 207 W, V̇O2peak = 3.93 l.min-1, capillary to fiber ratio = 1.90; B) CP 
= 353 W, V̇O2peak = 5.38 l.min-1, capillary to fiber ratio = 3.40. Type I fibers = red, type II fibers 
= blue, and capillaries = green. Scale Bar = 50 µm.  
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Figure 3.2. Correlations between CP and; A) % proportion of type I fibers, B) % proportion of 
type II fibers, C) CSA of type I fibers, D) CSA of type II fibers, E) capillary density, F) capillary 
to fiber ratio, G) capillary contacts around type I fibers, H) capillary contacts around type II 
fibers. CI = 95% confidence interval of the correlation coefficient.  
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Figure 3.3. Correlations between W' and; A) % proportion of type I fibers, B) % proportion of 
type II fibers, C) CSA of type I fibers, D) CSA of type II fibers, E) capillary density, F) capillary 
to fiber ratio, G) capillary contacts around type I fibers, H) capillary contacts around type II 
fibers. CI = 95% confidence interval of the correlation coefficient. 
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V̇O2peak correlates 
Absolute V̇O2peak was positively correlated with capillary to fiber ratio and CC type I and CC 
type II. In contrast, there was no correlation between V̇O2peak and capillary density. V̇O2peak 
was also positively correlated with % proportion and CSA of type I fibers and negatively 
correlated with % proportion of type II fibers. V̇O2peak was not correlated with CSA of type II 
fibers (Table 3.3).  
MAP correlates 
MAP was positively correlated with all measures of capillarity; capillary density, capillary to 
fiber ratio, CC type I and CC type II. MAP was also positively correlated with % proportion 
and CSA of type I fibers and negatively correlated with % proportion of type II fibers. MAP 
was not correlated with CSA of type II fibers (Table 3.3).  
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Table 3.3. Correlations between V̇O2peak and MAP and markers of skeletal muscle 
capillarization and muscle fiber composition 
 
 
 
  
 V̇O2peak  
(l.min-1) 
V̇O2peak  
(ml.min-1.kg-1) 
MAP (W) 
Type I fiber % 
r = 0.82 
P = 0.002 
CI = 0.43 – 0.95 
r = 0.33 
P = 0.32 
CI = -0.34 – 0.78    
r = 0.74 
P = 0.002 
CI = 0.34 – 0.91 
Type II fiber % 
r = -0.82 
P = 0.002 
CI = -0.43 – -0.95 
r = -0.33 
P = 0.32 
CI = 0.34 – -0.78 
r = -0.74 
P = 0.002 
CI = -0.34 – -0.91 
CSA fiber type I (μm-2) 
r = 0.81 
P = 0.003 
CI = 0.41 – 0.95 
r = 0.19 
P = 0.58 
CI = -0.46 – 0.71 
r = 0.69 
P = 0.01 
CI = 0.25 – 0.89 
CSA fiber type II (μm-2) 
r = 0.47 
P = 0.14 
CI = -0.18 – 0.83 
r = 0.22 
P = 0.52 
CI = -0.44 – 0.72 
r = 0.21 
P = 0.46 
CI = -0.36 – 0.67 
Capillary density (cap.mm-2) 
r = 0.43 
P = 0.19 
CI = -0.23 – 0.82 
r = 0.42 
P = 0.20 
CI = -0.24 – 0.81 
r = 0.55 
P = 0.04 
CI = -0.26 – 0.81 
Capillary to fiber ratio 
r = 0.94 
P < 0.001 
CI = 0.78 – 0.98 
r = 0.40 
P = 0.23 
CI = -0.26 – 0.81 
r = 0.86 
P < 0.001 
CI = 0.61 – 0.95 
CC type I 
r = 0.95 
P < 0.001 
CI = 0.81 – 0.99 
r = 0.40 
P = 0.22 
CI = -0.26 – 0.81 
r = 0.92 
P < 0.001 
CI = 0.76 – 0.97 
CC type II 
r = 0.81 
P = 0.003 
CI = 0.41 – 0.95 
r = 0.49 
P = 0.13 
CI = -0.16 – 0.84 
r = 0.68 
P = 0.01 
CI = 0.23 – 0.89 
Abbreviations: CC type I, capillary contacts around type I fibers; CC type II, capillary contacts around 
type II fibers; CSA fiber type I, cross sectional area of type I fibers; CSA fiber type II, cross sectional 
area of type II fibers; MAP, maximal aerobic power; Type I fiber %, % proportion of type I fibers; Type II 
fiber %, % proportion of type II fibers %; V̇̇ O2peak, peak oxygen uptake. CI = 95% confidence interval of 
the correlation coefficient. 
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3.6 DISCUSSION 
The novel findings of this study are the very strong positive correlations between CP and 
indices of capillarity in a homogenous group of endurance trained individuals. The findings of 
the current study also confirm previous observations, undertaken on recreationally active 
individuals, of a positive association between the proportion of type I skeletal muscle fibers 
and CP and extend these observations by indicting that CP is also positively associated with 
type I muscle fiber CSA.  In contrast, there were no correlations between W' and any index of 
skeletal muscle fiber type or capillarity. These observations add further support to our 
understanding of the physiological mechanisms that likely underpin CP and, by extension, 
endurance exercise performance.   
CP correlates 
In the current study CP was positively correlated with indices of skeletal muscle capillarity, in 
particular the number of capillary contacts with type I fibers, which displayed a correlation 
coefficient >0.9. These novel findings extend previous observations of significant correlations 
between capillary to fiber ratio and time to task failure during exercise trials lasting ~2-20 
minutes (Iaia et al. 2011), which span the spectrum of the tolerable duration of exercise within 
the severe exercise intensity domain (Jones et al. 2010; Poole et al. 2016). The strong positive 
correlations between CP and capillarity in the group of endurance trained individuals who 
participated in the present study imply that skeletal muscle capillary supply could be an 
important determinant of CP.  
A high capillary supply would be hypothesized to be beneficial to CP, and therefore the ability 
to sustain high rates of oxidative phosphorylation, through enhancing oxygen extraction, via 
improved muscle oxygen diffusion capacity (Roca et al. 1992; Wagner, 1992), and an enhanced 
ability to remove metabolites considered to be involved in skeletal muscle fatigue, such as H+ 
and K+ (Allen et al. 2008). In support of the latter, Iaia et al. (2011) demonstrated positive 
correlations between capillary supply and the rate of plasma K+ accumulation and muscle pH 
recovery. In contrast to the other markers of capillarity, there was only a modest (non-
significant) correlation between CP and capillary density. This is perhaps not surprising as it is 
important to note that capillary density is also a function of muscle fiber CSA (Olfert et al. 
2016) which was also positively correlated with CP, at least in type I fibers. Given that oxygen 
extraction is primarily determined by the number of red blood cells in contact with the 
contracting skeletal muscle fibers (Federspiel & Popel, 1986; Roca et al. 1992; Wagner, 1992) 
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this would suggest that the number of capillaries as opposed to capillary density per se would 
be important to oxygen extraction. This interpretation is supported by previous observations 
by Hepple et al. (2000) which demonstrated that an increase in capillary density following 
short-term immobilization did not increase muscle oxygen diffusing capacity, and supports the 
premise that a high capillary to fiber ratio and capillary contacts are more important 
determinants of CP.  
We have also demonstrated a positive correlation between CP and % proportion of type I fibers 
in endurance trained athletes, which is consistent with previous observations in recreationally 
active participants (Vanhatalo et al. 2016). We have further extended this observation by 
demonstrating that CP was also positively related to the CSA of type I fibers. These 
observations are in keeping with the notion that CP is a parameter largely dictated by facets of 
oxidative metabolism since type I fibers possess characteristics that facilitate high rates of 
oxidative metabolism including higher mitochondrial content, density and enzyme activity and 
a higher capillary supply, as well as greater fatigue resistance compared to type II fibers (Saltin 
et al. 1977; Schiaffino & Reggiani, 2011).  
It should be noted that the correlations do not establish causation. Indeed, there are multiple 
other adaptations that are also elicited through endurance training and associated with an 
‘endurance-trained’ phenotype, that could determine CP and would indirectly be associated 
with capillary supply and fiber composition. Nevertheless, there is a significant body of 
experimental evidence demonstrating CP to be a parameter of aerobic function. Given that 
capillary supply in particular is a critical determinant of oxygen extraction (Poole et al. 2013) 
this evidence would support that these correlations could be causative. For example, CP is 
negatively correlated with the fundamental time constant of the oxygen uptake response to 
constant load exercise within the severe intensity domain (Murgatroyd et al. 2011). CP is also 
sensitive to changes in oxygen delivery and has been demonstrated to decrease under systemic 
hypoxia (Dekerle et al. 2012) and with blood flow restriction (Broxterman et al. 2015). 
Moreover, CP has been shown to increase with both continuous (Gaesser & Wilson, 1988; 
Jenkins & Quigley, 1992) and HIIT (Gaesser & Wilson 1988; Poole et al. 1990; Vanhatalo et 
al. 2008), which increase both skeletal muscle capillarity (Andersen & Henriksson, 1977; 
Jensen et al. 2004a) and oxidative capacity (Burgomaster et al. 2008).  
We also demonstrated a negative correlation between CP and % proportion of type II fibers 
which supports the observation by Vanhatalo et al. (2016). In contrast, we have demonstrated 
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that there was no correlation when type II fiber composition was expressed relative to CSA, 
however, it is important to acknowledge that we did not distinguish between type IIa and IIx 
fibers. It has been demonstrated that type IIa fibers are larger than type IIx and type I fibers 
(Andersen & Henriksson, 1977; Ingjer, 1979; Saltin et al. 1977) and therefore the relative 
proportions of type IIa and type IIx fibers may affect this relationship. Furthermore, given that 
type IIa fibers possess greater oxidative capacity relative to type IIx fibers (Schiaffino & 
Reggiani, 2011), it could also be speculated that type IIx but not type IIa fiber proportion and 
CSA would be negatively correlated with CP. Indeed, Vanhatalo et al. (2016) demonstrated a 
negative correlation only between CP and type IIx fiber proportion, whereas CP was not related 
to type IIa fibers. Moreover, the mean CSA area of type I and type II fibers were similar in the 
present study. The endurance trained status of our participants is likely to explain this 
observation which is consistent with previous reports that fiber CSA is comparable between 
type I and type II fibers in a group of well-trained middle- and long-distance runners (Tesch & 
Karlsson, 1985) supporting the notion that preferential hypertrophy of type I fibers may occur 
with prolonged endurance training. 
W' correlates 
There were no correlations between W' and any of the skeletal muscle morphological 
measurements in the present study. The lack of correlation with the % proportion or CSA of 
type II muscle fibers may perhaps seem surprising given that type II fibers possess a greater 
resting content of PCr (Sahlin et al. 1997; Sant’ Ana Pereira et al. 1996) and glycolytic capacity 
(Greenhaff et al. 1993; Schiaffino & Reggiani, 2011), both of which has been suggested to play 
an integral role in determining W' i.e. the so-called “anaerobic capacity” (Moritani et al. 1981; 
Morton, 2006). Moreover, individuals with a greater proportion of type II fibers possess a 
greater V̇O2 slow-component (Pringle et al. 2003), which has been demonstrated to have a 
strong relationship with the magnitude of W' (Murgatroyd et al. 2011; Vanhatalo et al. 2011b). 
However, Vanhatalo et al. (2016) also demonstrated that there was no significant correlation 
between the magnitude of W' and the proportion of either type IIa or type IIx muscle fibers, 
suggesting that the determinants of W' are not specific to type II muscle fibers per se. It could 
be speculated that the absence of a correlation between W' and muscle morphology is 
attributable to the muscle fiber recruitment patterns that would be observed during exhaustive 
exercise in the severe intensity domain. For example, maximal sprint exercise has been shown 
to activate all muscle fiber types, as demonstrated by large reductions in PCr concentrations in 
type I and II fibers (including IIA and IIAX hybrid fibers; Karatzaferi et al. 2001; Sant’ Ana 
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Pereira et al. 1996), whereas during submaximal exercise at 75% of V̇O2max muscle fiber 
recruitment was shown to reach a steady state during 45 minutes of exercise, with only around 
55% of type II fibers recruited (Altenburg et al. 2007). Therefore, it is possible that during 
whole body exhaustive exercise in the severe intensity domain not all type II fibers would be 
fully recruited when task failure and complete W′ utilization occur.  This might account for the 
lack of a correlation between W′ and skeletal muscle fibre type reported in the current study 
and elsewhere (Vanhatalo et al. 2016) and suggests that W′ might be more closely linked to 
other physiological events.  For example, a recent study has demonstrated, in a group of elite 
track cyclists, that W′ is positively correlated with the maximum force generating capacity of 
the knee extensors and gross thigh volume (Kordi et al. 2018). Clearly, further research is 
required to resolve the physiological bases of W′.  
Limitations 
Whilst common practice, there are limitations to the skeletal muscle analysis methods utilised 
in the present investigation. Firstly, only a single biopsy, taken from one site of the vastus 
lateralis muscle was analysed. Previous investigations have elucidated that capillary supply, 
fiber type proportion and fiber CSA can display a heterogeneous distribution within the vastus 
lateralis muscle (Boman et al. 2015; Dwyer et al. 1999; Lexel & Taylor, 1989). Therefore, 
whilst a high number of fibers were analysed for each individual sample (analysis of the data 
from the present study demonstrated that there was a levelling off in the mean values of 
capillary contacts and muscle fiber CSA within the mean number of fibers analysed for each 
sample) it cannot be assumed that the samples taken are truly representative of the whole vastus 
lateralis muscle. Furthermore, the samples were only analysed in 2D. A 2D analysis of 
capillaries assumes that capillaries are structured parallel to the longitudinal axis of muscle 
fibers. However, capillaries are not arranged directly linear to the fibers but demonstrate a 
degree or tortuosity and branching anastomoses (Olfert et al. 2016). As a result, the 2D 
quantification of capillarity can underestimate the true capillary network (Cebask et al. 2010; 
Olfert et al. 2016). 
Conclusion 
This investigation has demonstrated very strong positive correlations between CP and skeletal 
muscle capillarity, particularly in relation to type I fibers, in endurance trained individuals. 
Moreover, CP was positively correlated with type I skeletal muscle fiber proportion and CSA. 
In contrast, there were no correlations between W' and capillarity or fiber type. Collectively, 
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these results add support to the notion that CP is a parameter of aerobic function and is 
associated to physiological processes that support oxidative metabolism.  
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CHAPTER 4 
THE COMBINED EFFECT OF SPRINT INTERVAL TRAINING AND 
POST-EXERCISE BLOOD FLOW RESTRICTION ON CRITICAL 
POWER, CAPILLARY GROWTH AND MITOCHONDRIAL PROTEINS 
IN TRAINED CYCLISTS. 
 
 
The study presented in this experimental chapter has been published and has the following 
citation: 
Mitchell EA, Martin NRW, Turner MC, Taylor CW, Ferguson RA (2018). The combined effect 
of sprint interval training and post-exercise blood flow restriction on critical power, capillary 
growth, and mitochondrial proteins in trained. J Appl Physiol 126: 51–59. 
This chapter presents the published manuscript.  
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4.1 ABSTRACT 
Sprint interval training (SIT) combined with post-exercise BFR is a novel method to increase 
V̇O2max in trained individuals, and also provides a potent acute stimulus for angiogenesis and 
mitochondrial biogenesis. The efficacy to enhance endurance performance has however yet to 
be demonstrated. 21 trained male cyclists (V̇O2max; 62.8 ± 3.7 ml.min-1.kg-1) undertook 4 weeks 
of SIT (repeated 30 s maximal sprints) either alone (CON; n = 10) or with post-exercise BFR 
(n = 11). Before and after training V̇O2max, CP and Wʹ were determined and muscle biopsies 
obtained for determination of skeletal muscle capillarity and the content of mitochondrial 
proteins. CP increased (P = 0.001) by a similar extent following CON (287 ± 39 W to 297 ± 
43 W) and BFR (296 ± 40 W to 306 ± 36 W). V̇O2max increased following BFR by 5.9% (P = 
0.02) but was unchanged after CON (P = 0.56). All markers of skeletal muscle capillarity and 
the content of mitochondrial proteins were unchanged following either training intervention. 
In conclusion, 4 weeks of SIT increased CP, however this was not enhanced further with BFR. 
SIT was not sufficient to elicit changes in skeletal muscle capillarity and the content of 
mitochondrial proteins with or without BFR. However, we further demonstrate the potency of 
combining BFR with SIT to enhance V̇O2max in trained individuals. 
 
4.2 NEW AND NOTEWORTHY 
This investigation has demonstrated that 4 weeks of SIT increased CP in trained individuals; 
however, post-exercise BFR did not enhance this further. SIT, with or without BFR, did not 
induce any changes in skeletal muscle capillarity or the content of mitochondrial proteins in 
our trained population. We do, however, confirm previous findings that SIT combined with 
BFR is a potent stimulus to enhance maximal oxygen uptake. 
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4.3 INTRODUCTION 
Well-trained individuals are typically accustomed to high training volumes across a broad 
spectrum of intensities. However, it is generally accepted that eliciting further adaptations 
within this population becomes challenging (Laursen & Jenkins, 2002; Londeree, 1997). Early 
research has highlighted the reduced plasticity of skeletal muscle in the trained state (Hoppeler 
et al. 1985; Slatin et al. 1977) and a body of literature exists demonstrating that an increase in 
traditional endurance training volume alone is insufficient to improve aerobic performance or 
associated physiological determinants in well-trained and ‘physically active’ individuals 
(Costill et al. 1988; Daniels et al. 1978). This blunting of the adaptive scope in trained 
individuals is also reflected at a molecular level (Flueck, 2010; Perry et al. 2010) as 
demonstrated by an attenuated acute transcriptional response as individuals become 
accustomed to a specific exercise bout (Perry et al. 2010). Therefore, the development of 
effective novel training methods is of particular relevance to this population.  
We have recently demonstrated the potency of combining SIT with BFR in enhancing the 
adaptive responses in well-trained individuals (Taylor et al. 2016a). The addition of BFR 
elicited an increase in V̇O2max of ~4.5%, compared to no change with SIT alone. Alongside this 
we presented preliminary mechanistic evidence that SIT combined with BFR led to enhanced 
angiogenic signalling, suggesting the potential for a greater capillary growth with this novel 
intervention. Increased muscle capillarity is a critical adaptation to enhance oxygen and 
substrate delivery (Joyner & Coyle, 2008). Classic work in skeletal muscle has shown that the 
number of capillaries per fibre is proportional to the oxidative activity of that fibre (Romanul, 
1964) and subsequently demonstrates a strong correlation with V̇O2max (Saltin et al. 1977). An 
enhanced capillary network also facilitates the greater removal of metabolic end products, 
which would improve sub-maximal exercise tolerance (Joyner & Coyle, 2008). Both SIT 
combined with BFR and SIT alone were also potent in upregulating PGC-1α expression 
suggesting the potential for mitochondrial biogenesis (Taylor et al. 2016a). Therefore, it was 
surprising that despite the gains in V̇O2max Taylor et al. (2016a) did not observe any 
improvements in exercise performance, measured through a 15 km time trial. This might be 
because the relative contribution of central and peripheral factors to performance of such a self-
paced exercise is task dependent, with increased contribution of central fatigue within longer 
low intensity time trials (>30 min) and a greater degree of peripheral fatigue after shorter high 
intensity efforts (approximately 6 min) (Thomas et al. 2015). Therefore, the peripheral 
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adaptations that we have hypothesised may not be reflected in the performance measure 
selected but would be more relevant to shorter high intensity efforts.  
Since its introduction by Monod and Scherrer (1965) the CP concept has been used to describe 
the relationship between the tolerable duration that high intensity exercise can be maintained 
at a given power output for whole body exercise, (i.e. the power-duration relationship) (Poole 
et al. 1988). This hyperbolic relationship can be described by two constants; the asymptote CP, 
which is considered to represent the greatest rate of oxidative metabolism that can be 
maintained in the absence of a progressive loss of muscle metabolic homeostasis; and the 
curvature constant (Wʹ) representing the capacity for work performed above CP (Jones et al. 
2010; Morton, 2006; Vanhatalo et al. 2016). Accordingly, performance within the severe 
intensity domain is a function of CP and Wꞌ, which makes them important determinants of 
performance (Jones et al. 2010; Vanhatalo et al. 2011a). CP is enhanced under conditions of 
increased oxygen delivery and is linked to the ability to maintain a metabolic steady state 
(Poole et al. 2016; Vanhatalo et al. 2016), therefore CP could be hypothesised to be sensitive 
to changes in skeletal muscle capillarity. Indeed, we recently demonstrated a strong positive 
association between CP and skeletal muscle capillarity in well-trained individuals (Mitchell et 
al. 2018). Furthermore, since CP represents the highest sustainable rate of oxidative 
metabolism, it is likely to be closely related to mitochondrial content and could therefore be 
sensitive to an increase in the content of mitochondrial enzymes.  
Therefore, the present investigation assessed the potency of SIT combined with BFR in 
enhancing CP. Furthermore, the angiogenic and mitochondrial biogenic potential of SIT 
combined with BFR was also assessed. It was hypothesised that SIT combined with BFR would 
result in a greater increase in CP, which would be associated with a greater increase in skeletal 
muscle capillarity and the content of mitochondrial proteins, compared to SIT alone. 
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4.4 METHODS 
Participants 
21 healthy males (age 23 ± 5 yr, height, 179.5 ± 6.4 cm, body mass, 75.5 ± 7.9 kg) volunteered 
to take part in the study. Participants were competitive cyclists or triathletes and had to achieve 
the inclusion criteria of V̇O2max ≥60 ml.min-1kg-1.  All completed health and biopsy screening 
questionnaires prior to participation to mitigate for contraindications to maximal exercise, 
muscle biopsy procedures and BFR. Participants did not have a history of neuromuscular, 
haematological or musculoskeletal abnormalities and were not using pharmacological 
treatments during the study period. All experimental procedures were approved by the 
Loughborough University Ethics Approvals (Human Participants) Sub-Committee and 
conformed in all respects with the Declaration of Helsinki. Participants were fully informed of 
the risks and discomforts associated with all experimental trials before providing written, 
informed consent. 
Experimental protocol 
The study used an independent-groups design whereby participants were assigned to one of 
two groups to perform four weeks of SIT either on its own (CON, n = 10) or combined with 
post-exercise BFR (BFR, n = 11). Participants were pair matched between groups based upon 
initial V̇O2max, maximal aerobic power (MAP) and CP. Participants were initially familiarized 
to the testing and training procedures during preliminary visits. Pre-training outcome measures 
were assessed over a period of 10 days. V̇O2max was tested initially to ensure participants 
attained the appropriate inclusion criteria. After approximately two days the pre-training 
muscle biopsy was then obtained. After a further two days the power-duration relationship for 
determination of CP and Wʹ was assessed, with a minimum of 24 hours separating each test. 
Participants then embarked on the four-week supervised training programme. After a 
maximum of four days following the final training session the post-training outcome measures 
were assessed in the same order and over a similar time period 
All performance tests were conducted on an electronically braked cycle ergometer (Lode 
Excalibur Sport, Lode B.V. Gronigen, The Netherlands). Ergometer saddle and handlebar 
dimensions were recorded for each participant during preliminary testing and remained 
standardised for the rest of the study. Participants were instructed to maintain a normal diet 
during the pre-training testing and replicate that diet during the post-training measures. 
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Participants were instructed to refrain from ingesting alcohol and caffeine during the 48 hours 
preceding testing. Exercise trials were undertaken at approximately the same time each day (± 
2 hours). Laboratory conditions during pre- and post-training exercise measurements remained 
constant (19-21°C, 40-50% humidity). 
Pre and post training outcome measures 
V̇O2max and MAP 
Participants performed an incremental test to exhaustion to establish V̇O2max and MAP. 
Participants began cycling, at a freely chosen, constant pedal cadence for 1 min at 50 W, after 
which power increased 25 W every 60 s until volitional exhaustion or when cadence fell 10% 
below the freely chosen cadence for more than 5 s, despite strong verbal encouragement. 
Pulmonary gas exchange was measured continuously throughout exercise (Cortex MetaLyzer 
3B, Leipzig, Germany). V̇O2max and MAP were defined as the highest V̇O2 and power output 
achieved for a 30 and 60 s period during the test, respectively.  
CP and Wʹ 
Participants performed a series of 3-5 constant-load tests that were continued until the limit of 
tolerance at between 70-100% of MAP, the sequence of which was randomised. These were 
designed to elicit exhaustion within 2 to 15 min (Poole et al. 1988). Time to exhaustion (t) was 
recorded to the nearest second and was taken as either volitional exhaustion or when cadence 
fell 10% below the freely chosen cadence for more than 5 s, despite strong verbal 
encouragement. No feedback regarding the power output or times achieved were provided, 
however participants were permitted to view pedal cadence throughout. To enhance the 
accuracy of parameter estimates, when the standard error of CP was >5% and Wʹ >10% an 
additional test was performed.  
The parameters of the power-duration relationship, CP and Wʹ, were calculated using the 
inverse linear relationship (equation 1), the linear work-time model (equation 2) and the 
hyperbolic relationship (equation 3). The equation associated with the lowest combined 
standard error was selected and used for all further analysis. 
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 P = Wʹ · (1/t) + CP  (1) 
W = CP . t + Wˈ  (2) 
 t = Wʹ / (P – CP)  (3) 
 
Muscle sampling and analysis 
16 participants consented to provide muscle biopsy samples (CON, n = 7; BFR, n = 9). Muscle 
biopsies were obtained, at rest, from the lateral portion of the vastus lateralis muscle under 
local anaesthesia (1% lidocaine) using the percutaneous needle biopsy technique with suction. 
Pre- and post-training samples were obtained through separate incisions 2 cm apart on the same 
leg. Muscle samples were split into two portions. One portion was immediately embedded in 
mounting medium (Tissue-Tek OCT Compound, Sakura Finetek Europe, The Netherlands) 
and immediately frozen in liquid nitrogen-cooled isopentane. The other portion was snap-
frozen in liquid nitrogen. All samples were then stored at -80°C until analysis. 
Immunohistochemistry 
Transverse serial sections (8 μm) were obtained using a cryotome and placed onto poly L-
lysine coated glass slides. Sections were fixed for 10 min in 3.7% formaldehyde at room 
temperature and blocked with phosphate buffered saline (PBS) containing 2% bovine serum 
albumin (BSA) and 5% goat serum for 1 h at room temperature. Serial muscle sections were 
then incubated with either primary antibody CD-31 (ab119339, abcam, Cambridge, UK) 
diluted 1:100 and MHC II (ab91506, abcam, Cambridge, UK) diluted 1:1000 in PBS-2% BSA 
or MHC I (A4.951, DSHB, Iowa, USA) diluted 1:500 in PBS-2% BSA for 1 h at room 
temperature. A separate slide was also incubated in CD-31 as described above and was 
subsequently incubated with Ki-67 (ab92742, abcam, Cambridge, UK) diluted 1:250 in PBS-
2% BSA overnight at room temperature. Sections were then incubated for 2 h at room 
temperature with the appropriate secondary antibodies; goat anti-mouse Alexa Fluor 488, (CD-
31, MHC I) and goat anti-rabbit Alexa Fluor 594 (MHC II, Ki-67) diluted 1:500 in PBS-2% 
BSA.  Following incubation cover slips were mounted with fluoromount aqueous mounting 
medium (F4680, Sigma-Aldrich, Dorset, UK). Specificity of staining was assessed with no 
primary antibody negative controls. 
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Images were captured with a fluorescence microscope (Leica DM2500) at 20x magnification. 
Images were taken across the entire CSA of the sample to avoid bias toward smaller fibres. 
Camera exposure time and gain were adjusted and kept consistent for all images captured for 
each participant. An average of 117 ± 43 type I and 90 ± 49 type II fibres were analysed per 
sample. Capillarity was expressed as; capillary to fibre ratio, capillary density and number of 
capillary contacts around type I (CC type I) and type II fibres (CC type II). Ki-67 positive 
nuclei co-localised within capillaries were expressed per fibre (all Ki-67 data are CON n = 6 
and BFR n = 9, with one participant missing due to insufficient tissue sample size). Only 
transverse fibres were included in the analysis, which was assessed primarily by the 
presumption of circularity. Any fibres that were clearly oblique or not transverse to the long 
axis of the fibre were excluded from analysis. Cross sectional area (CSA) of fibres was assessed 
by manually drawing the perimeter of each muscle fibre with the image analysis software Fiji 
(ImageJ). Although absolute fibre size may be overestimated because of fibre swelling during 
thawing of frozen sections, this should be consistent between all samples. The investigator was 
blinded to the exercise training status and condition of samples for all analysis.  
Western blot analysis 
Muscle tissue was homogenised in cold lysis buffer containing PBS-0.2% Triton X-100 and 
protease and phosphatase inhibitor cocktail (Fisher Scientific, Loughborough, UK). Samples 
were blitzed using a tissue lyser (Qiagen, UK) twice for 2 min at 20 Hz and centrifuged at 
12000 g for 10 min to pellet insoluble material. The supernatant was transferred to a fresh 
Eppendorf tube and protein concentrations were determined by Pierce 660 protein assay 
according to the manufacturer’s instructions (Fisher Scientific, Loughborough, UK). Samples 
were mixed with dH2O, 4x LDS sample buffer (Invitrogen, Loughborough, UK) and 0.1% β-
mercaptoethanol (Sigma, Dorset, UK) to a concentration of 1.5 μg.μl and were boiled for 5 min 
at 95℃. 15 μg of protein was loaded on to 4-20% TGX polyacrylamide gels (Bio-Rad, Herts, 
UK) and separated by electrophoresis at 100 V for 80 minutes. All samples were run in 
duplicate to establish coefficients of variation for a measure of technical variability. Proteins 
were transferred onto PVDF membrane at 30 V for 90 minutes (Bio-Rad, Herts, UK) and 
washed for 5 min in Tris buffered saline with tween (TBST) before being blocked in 5% 
blotting grade milk (Bio-Rad, UK) for 1 h at room temperature. Membranes were washed three 
times for 5 min in TBST and were incubated overnight with the primary antibodies; citrate 
synthase (CS) (ab129095, abcam, Cambridge, UK), cytochrome c oxidase (COX) subunit II 
(ab110258, abcam, Cambridge, UK) and COX IV (ab33985, abcam, Cambridge, UK ) diluted 
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1:1000 in 3% blotting grade milk at 4°C. Membranes were then washed three times for 5 min 
in TBST and incubated with the appropriate secondary antibody; anti-mouse horseradish 
peroxidase-conjugated secondary antibody (Dako, Stockport, UK) or anti-rabbit horseradish 
peroxidase-conjugated secondary antibody (Bio-Rad, Herts, UK) diluted 1:10,000 in 3% 
blotting grade milk for 1 h at room temperature. Following three 5 min washes in TBST, 
membranes were incubated with enhanced chemiluminescence substrate (ClarityMax, Bio-
Rad, Herts, UK) for 5 min. Membranes were visualised using image analysis (ChemiDocTM 
XRS+, BioRad, Herts, UK) and band densities determined using image analysis software 
(Quality One 1-D analysis software v 4.6.8, Bio-Rad, Herts, UK).  GAPDH was used as a 
loading control, as it remained stable across time for both conditions (CON P = 0.30; BFR P = 
0.39;  Fig. 4.4). Protein content was expressed in arbitrary units relative to GAPDH. All protein 
content data are CON n = 7 and BFR n = 7, with two participants missing due to insufficient 
tissue sample size. The coefficients of variation for CS, COXII and COXIV were 5.1 ± 3.9%, 
6.8 ± 5.8% and 4.3 ± 3.2% respectively.  
Exercise training 
Participants completed a four-week supervised SIT programme (2 sessions per week) each 
session being separated by a minimum of 48 h. Participants were encouraged to maintain their 
regular training regime with the exception of performing any form of interval training. This 
was to ensure a substantial reduction in training volume was avoided. Each training session 
consisted of repeated 30 s maximal sprints performed on a mechanically braked cycle 
ergometer (SE-780 50, Monark, Stockholm, Sweden) against a manually applied resistance 
equivalent to 0.075 kg/kg body mass. The training was progressive whereby all participants 
performed a total of 4, 5, 6 and 7 maximal 30 s sprints in weeks 1, 2, 3 and 4, respectively. 
Each sprint was separated by a 4.5 min recovery period, during which participants immediately 
dismounted the cycle ergometer and lay in a semi-supine position upon a couch. In BFR 
participants were subjected to BFR (applied within 25 s of each sprint). This was achieved by 
rapidly applying pneumatic pressure cuffs (Hokanson SC12L) as high up as possible on the 
proximal portion of each thigh, which were inflated (E20 Rapid Cuff Inflator and AG101 Cuff 
Inflator Air Source, Hokanson, WA) to a pressure of ~ 120 mmHg for 2 min (this pressure was 
kept constant throughout the four-week training period). The cuffs were then rapidly deflated 
and participants remained in the supine position until 30 s prior to the next sprint where they 
re-mounted the ergometer in time for the subsequent sprint which began precisely 4.5 min after 
the previous sprint ended. In CON participants remained in the semi-supine position before re-
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mounting the ergometer in time for the subsequent sprint. Pre- and post-training measurements 
of peak power output (PPO) and mean power output (MPO) were obtained (Monark software) 
from the best sprint within the first and last training sessions respectively. Total work 
completed throughout the training period was calculated as a sum of the product of the MPO 
from each sprint and sprint duration.   
Statistics 
Training data were analysed using an unpaired t-test. Two-factor repeated-measures ANOVA, 
with one within factor (time; pre vs post) and one between factor (condition; CON vs BFR) 
were utilised to undertake all subsequent analysis. Where significant interaction effects were 
observed Bonferroni-corrected post hoc paired t-tests were used to locate differences. Data are 
presented as mean ± SD. Significance was accepted at P ≤ 0.05. 
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4.5 RESULTS 
Performance measures 
There were no differences in physiological and performance measures prior to training between 
groups (Table 4.1). Participants completed 99% of the assigned training sessions without any 
complications (one participant missed one training session). The total amount of work done 
throughout the training was not different (interaction; P = 0.75) between CON (815 ± 88 kJ) 
and BFR (830 ± 129 kJ).  
Physiological and performance variables measured before and after CON and BFR are 
presented in Table 4.1. There were significant interactions for absolute and relative V̇O2max. 
Subsequent post hoc tests revealed both absolute (Fig. 4.1A) and relative V̇O2max increased 
following BFR (absolute P = 0.02; relative P = 0.01) but not in CON (absolute P = 0.56; relative 
P = 0.88). Absolute MAP (Fig. 4.1B) was unchanged with training in either group.  Relative 
MAP increased with training (main effect for time; P = 0.03), however there was no difference 
between CON and BFR.  
The inverse linear relationship produced the lowest combined standard error for CP (CON, Pre; 
1.8 ± 1.0%, Post; 1.1 ± 0.7%, BFR, Pre; 1.7 ± 0.8%, Post; 1.9 ± 1.1%) and Wʹ (CON, Pre; 7.4 
± 4.4%, Post; 4.9 ± 3.5%, BFR, Pre; 8.4 ± 5.7%, Post; 9.1 ± 5.9%) and therefore this equation 
was used to calculate parameter estimates. CP (Fig. 4.1C) increased with training, however 
there was no difference between CON and BFR. Wʹ (Fig. 4.1D) was unchanged with training 
in either group.  
Absolute (Fig. 4.1E) and relative PPO and absolute (Fig. 4.1F) and relative MPO increased 
with training, however there were no differences between CON and BFR.  
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Table 4.1. Physiological and performance variables before and after control (CON) and blood-flow restriction (BFR) training interventions. 
 CON  BFR    
Parameter Pre Post 
Percentage 
change 
 
Pre Post 
Percentage 
change 
ANOVA 
interaction 
P value 
ANOVA 
main effect 
of time P 
value 
ANOVA 
main effect 
of condition 
P value 
Body Mass (kg) 74.6 ± 7.7 74.3 ± 8.5 -0.3  76.3 ± 8.3 75.6 ± 7.7 -0.8 0.59 0.24 0.67 
V̇O2max (l.min-1) 4.59 ± 0.46 4.56 ± 0.48  -0.8  4.70 ± 0.63  4.98 ± 0.72 * 5.9 0.02 0.08 0.45 
V̇O2max (ml.min-1.kg-1)   63.2 ± 4.4  63.0 ± 5.9  -0.3  62.2 ± 3.4  65.2 ± 4.4 * 4.9 0.04 0.06 0.79 
MAP (W) 393 ± 47  397 ± 51  1.0  402 ± 51  412 ± 41  2.6 0.44 0.09 0.56 
MAP (W.kg-1) 5.3 ± 0.5  5.4 ± 0.6  1.5  5.3 ± 0.4  5.5 ± 0.4  3.5 0.40 0.03 0.81 
CP (W) 287 ± 39 297 ± 43 3.6  296 ± 40 306 ± 36 3.3 0.93 0.001 0.58 
Wʹ (kJ) 18.1 ± 5.1 16.2 ± 4.3 -10.4  17.9 ± 6.5 17.4 ± 5.1 -3.0 0.53 0.26 0.80 
PPO (W) 1057 ± 174 1112 ± 179 5.2  1065 ± 245 1142 ± 262 7.2 0.62 0.008 0.85 
PPO (W.kg-1) 14.3 ± 2.3 15.0 ± 2.2 5.4  13.8 ± 2.7 14.9 ± 2.8 8.3 0.53 0.004 0.80 
MPO (W) 686 ± 73 692 ± 62 0.8  701 ± 113 722 ± 112 3.1 0.23 0.05 0.60 
MPO (W.kg-1) 9.2 ± 0.6 9.3 ± 0.6 1.4  9.1 ± 1.0 9.5 ± 1.1 4.2 0.22 0.01 0.99 
Values are mean ± SD. Abbreviations: CP, critical power; MAP, maximal aerobic power; MPO, mean power output during 30 s sprint; PPO, peak power output during 
30 s sprint; VO2max, maximal oxygen uptake and Wʹ, curvature constant. All data are CON n = 10 and BFR n = 11, except for V̇̇ O2max where n = 8 and PPO and MPO 
where n = 10. * Denotes significantly different to Pre-training (Bonferroni-corrected post hoc paired t-test; P < 0.05). 
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Figure 4.1. Individual responses of V̇O2max (A), MAP (B), CP (C), Wʹ (D), PPO (E) and MPO 
(F) before and after control (CON) and blood flow restriction (BFR) training interventions. 
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Capillarisation and muscle morphology 
All measures of capillarisation (Fig. 4.2) were unchanged with training in either group (Table 
4.2). The number of Ki-67 proliferating cells co-localised with capillaries was not significantly 
changed (interaction; P = 0.06) with training in either group (Fig. 4.3). CSA of type I and type 
II fibres were unchanged with training in either group (Table 4.2).  
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Figure 4.2. Muscle capillaries before and after control (CON) and blood-flow restriction (BFR) 
training interventions. A) Representative images of muscle capillaries stained with CD-31 
(green) and type II fibres (blue). Scale Bar = 50 µm. B) Individual responses of capillary 
density and capillary to fibre ratio. Data are CON n = 7; BFR n = 9.   
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Figure 4.3. Presence of proliferating endothelial cells before and after control (CON) and 
blood-flow restriction (BFR) training interventions. A) Representative image of Ki-67 (red) 
positive endothelial cell (green). Scale Bar =50 µm. B) Individual responses of Ki-67 positive 
endothelial cells per fibre. Data are CON n = 6; BFR n = 9.  One bar for BFR is hidden as data 
are pre =0.00 and post = 0.00. 
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Table 4.2. Capillarisation and muscle morphology before and after control (CON) and blood-flow restriction (BFR) training interventions. 
 CON  BFR    
 
Parameter 
 
Pre 
 
Post 
 
Percentage 
change 
 
 
Pre 
 
Post 
 
Percentage 
change 
ANOVA 
interaction  
P value 
ANOVA 
main effect 
of time P 
value 
ANOVA main 
effect of 
condition  
P value 
Capillary Density 
(mm-2) 
405 ± 65 386 ± 27 -4.6 
 
420 ± 30 415 ± 40 -1.3 0.49 0.22 0.27 
Capillary to fibre 
ratio 
2.97 ± 0.63 2.98 ± 0.71 0.4 
 
2.87 ± 0.64 2.97 ± 0.75 3.5 0.68 0.60 0.88 
CC Type I 7.03 ± 1.21 6.92 ± 1.54 -1.6  6.99 ± 1.25 7.19 ± 1.43 2.7 0.44 0.85 0.86 
CC Type II 6.45 ± 1.09 6.63 ± 1.40 2.8  6.01 ± 1.06 6.32 ± 1.53 5.1 0.73 0.20 0.56 
CSA Type I (µm-2) 6456 ± 1651 6379 ± 1764 -1.2  6146 ± 1242 6375 ± 1472 3.7 0.62 0.81 0.83 
CSA Type II (µm-2) 6908 ± 1463 6998 ± 1415 1.3  5896 ± 963 6364 ± 1639 7.9 0.47 0.29 0.23 
Ki-67/fibre    0.07 ± 0.05 0.06 ± 0.04 -19.7  0.05 ± 0.06 0.10 ± 0.09 103.4 0.06 0.29 0.85 
Values are mean ± SD. Abbreviations: CC Type I, capillary contacts of type I muscle fibres; CC Type II, capillary contacts of type II muscle fibres; CSA Type I, cross 
sectional area of type I muscle fibres; CSA Type II, cross sectional area of type II muscle fibres and Ki-67/fibre, Ki-67 positive capillaries per fibre. All data are CON 
n = 7 and BFR n = 9, except Ki-67/fibre which is CON n = 6 and BFR n = 9. 
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Content of mitochondrial enzyme proteins 
Protein content of CS, COXII and COXIV (Fig. 4.4) were all unchanged with training in either 
group.  
 
 
Figure 4.4. Content of CS (A), COXII (B) and COXIV (C) protein before and after control 
(CON) and blood flow restriction (BFR) training interventions. Values are expressed as fold 
changes relative to pre-training values. Bars represent the mean and lines represent individual 
responses.  Data are CON n = 7; BFR n = 7.   
  
GAPDH 
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4.6 DISCUSSION 
This study has demonstrated that 4 weeks of SIT increased CP in trained individuals, however 
the addition of BFR did not enhance this further. Furthermore, SIT, with or without BFR, did 
not induce any changes in skeletal muscle capillarity or the content of mitochondrial proteins 
in our trained population. The study has, however, confirmed the potency of SIT combined 
with BFR in increasing V̇O2max to a greater extent than SIT alone.  
We had hypothesised that the increase in CP following SIT would be further enhanced with 
BFR. In contrast to this hypothesis, whilst there was an increase in CP of 3.6% with SIT, there 
was no greater enhancement with BFR which had a similar magnitude of increase of 3.3%. The 
improvement in CP is in line with previous research which has demonstrated increases in CP 
following HIIT (Gaesser & Wilson, 1988; Poole et al. 1990). The increases of 10-15% in the 
aforementioned studies are notably greater than that of the present study; however, considering 
our shorter training period and well-trained participants this is not surprising. Nevertheless, it 
is important to note that the gains of ~3.5% are greater than the smallest worthwhile change in 
power for well-trained individuals of 1% (Paton & Hopkins, 2001) and therefore represents a 
meaningful observation. 
Given the established relationship between capillarity and high intensity exercise performance 
(Iaia et al. 2011), particularly CP (Mitchell et al. 2018), together with the potency of the acute 
angiogenic stimulus our novel training intervention provides (Taylor et al. 2016a), it was 
surprising that we did not observe an increase in any measure of capillarity in either training 
group. The lack of increase in capillarity could be due to the volume of training undertaken, 
given that, in comparison to rodents where angiogenesis can occur within a week (Waters et 
al. 2004), in humans it is generally considered that angiogenesis manifests later than other 
training adaptions, typically occurring after 4-5 weeks of training (Andersen & Henriksson, 
1977; Jensen et al. 2004a). Whilst the current training protocol was 4 weeks in duration it 
involved only 8 low volume training sessions. Although SIT has been shown to increase 
skeletal muscle capillarity, this was in untrained individuals (V̇O2max of 41.9 ± 1.8 ml.min-1.kg-
1) and was after 18 sessions over a longer period of 6 weeks (Cocks et al. 2013), resulting in a 
training volume more than double that of the present study. Volume of training seems to play 
a greater role than intensity in stimulating angiogenesis (Gliemann, 2016). For example, HIIT 
has been shown to produce a lower acute angiogenic response in interstitial fluid than moderate 
intensity training (Hoier et al. 2013a) and an increase in training intensity at the expense of the 
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volume of training in trained individuals has been demonstrated to reduce skeletal muscle 
VEGF protein content (Gliemann et al. 2015) and stunt increases in capillarisation (Hoier et 
al. 2013a). Therefore, in spite of our hypothesis, the 8 sessions may still have been an 
insufficient stimulus to induce an increase in capillarisation. This is further exacerbated by the 
trained nature of our participants in which the baseline capillary to fibre ratio of 2.9 is around 
double that previously reported in untrained participants of ~1.4 (Andersen & Henriksson, 
1977; Jensen et al. 2004a).  
Nevertheless, the angiogenic potential of the present training intervention was further explored 
by investigating the presence of proliferating endothelial cells. The antibody Ki-67 detects a 
proliferation-associated nuclear antigen whereby its co-localisation within endothelial cells in 
skeletal muscle allows the identification of proliferating endothelial cells and thus location of 
growing capillaries (Hoier et al. 2010; Jensen et al. 2004a) and is therefore a measure that 
would precede increases in skeletal muscle capillarity. There was no significant change in Ki-
67 positive endothelial cells following training in either group, although the interaction effect 
was P = 0.06 and there was an approximate 100% increase in Ki-67 positive endothelial cells 
following BFR, which was not present after CON. Indeed, there was a greater presence of the 
number of Ki-67 positive endothelial cells in 7 out of 9 participants of the BFR group compared 
to only one participant demonstrating any evidence of increased EC proliferation in CON and 
a calculation of Cohen’s d revealed a medium effect size of 0.63. These observations suggest 
the potential of post-exercise BFR to enhance angiogenesis is worth further exploration and to 
induce measurable further adaptation in this already well adapted population may require a 
greater training period or a higher training volume.  
There were no changes in the content of mitochondrial proteins CS, COXII and COXIV 
following either training group. This contrasts with previous findings which have consistently 
demonstrated increases in markers of mitochondrial biogenesis following SIT, including 
increased activity of CS and COX (Burgomaster et al. 2005; 2006; 2008; Gibala et al. 2006), 
increased protein content of COXII and COXIV (Burgomaster et al. 2007; Gibala et al. 2006) 
and increased maximal mitochondrial respiration (Granata et al. 2016). These previous 
investigations have, however, only been undertaken on untrained or recreationally active 
populations; therefore, it seems likely that the lack of effect in the present study is attributable 
to our already well adapted trained population.  
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In the absence of any observable angiogenesis and mitochondrial biogenesis the improvement 
in CP in both groups could be attributable to multiple factors related to the so-called anaerobic 
capacity of skeletal muscle. For example, increases in skeletal muscle buffering capacity 
(Weston et al. 1997) and monocarboxylate transporter protein (Bickham et al. 2006) have been 
demonstrated following HIIT in trained individuals. These adaptations, which would enhance 
the ability for the removal of fatigue inducing metabolites and thus be expected to increase the 
power at which the loss of metabolic homeostasis occurs, could be hypothesised to increase 
CP. Such adaptations may also be expected to increase Wʹ which, as the second parameter of 
the power-duration relationship, has classically been considered to represent an anaerobic 
component (Morton, 2006). Wʹ was, however, unchanged in the present study, as has typically 
been reported in many high-intensity training studies that have reported an increase in CP 
(Gaesser & Wilson, 1988; Poole et al. 2016; Vanhatalo et al. 2008). It is important to consider 
the interrelated nature of CP and Wʹ which have regularly been reported to change in opposite 
directions in response to multiple interventions (Poole et al. 2016) and as such the observed 
increase in CP may have offset any increases in Wʹ.  
Although CP increased in both groups, V̇O2max increased in the BFR group only. This supports 
our previous work (Taylor et al. 2016a) which initially demonstrated the potency of this novel 
training intervention, with an increase in V̇O2max of ~4.5%, and agrees with further studies 
which have demonstrated an increase in V̇O2max with the addition of BFR to low intensity 
(~40% of V̇O2max) exercise (Abe et al. 2010a; Park et al. 2010). Improvements in V̇O2max have 
been demonstrated to precede increases in skeletal muscle capillaries (Andersen & Henriksson, 
1977) and while submaximal thresholds are predominantly determined by peripheral 
mechanisms (Joyner & Coyle, 2008), central components, in particular maximal cardiac output, 
are considered to be the principal limiting factors of V̇O2max, at least within whole body exercise 
such as cycling (Bassett & Howley, 2000; Joyner & Coyle, 2008). Therefore, on the basis we 
have not observed any increase in capillarity, the increase in V̇O2max following BFR is perhaps 
more likely to be attributable to central adaptations, i.e. increased cardiac output, with SIT 
alone not presenting a sufficient challenge within our trained population. The addition of BFR 
during and after exercise poses a significant challenge to the central cardiovascular system 
through the induction of the exercise pressor reflex (Alam & Smirk, 1937; Spranger et al. 2015) 
that results in an increase in HR and systolic blood pressure (Bull et al. 1989; Iida et al. 2007; 
Poton & Polito, 2015; Renzi et al. 2010; Staunton et al. 2015). Central cardiovascular 
adaptations have previously been reported with BFR exercise whereby Park et al. (2010) 
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demonstrated that 2 weeks of walk training combined with BFR increased stroke volume by 
21.4%. Although no assessment of stroke volume was made in the control group of that study, 
so the effect of exercise alone is unknown, it seems plausible that the pressor reflex related 
stimulus of BFR could induce a central adaptive response that contributes to an increase in 
maximal cardiac output and thus V̇O2max.  
The present study is not without its limitations. Whilst the use of trained individuals clearly 
enhances the validity of the application of the study findings to elite training practice, this 
resulted in a reduced sample size, in particular of participants who consented to muscle 
biopsies. Although typical of the current literature, the sample size must therefore be 
considered when interpreting the results, which is likely to have reduced the chances of 
correctly accepting or rejecting the null hypotheses. This is perhaps reflected in the present 
study with several parameters which displayed P values close to the critical value.  An absolute 
BFR cuff pressure of 120 mmHg was also utilised for all participants. It is known that there is 
a variation between individuals in the level of BFR imposed by a standard absolute external 
cuff pressure (Hunt et al. 2016) which will affect the level of muscle oxygenation and muscle 
metabolite accumulation (Karabulut et al. 2011; Takarada et al. 2000). Indeed, unpublished 
work in our laboratory using the same standard cuff pressure suggests that the decrease in 
muscle oxygenation imposed by the post-exercise BFR in the present training protocol varies 
between 11 and 43% (Mitchell EA, Bailey SJ & Ferguson RA, unpublished observations). It is 
therefore possible that the physiological signals imposed with the addition of post-exercise 
BFR were not consistent between individuals and may have impacted the extent of any 
adaptations. Furthermore, the present study only focused on the peripheral adaptations to the 
current intervention. As discussed above it seems likely that the observed increase in V̇O2max 
could be attributable to central adaptations, such as increased cardiac output. The central 
adaptive responses to BFR exercise clearly require further investigation.  
In conclusion, the addition of post-exercise BFR did not enhance the increase in CP observed 
after 4 weeks of SIT in trained individuals. SIT with or without BFR did not induce any changes 
in skeletal muscle capillarity or the content of mitochondrial proteins. The study has, however, 
confirmed previous findings of the potency of combining post exercise BFR during SIT in 
enhancing V̇O2max in trained individuals. 
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CHAPTER 5 
THE EFFECT OF COMBINED SPRINT INTERVAL TRAINING AND 
POST-EXERCISE BLOOD FLOW RESTRICTION ON SKELETAL 
MUSCLE OXYGENATION 
 
 
5.1 INTRODUCTION 
A reduction in skeletal muscle oxygenation elicits an accumulation of the oxygen-sensing 
subunit HIF-1α and its translocation into the nucleus (Ameln et al. 2005; Jiang et al. 1996). In 
the nucleus HIF-1α binds to DNA and activates the expression of multiple target genes, one of 
which is the pro-angiogenic factor VEGF (Forsythe et al. 1996; Ke & Costa, 2006). 
Accordingly, skeletal muscle hypoxia is considered as a potent angiogenic stimulus (Egginton, 
2009). Indeed, it has been demonstrated that undertaking training sessions under systemic 
hypoxia can elicit increases in skeletal muscle capillary supply which do not arise when the 
same exercise training is performed in normoxia (Desplanches et al. 1993; Geiser et al. 2001; 
Kon et al. 2014). 
BFR reduces skeletal muscle oxygenation during low-load exercise (Tanimoto et al. 2005; 
Ganesan et al. 2015; Downs et al. 2014; Corvino et al. 2017). Moreover, when BFR is 
maintained during rest intervals the reductions in muscle oxygenation are sustained (Downs et 
al. 2014; Ganesan et al. 2015). Post-exercise BFR could therefore, have the potential to elicit 
a hypoxic environment which may be an important factor for optimising the angiogenic 
potential. Taylor et al. (2016) provided preliminary evidence to support this by demonstrating 
that HIF-1α mRNA expression was enhanced 3 hours post SIT with the addition of post-
exercise BFR. Acute exercise elicits transient increases in HIF-1α mRNA expression when 
muscle is exposed to a sufficient hypoxic stimulus (Vogt et al. 2001). Therefore, the increase 
in HIF-1α mRNA expression observed likely reflects a reduction in skeletal muscle 
oxygenation during the restriction periods. This suggests that post-exercise BFR applied for 
only short periods (4 x 2 min) is adequate to reduce skeletal muscle oxygenation, however this 
has yet to be established. 
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In Chapter 4, it was observed that post-exercise BFR did not enhance performance, as assessed 
by CP, or skeletal muscle capillarity following 4 weeks of SIT. Given that training volume 
appears to be a more important factor than training intensity in eliciting angiogenesis in trained 
individuals (Gliemann et al. 2015; 2016; Hoier et al. 2013a), it seems likely the training volume 
may have been too low to elicit an increase in skeletal muscle capillarity in the trained 
population. Nevertheless, increasing the post-exercise BFR stimulus may also enhance the 
adaptive potential. BFR has previously been shown to reduce skeletal muscle oxygenation in a 
dose-response manner with the level of restriction pressure applied (Karabulut et al. 2011). 
Moreover, the extent of HIF-1α accumulation is increased with increasing reductions in muscle 
oxygenation (Jiang et al. 1996). Therefore, the hypoxia related stimulus of post-exercise BFR 
may be enhanced with different restriction protocols.  
Therefore, the aim of the present study was to establish the level of skeletal muscle oxygenation 
using near-infrared spectroscopy (NIRS) during SIT with and without post-exercise BFR of 
the vastus lateralis (VL) and rectus femoris (RF) muscles (Study 1) and secondly to investigate 
whether the level of skeletal muscle oxygenation would be altered with different restriction 
protocols (Study 2). It was hypothesised that post-exercise BFR would reduce skeletal muscle 
oxygenation during the recovery periods and that this reduction would be greater with a higher 
cuff pressure.  
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5.2 METHODS 
Study 1 
Experimental Design 
Six healthy males, all of whom undertook regular endurance training, volunteered to participate 
in the study. In a repeated measures design, participants undertook two sessions of SIT; alone 
(CON) and with post-exercise BFR (BFR) in a randomised order. The testing sessions were 
separated by a minimum of 72 hours. All testing protocols were undertaken on a mechanically 
braked cycle ergometer (SE-780 50, Monark, Stockholm, Sweden). Seat dimensions were 
adjusted during the initial visit and were kept consistent for the second session. Participants 
were instructed to arrive in a rested state, having refrained from strenuous exercise for 24 hours 
and abstained from caffeine and alcohol for 12 and 24 hours prior to the sessions, respectively. 
Experimental Protocols 
Following a 5 min warm-up at a frictional resistance of 1 kg, participants performed four 
repeated 30 s maximal sprints against a manually applied resistance equivalent to 0.075 kg/kg 
body mass. Each sprint was interspersed by a 4.5 min recovery period during which participants 
immediately dismounted the bike and lay in a semi-supine position upon a couch. In BFR, 
lower limb BFR was applied within 25 s of finishing each sprint. This was achieved through 
the rapid application of a pneumatic pressure cuff (13.5cm wide, Hokanson SC12L) to the 
proximal portion of each thigh, rapidly inflated (E20 Rapid Cuff Inflator and AG101 Cuff 
Inflator Air Source; Hokanson, Bellevue, WA, USA) to a pressure of ~120 mmHg for 120 s. 
The cuffs were then rapidly deflated and participants remained in the supine position until 30 
s prior to the next sprint where they re-mounted the ergometer. In CON participants remained 
in the semi-supine position before re-mounting the ergometer in time for the subsequent sprint.  
Study 2 
In a case study format one participant undertook four sessions of SIT, which were undertaken 
as described above but with variations to the recovery protocol. These sessions were separated 
by a minimum of 6 days to minimise any training effects. The sessions the participant 
undertook were: 1) SIT with post-exercise BFR at 120 mmHg for 120 s (BFR120); 2) SIT alone 
(CON); 3) SIT with post-exercise BFR at 160 mmHg for 90 s (BFR160) and 4) SIT with post-
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exercise BFR at 120 mmHg for 60 s, deflated for 30 s and re-inflated for a further 60 s 
(BFR2min).  
Experimental Measures 
A NIRS (NIRO-200NX, Hamamatsu Photonics KK) was utilised to monitor changes in muscle 
oxygenation status throughout the testing protocols. Two NIRS probes were affixed to the left 
leg; upon the RF and the VL, in line with two-thirds of the distance between the top of the 
patella and the inguinal crease, using double-sided adhesive tape. Participants wore elastic 
shorts which covered the probes to help prevent movement and reduce extraneous light 
exposure during data collection. Light was emitted at wavelengths of 735, 810 and 850 nm, 
with a light source-detector separation distance of 3 cm. The relative contribution of 
haemoglobin and myoglobin to the NIRS signal is unresolved; the changes in the 
concentrations of deoxy-haemoglobin and myoglobin (HHb) and oxy-haemoglobin and 
myoglobin (O2Hb) were calculated using the modified Beer-Lambert method, and the tissue 
oxygenation index (TOI) was used to describe the oxygenation of the muscle during the 
protocol. All variables were sampled at 2 Hz and were interpolated into 1-s intervals. In study 
1 data was expressed as a mean over the sprint (30 s), restriction (2 min when blood flow 
restriction was applied in BFR) and rest (final 30 s in supine position) periods for each 
repetition. In study 2, data is presented as 10 s averages, averaged across the four sprint 
repetitions for each session.   
Statistics 
For study 1 total work done was analysed using a paired samples t test and three factor 
(condition; BFR vs CON, repetition 1-4 and part; sprint vs restriction vs rest) repeated measures 
ANOVAs were utilised to analyse all subsequent analysis. When significant effects were 
identified paired samples t tests corrected with the Holm-Bonferroni step-wise method were 
used to locate differences (Atkinson, 2002). Data are displayed as mean ± SD. Significance 
was accepted at P ≤ 0.05, and a statistical trend was accepted as P ≤ 0.10. 
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5.3 RESULTS 
Study 1 
Total word done during each session was not different between CON (72 ± 3 kJ) and BFR (72 
± 3 kJ) conditions (P =0.33). All participants completed the full protocol in CON, however, 
two participants were unable to undertake the final sprint and restriction within BFR.  
O2Hb in RF (Fig 5.1A) and VL (Fig 5.1B) decreased during the sprints (P < 0.01) and increased 
during the recovery periods (P < 0.001; main effect of part P < 0.001). There was no difference 
between groups throughout the protocol in RF (main effect of group P = 0.65; group*part 
interaction effect; P = 0.16), although there was a trend for lower O2Hb in BFR than CON in 
VL (main effect of group P = 0.07; group*part interaction effect; P = 0.06). 
HHb in both RF (Fig. 5.1C) and VL (Fig. 5.1D) (main effect of part: P < 0.001) in BFR (P < 
0.05), and in VL in CON increased during the sprints (P < 0.05) and tended to increase in the 
RF in CON (P < 0.10). HHb decreased during the restriction period in CON in the VL (P < 
0.01) and tended to decrease in the RF (P < 0.10), however, in BFR HHb increased in RF (P < 
0.05) and VL (P < 0.05; group*part interaction effect P = 0.001 and P < 0.001, respectively). 
During the restriction period HHb was 19 ± 8 and 15 ± 5 higher in BFR than CON in RF and 
VL respectively (main effect of group P = 0.005 and P = 0.003). During the rest period HHb 
decreased in BFR in RF and VL (P < 0.05) and in CON in VL (P < 0.05) and tended to decrease 
in RF (P < 0.10).  
TOI in both RF (Fig. 5.1D) and VL (Fig. 5.1E) decreased during the sprints (main effect of 
part: P < 0.001) in both CON and BFR (P < 0.05). Following the sprint in CON TOI increased 
in both RF and VL during the initial recovery period (P < 0.05), however, excluding the initial 
sprint in VL, in BFR TOI in RF and VL was unchanged from the sprint during the restriction 
period (P > 0.05; group*part interaction effect P = 0.006, P < 0.001, respectively). During the 
restriction period TOI was 20 ± 10% and 11 ± 5% lower in BFR than CON in RF and VL 
respectively (main effect of group P = 0.003 and P = 0.001, respectively). TOI increased in the 
final recovery period in CON and BFR in RF (P < 0.05) and tended to increase in VL (P < 
0.10).  
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Figure 5.1. O2Hb in RF (A) and VL (B), HHb in RF (C) and VL (D) and TOI in RF (E) and 
VL (F) during control (CON) (open circles) and blood flow restriction (BFR) (closed circles) 
sprint interval training sessions. * denotes significantly different to CON, P < 0.05. 
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Study 2 
O2Hb in RF (Fig. 5.2A) was similar between all four protocols at the end of the initial recovery 
period. In contrast in the VL (Fig. 5.2B) O2Hb was lower in all three restriction protocols than 
CON during the initial recovery period. Following the initial cuff deflation in BFR2 O2Hb 
increased to levels similar to CON and was only slightly reduced (2.0 a.u) upon the second 
restriction.   
During the initial recovery period HHb decreased in RF (Fig. 5.2C) and VL (Fig. 5.2D) in CON 
but increased in all restriction protocols. BFR160 increased during the restriction period by a 
greater extent (256.9% in RF and 61.9% in VL) than BFR120 (184.4% in RF and 42.3% in VL) 
and BFR2min (126.0% in RF and 23.5% in VL). In BFR2 HHb was reduced during the 30 s 
deflation period but did not reach baseline values. The peak during the second restriction period 
was 14.2% and 24.0% lower in the RF and VL, respectively, than the first 60 s restriction 
period.   
In RF (Fig. 5.2E) during the first 60 s of the restriction period mean TOI was similar in all three 
restriction protocols (BFR120 = 46.9%; BFR160 = 45.0%; BFR2 = 48.4%), but was notably 
lower than CON (67.7%). During the 30 s reperfusion period in BFR2 TOI increased towards 
baseline but was still 7.1% lower than CON at the same time point. The TOI during the second 
60 s restriction period was 11.8% lower than the first restriction. TOI in the VL (Fig. 5.2F) was 
lower during the restriction protocols (BFR120 = 53.6; BFR160 = 57.9; BFR2 = 55.7) than 
CON (60.4%), but demonstrated much smaller differences than RF.  
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Figure 5.2. O2Hb in RF (A) and VL (B), HHb in RF (C) and VL (D) and TOI in RF (E) and 
VL (F) during a single sprint and recovery period in CON (red), BFR120 (green), BFR160 
(purple) and BFR2 (blue) sprint interval training sessions. 
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5.4 DISCUSSION 
This study has demonstrated that the addition of post-exercise BFR to SIT reduces skeletal 
muscle oxygenation and increases HHb during the restriction periods. Whilst the restriction 
protocol had little effect on the extent of the reduction in TOI, a higher restriction pressure 
enhanced the increase in HHb. 
In agreement with the hypothesis, post-exercise BFR combined with SIT reduced TOI during 
the recovery periods by ~20 and ~11% in the RF and VL muscle, respectively, compared with 
SIT alone. In addition, post-exercise BFR also substantially increased HHb. The HHb signal 
from NIRS is considered to provide a non-invasive index of local oxygen extraction and 
therefore reflects the balance between muscle oxygen delivery and utilisation (DeLorey et al. 
2003; Grassi et al. 2003). Thus, the increase in HHb could be attributed to both the reduced 
arterial inflow and the occluded venous outflow with BFR application (Takano et al. 2005). 
Indeed, it is possible that a reduction in the rate of blood flow due to the venous occlusion 
facilitated oxygen extraction of the available blood supply (Ganesan et al. 2015) contributing 
to the continual rise in HHb. Perhaps surprisingly, there was no concomitant significant 
decrease in O2Hb with post-exercise BFR. This is, however, consistent with previous 
observations in BFR exercise (Ganesan et al. 2015). The lack of change could, at least in part, 
be attributable to the fact that O2Hb is more sensitive to changes in blood volume and total 
haemoglobin levels (Grassi & Quaresima, 2016) which are altered during BFR (Ganesan et al. 
2015).  
The reduction in TOI and increase in HHb are consistent with previous observations of 
enhanced HIF-1α mRNA following SIT combined with post-exercise BFR (Taylor et al. 
2016a), and confirm that short periods of post-exercise BFR at a relatively low restriction 
pressure are sufficient to reduce skeletal muscle oxygenation of the quadriceps muscle. 
Hypoxic conditions are known to elicit angiogenic signalling (Ameln et al. 2005; Forsythe et 
al. 1995). Previous investigations have also demonstrated that undertaking exercise training 
sessions under conditions of systemic hypoxia can elicit increases in indices of skeletal muscle 
capillarity following both continuous endurance-type (Desplanches et al. 1993; Geiser et al. 
2001) and resistance-type exercise (Kon et al. 2014). Therefore, these findings tentatively 
suggest that the local hypoxic conditions elicited with post-exercise BFR could contribute to 
an enhanced angiogenic response to interval training. Whilst this was not confirmed by the 
findings of Chapter 4 of this thesis, which demonstrated no increase in any indices of skeletal 
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muscle capillarity following SIT with or without post-exercise BFR, as discussed in Chapter 4, 
it seems likely that this could have been attributable in part to a training volume that was too 
low to elicit angiogenesis (Gliemann, 2016).  
Alongside raising the volume of training, it is also possible that alterations to the post-exercise 
BFR protocols used in Chapter 4 could enhance the adaptive stimulus of future post-exercise 
BFR training protocols. Therefore, the aim of the second part of the present study was to 
investigate the effect of different BFR protocols on the hypoxic response of post-exercise BFR. 
In contrast to the hypothesis, a higher restriction pressure did not notably further reduce TOI. 
The small variations observed were perhaps more likely to be attributable to the variation 
arising from the replacement of the NIRS probes between the different protocols. However, 
HHb was considerably increased at 160 mmHg compared to 120 mmHg. This suggests that 
there was a greater imbalance between muscle oxygen delivery and utilisation during post-
exercise BFR (DeLorey et al. 2003; Grassi et al. 2003) and therefore implies an increased 
hypoxic stimulus.  
In addition to investigating different cuff pressures, the BFR2 protocol was selected to increase 
the number of BFR applications and reperfusions. Following cuff deflation there is a sustained 
hyperaemic response (Takarada et al. 2000; Gundermann et al. 2012) that would be expected 
to increase the level of shear stress, which is a key stimulus of angiogenesis (Egginton, 2009; 
Williams et al. 2006; Zhou et al. 1998). Therefore, an increased number of reperfusions could 
be hypothesised to enhance any shear stress mediated angiogenic stimulus of post-exercise 
BFR (Egginton, 2009; Williams et al. 2006; Zhou et al. 1998). The present study, however, 
demonstrated that following the initial 30 s reperfusion period that the magnitude of decrease 
in TOI and increase in HHb was reduced during the second 60 s restriction period. Therefore, 
although this protocol could enhance the shear stress stimulus, these findings suggest it may 
concomitantly reduce the level of hypoxia and subsequent signals induced. 
NIRS is a non-invasive method used to give an indirect assessment of oxygenation of skeletal 
muscle, therefore it is important to note that there are limitations to this method. Firstly, the 
NIRS only measures the area directly beneath the probes. It is known that NIRS measurements 
can demonstrate spatial heterogeneity across the quadriceps muscle group (Koga et al. 2007). 
Both the RF and VL were investigated in the present investigation to account for this, 
nevertheless, it is still unclear whether these sites measured are reflective of muscle 
oxygenation across the whole quadriceps. It is also important to acknowledge that the NIRS 
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signal reflects a combination of microvascular haemoglobin and intracellular myoglobin, with 
the true relative contribution to the NIRS signal currently unknow. Indeed, current estimates 
suggest that myoglobin may contribute anywhere in a range of 60-90% to the NIRS signal 
(Barstow, 2019). Furthermore, the relative contribution of the arterioles, veins and capillaries 
to the haemoglobin signal is also unknown, with little or no information available on the 
relative PO2 gradients between the capillaries and both the arterioles and veins during exercise 
and occlusion protocols (Barstow, 2019). Moreover, the interpretation of the NIRS device can 
be complicated by high adipose tissue thickness and increased skin blood flow, as occurs during 
exercise (Barstow, 2019). However, the NIRS derived HHb and TOI, which the conclusions of 
the present investigation are largely based on, have been shown not to be substantially altered 
by increased blood flow (Grassi & Quaresima, 2016; Koga et al. 2015; Messere & Roatta, 
2013). In addition, the participants in the present investigation were all lean endurance trained 
individuals. It is therefore expected that these individuals did not possess sufficient adipose 
tissue thickness that would prevent the NIRS signal, which penetrates a distance of half of the 
source detector distance (Barstow, 2019), penetrating into the muscle.  
In conclusion, this study has demonstrated that short periods of post-exercise BFR during SIT 
reduced TOI and increased HHb during the recovery intervals. Furthermore, the present results 
demonstrated that the increase in HHb with the addition of post-exercise BFR was increased 
with a higher cuff pressure, suggesting to optimise the hypoxic stimulus of post-exercise BFR 
protocols that where tolerable for sufficient durations, higher restriction pressures should be 
used.  
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CHAPTER 6 
TIME COURSE OF THE TRANSCRIPTIONAL, TRANSLATIONAL 
AND PHENOTYPIC RESPONSE TO HIGH INTENSITY INTERVAL 
TRAINING COMBINED WITH POST-EXERCISE BLOOD FLOW 
RESTRICTION 
 
 
Chapter 4 demonstrated that 4 weeks of SIT with or without post-exercise BFR did not elicit 
an increase in skeletal muscle capillarity. There was, however, a trend for an increase in 
proliferating endothelial cells after 4 weeks only when SIT was combined with post-exercise 
BFR. Given the importance of training volume for eliciting angiogenesis in trained individuals 
(Gliemann et al. 2015; Hoier et al. 2013a), it is therefore possible that the training volume of 
the SIT protocol was too low to elicit an increase in capillarity and that with a higher training 
volume post-exercise BFR could have elicited an increased capillary supply. Moreover, 
training volume also appears to be an important stimulus for increasing mitochondrial content 
(Granata et al. 2018). 
In order to increase the training volume above that of the SIT protocol utilised in Chapter 4, 
this chapter investigated the use of post-exercise BFR during a higher volume interval training 
protocol, i.e. HIIT. In addition, given that Chapter 5 demonstrated that an increased restriction 
pressure enhanced the level of hypoxia, the restriction pressure was increased from ~120 
mmHg to ~160 mmHg, which was possible for participants to tolerate given the reduced 
training intensity of HIIT vs SIT.   
The main purpose of this chapter was to investigate the addition of post-exercise BFR to two 
weeks of HIIT on the magnitude and maintenance of the transient transcriptional response of 
angiogenic and biogenic genes and the translational and phenotypic response. 
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6.1 INTRODUCTION 
Skeletal muscle demonstrates remarkable plasticity in its adaptive response to endurance 
exercise training, including increases in capillary supply and mitochondrial content (Hoppeler, 
2016). Following an acute bout of exercise there is a transient increase in the mRNA expression 
of genes involved in the adaptive response which typically peak after several hours (Hoier et 
al. 2012; Jensen et al. 2004b; Pilegaard et al. 2003; 2005; Richardson et al. 1999; 2000; Hoier 
et al. 2012) as well translocation (Little et al. 2010a; Hoier et al. 2013b) and post-translational 
modification of key adaptive proteins (Egan & Zierath, 2013; Granata et al. 2017). Overtime, 
the cumulative effect of repeated training sessions elicits gradual increases in protein content, 
enzyme activity and phenotypic remodelling, ultimately leading to functional performance 
enhancements (Egan & Zierath, 2013; Perry et al. 2010).  
As individuals become accustomed to an exercise stimulus there is a blunting of both the acute 
angiogenic (Richardson et al. 2000; Hoier et al. 2012) and mitochondrial biogenic (McConnel 
et al. 2005; Schmutz et al. 2006) molecular response. For example, Perry et al. (2010) clearly 
demonstrated an early attenuated transcriptional response to a specific exercise bout of the 
transcriptional coactivator PGC-1α, which is considered as the ‘master regulator’ of 
mitochondrial biogenesis (Hood, 2009; Puigserver & Spiegelman, 2003; Wu et al. 1999). They 
took muscle biopsies 4 hours after 4 training sessions at 5-day intervals over a 15-day training 
period of HIIT and observed a continual reduction in the acute increase in PGC-1α mRNA 
expression. This attenuation of gene expression was observed even with a continued 
progression in absolute training intensity. This blunting of the molecular response is reflected 
with attenuated increases in protein content and functional and structural adaptation in the 
trained state (Hoppeler et al. 1985; Perry et al. 2010; Saltin et al. 1977). Therefore, to promote 
continued adaptation in endurance trained individuals, who are accustomed to high training 
volumes across a range of exercise intensities, novel training methods capable of overcoming 
and better maintaining the attenuated molecular response are required.  
Post-exercise BFR is a potential training tool that could enhance both the angiogenic and 
mitochondrial biogenic stimulus to training. Recent studies have demonstrated the potential 
potency of this novel training method, observing SIT combined with post-exercise BFR to 
increase V̇O2max by ~4.5-6% in already trained individuals following just 4 weeks (Chapter 4; 
Taylor et al. 2016a). BFR can elicit multiple signals upon its application i.e. reduced muscle 
oxygenation (Karabulut et al. 2011) and increased shear (Gundermann et al. 2012), metabolic 
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(Suga et al. 2009; 2012) and oxidative stress (Christiansen et al. 2018), all of which are 
considered key stimuli of exercise-induced angiogenesis (Egginton, 2009) and/or 
mitochondrial biogenesis (Hood, 2009; Ljubicic et al. 2010).  
The angiogenic and mitochondrial biogenic potential of both SIT combined with post-exercise 
BFR and SIT alone has been demonstrated with acute increases both in PGC-1α and VEGF 
mRNA (Taylor et al. 2016a), which is well regarded as the most central pro-angiogenic factor 
in skeletal muscle (Neufeld, et al. 1999; Olfert et al. 2016). Therefore, it was surprising that in 
Chapter 4 there was no increase in skeletal muscle capillarity or content of mitochondrial 
proteins following 4 weeks of SIT with BFR or SIT alone. This might have been due to the 
short training volume of the SIT intervention, being only 8 short training sessions in total, given 
that current evidence supports the importance of training volume over intensity for eliciting 
both angiogenesis (Gliemann et al. 2015; 2016; Hoier et al. 2013a) and increases in 
mitochondrial content (Granata et al. 2018). Therefore, it is possible that combining post-
exercise BFR with a lower intensity HIIT protocol, which would allow for a greater training 
volume than SIT and an increased number of BFR applications and reperfusions, could elicit 
an enhanced adaptive response.  
Therefore, the purpose of the present study was to assess the effect of post-exercise BFR during 
two-weeks of HIIT on the magnitude and maintenance of the transient transcriptional response 
of key angiogenic and mitochondrial biogenic genes and the translational and phenotypic 
response across the training period. It was hypothesised that the addition of post-exercise BFR 
would enhance and better maintain the acute transcriptional response of VEGF, PGC-1α and 
HIF-1α and elicit greater increases in VEGF protein and mitochondrial protein content and 
enzyme activity.   
93 
 
6.2 METHODS 
Participants 
Eleven healthy males (age; 22 ± 1 yr, height; 182.5 ± 6.8 cm, body mass; 84.6 ± 10.7 kg) 
volunteered to participate in the study. Participants were physically active, but none undertook 
regular endurance training. All completed health and muscle biopsy screening questionnaires 
prior to participation to mitigate for contraindications to maximal exercise, muscle biopsy 
procedures and BFR. Participants did not have a history of neuromuscular, haematological or 
musculoskeletal abnormalities and were not using pharmacological treatments during the study 
period. All experimental procedures were approved by the Loughborough University Ethics 
Approvals (Human Participants) Sub-Committee and conformed in all respects with the 
Declaration of Helsinki. Participants were fully informed of the risks and discomforts 
associated with all experimental trials before providing written, informed consent. 
Experimental design  
The study used an independent groups design, where participants were assigned to one of two 
groups to perform seven HIIT sessions over a two-week period either without (CON = 5) or 
combined with post-exercise BFR (BFR = 6). Muscle biopsies were obtained before and 3 
hours after the first, fourth and seventh training sessions (Fig. 6.1). Prior to training participants 
were familiarised to training procedures and undertook a maximal ramp incremental test a 
minimum of 4 days before the first training session. Following a minimum of 2 days after 
completing the training, participants repeated the ramp incremental test.  
 
 
 
 
 
 
 
Figure 6.1. Schematic of training schedule and muscle biopsy timings 
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All performance tests and training sessions were conducted on an electronically braked cycle 
ergometer (Lode Excalibur Sport, Lode B.V. Gronigen, The Netherlands). Ergometer saddle 
and handle bar dimensions were recorded for each participant during preliminary testing and 
remained standardised for the rest of the study. Participants were instructed to maintain a 
normal diet throughout the study and to record dietary intake 24 hours prior to the maximal 
incremental ramp tests and the muscle biopsy experimental sessions. Participants were asked 
to replicate these leading up to the repeated assessments. Participants were further instructed 
to refrain from ingesting alcohol and caffeine 24 hours preceding the ramp incremental tests. 
Participants were instructed to abstain from any strenuous exercise 24 hours prior to the ramp 
incremental tests and any physical activity 48 hours prior to pre-training muscle biopsies. Ramp 
incremental tests and muscle biopsies were undertaken at approximately the same time each 
day (± 2 hours). Laboratory conditions during pre- and post-training exercise measurements 
remained constant (19-21°C, 40-50% humidity). 
Maximal ramp incremental test 
Participants performed a ramp incremental test to exhaustion to establish V̇O2max, maximal 
aerobic power (MAP) and the gas exchange threshold (GET). Participants began cycling, at a 
freely chosen, constant pedal cadence at 25 W, which was increased at a rate of 25 W.min-1 in 
a linear fashion (0.4 W.sec-1) until either volitional exhaustion or when cadence fell 10% below 
the freely chosen cadence for more than 5 s, despite strong verbal encouragement.  Pulmonary 
gas exchange was measured continuously throughout exercise (Jaeger CPX, San Diego, USA). 
V̇O2max and MAP were defined as the highest V̇O2 achieved for a 30 s period and the final 
power reached during the test, respectively. GET was determined using a cluster of 
measurements: the first disproportionate increase in carbon dioxide production vs V̇O2, an 
increase in expired ventilatory equivalent of oxygen in the absence of a concomitant increase 
in the expired ventilatory equivalent of carbon dioxide and an increase in end-tidal oxygen 
tension in the absence of a decrease in end-tidal carbon dioxide tension (Beaver et al. 1986; 
Whipp et al. 1986).  
Exercise training 
Participants completed seven supervised HIIT training sessions over a 15-day period, sessions 
were separated by a minimum of 48 hours. Each training session consisted of ten 3 min 
intervals performed at a power output equivalent to 60% Δ of the power achieved at GET and 
MAP. In the few instances when participants were unable to maintain the set power output for 
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10 intervals during the first session, the power output was lowered slightly so participants could 
complete the full training session. The mean power output undertaken during the training 
intervals was calculated, and participants then performed all subsequent training sessions at 
this power output. Each interval was separated by a 3 min recovery period, during which 
participants immediately dismounted the cycle ergometer and lay in a semi-supine position 
upon a couch. In BFR, pneumatic pressure cuffs (Hokanson SC12L) were applied as high up 
as possible on the proximal portion of each thigh and were rapidly inflated (E20 Rapid Cuff 
Inflator and AG101 Cuff Inflator Air Source, Hokanson, WA) within 20 s to a pressure of ~160 
mmHg. The cuffs remained inflated for 2 min before being rapidly deflated and participants 
remained in the supine position until 30 s prior to the next interval where they re-mounted the 
ergometer. In CON, participants remained in the semi-supine position until remounting the 
ergometer in time for the subsequent interval. Heart rate (HR) and the Borg rating of perceived 
exertion (RPE; 6-20 scale) were recorded at 2.5 min in each training interval. HR was also 
recorded 2 min into each recovery period. HR and RPE were averaged across the 10 intervals 
to give a mean HR and RPE for each training session. The intensity of training and pressure 
were kept constant throughout the training period. Total work completed during the training 
sessions was calculated as a sum of the product of the power output of each interval and interval 
duration.  
Muscle biopsy procedure 
Muscle biopsies were obtained, at rest, before and exactly 3 hours following completion of the 
first, fourth and seventh training session from the lateral portion of the vastus lateralis muscle. 
The post-training muscle biopsies were sampled at 3 hours post-exercise to coincide within the 
period peak mRNA expression of VEGF and PGC-1α have previously been observed post-
exercise (Hoier et al. 2012; Jensen et al. 20014b; Little et al. 2011; Pilegaard et al. 2003) and 
close to the time HIF-1α mRNA has been demonstrated to be increased after BFR exercise 
(Larkin et al. 2012; Taylor et al. 2016a).  Biopsies were performed under local anaesthesia (1% 
lidocaine) using the percutaneous needle biopsy technique with suction. Pre- and post-training 
biopsies during each experimental training session were taken on the same leg from separate 
incisions 2 cm apart. The leg biopsies were taken from were alternated between each 
experimental training condition. Muscle samples were snap-frozen in liquid nitrogen and 
subsequently stored at -80°C until analysis. 
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Muscle analysis 
Real-time RT-PCR 
One-step quantitative RT-PCR was used to determine muscle mRNA expression, with primer 
sequences designed by Sigma-Aldrich (PGC-1α, HIF-1α, eNOS and RPII) or Primer design 
(VEGF) (Table 6.1). Snap frozen muscle samples were homogenised in TRIzol reagent using 
a handheld TissueRuptor probe (Qiagen). Chloroform was added and following centrifugation 
the aqueous phase was separated. RNA was isolated following precipitation with 2-Propanol. 
The subsequent RNA pellet was washed once with 75% ethanol and was air-dried and 
resuspended in 50 µl of RNA storage solution (Fisher Scientific, Loughborough, UK). Sample 
RNA concentration (230 ± 117 ng/µl) and purity (260/280: 1.9 ± 0.1) were analysed using 
spectrophotometry (Nanodrop 2000, Thermo Scientific, Loughborough, UK). 10 µl PCR 
reactions were made as follows in 384 well plates: 18 ng of RNA in 4.5 µl of RNAase-free 
water, 5 µl of Precision PLUS One Step RT-qPCR Master Mix premixed with SYBR green 
(Primer Design, Southampton, UK) and 0.1 µl of both forward and reverse primers and 0.3 µl 
of RNAase-free water for Sigma-Aldrich primers or 0.5 µl of primer mix for Primer design 
primers. All reactions were run in triplicate. Following preparation of PCR plates, they were 
transferred to the qPCR cycler (ViiA 7 Real-Time PCR System, Applied Biosystems, Carlsbad, 
USA), with cycling conditions of one cycle at 55°C for 10 min and 95°C for 10 min followed 
by 40 cycles of 95°C for 10 s and 60°C for 60 s. Fluorescence was assessed at the end of each 
repeated cycle. mRNA expression levels were determined using the 2-ΔΔCt method, with RNA 
polymerase II (RPII) used as the reference gene. At the end of each PCR, melt curve analysis 
was undertaken to assess the specificity of primers. Values are reported as fold changes relative 
to the values from the pre-training biopsy. 
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Table 6.1. Primers used for real-time RT-PCR analyses 
Preparation of whole muscle homogenate 
Approximately 20–50 mg of frozen muscle tissue was homogenised in cold lysis buffer (1:10 
Wet weight/volume) containing PBS, 0.2% Triton X-100 and protease and phosphatase 
inhibitor cocktail (Fisher Scientific, Loughborough, UK). Samples were blitzed using a tissue 
lyser (Qiagen, UK) for 4 min at 20 Hz and centrifuged at 12000 g for 10 min to pellet insoluble 
material. The supernatant was then transferred to a fresh Eppendorf tube. Protein 
concentrations were determined by Pierce 660 protein assay according to the manufacturer’s 
instructions (Fisher Scientific, Loughborough, UK). Muscle homogenates were subsequently 
analysed for protein content (Western blotting) and CS enzyme activity. 
Western blot analysis 
Samples were mixed with dH2O, 4x LDS sample buffer (Invitrogen, Loughborough, UK) and 
0.1% β-mercaptoethanol (Sigma, Dorset, UK) and were boiled for 5 min at 95℃. 15-60 μg of 
protein was loaded on to TGX polyacrylamide gels (Bio-Rad, Herts, UK) and separated by 
electrophoresis at 100 V for 80 minutes. Proteins were transferred onto PVDF membrane at 30 
V for 90 minutes (Bio-Rad, Herts, UK) and washed for 5 min in Tris buffered saline with tween 
(TBST) before being blocked in 5% blotting grade milk (Bio-Rad, UK) for 1 h at room 
temperature. Membranes were washed three times for 5 min in TBST and were incubated 
overnight at 4℃ with the primary antibodies; CS (ab129095, abcam, Cambridge, UK), COXII 
Target gene Primer sequence 
VEGF Forward CACTGAGGAGTCCAACATCAC 
 Reverse TGTGCTGTAGGAAGCTCATCTC 
PGC-1α Forward ACTCTCGCTTCTCATACTC 
 Reverse CCTCTTCAAGATCCTGCTA 
HIF-1α Forward AATCTGTGTCCTGAGTAGAA 
 Reverse TCACCTGAGCCTAATAGTC 
eNOS Forward TGTGAAGGCTGTAGGTTAT 
 Reverse CAAGTTGGAATCTCGTGAA 
RPII Forward AAGGCTTGGTTAGACAACAG 
 Reverse TATCGTGGCGGTTCTTCA 
Abbreviations: eNOS, endothelial nitric oxide synthase; HIF-1α, hypoxia inducible factor 1α; PGC-
1α, peroxisome proliferator-activated receptor-γ coactivator 1α; RNA polymerase II; VEGF, vascular 
endothelial growth factor.  
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(ab110258, abcam, Cambridge, UK), COX IV (ab33985, abcam, Cambridge, UK) and VEGF 
(sc-7269, Santa Cruz Biotechnology, CA, USA) diluted at a concentration of 1:1000 in 2-3% 
milk. Membranes were then washed three times for 5 min in TBST and incubated with the 
appropriate secondary antibody; anti-mouse horseradish peroxidase-conjugated secondary 
antibody (Dako, Stockport, UK) or anti-rabbit horseradish peroxidase-conjugated secondary 
antibody (Bio-Rad, Herts, UK), diluted 1:10,000 in 2-3% blotting grade milk for 1 h at room 
temperature. Following three 5 min washes in TBST, membranes were incubated with 
enhanced chemiluminescence substrate (ClarityMax, Bio-Rad, Herts, UK) for 5 min. 
Membranes were visualised using image analysis (ChemiDocTM XRS+, BioRad, Herts, UK) 
and band densities determined using image analysis software (Quality One 1-D analysis 
software v 4.6.8, Bio-Rad, Herts, UK). GAPDH was used as a loading control and protein 
content was expressed in arbitrary units relative to GAPDH.  
Enzyme activity analysis 
CS activity was analysed on a 96 well plate. Each well contained: 150 µl 100 mM TRIS buffer 
(pH 8.3), 10 µl of 1 mg/ml muscle homogenate, 25 µl of 1 mM 5,5-dithio-bis (2-nitrobenzoic 
acid), 40 µl of 3 mM Acetyl coenzyme A and 10 µ of 1% Triton X-100. 15 µl of 10 mM 
oxaloacetate (pH 8.3) was added to each well and the plate was immediately placed in a 
spectrophotometer (Varioskan Flash, Thermo Scientific, Loughborough, UK) maintained at 
30℃. Following 30 s of linear agitation, absorbance at 412 nm was measured every 15 s for 3 
min. Values were corrected for the pathlength of the plate and were expressed as mol.hr-1.kg-1. 
The coefficient of variation for CS activity was 4.8 ± 3.1%.  
Statistics 
Training data was analysed using an unpaired t-test. Two-factor repeated measures ANOVAs 
with one within factor (time; pre vs post, 1-3, 1-6 or 1-7) and one between factor (condition; 
CON vs BFR) were utilised to analyse all subsequent analysis. Where significant effects were 
observed LSD post hoc analysis was undertaken to locate differences. Data are presented as 
mean ± SD unless otherwise stated. Significance was accepted at P ≤ 0.05 and a statistical trend 
as P ≤ 0.10. 
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6.3 RESULTS 
There were no differences in physiological and performance measures prior to training between 
groups (Table 6.2). Participants completed 100% of the assigned training sessions without any 
complications, with the exception that one participant was unable to complete ten repetitions 
in the initial training session so undertook nine intervals for each session. The total amount of 
work done throughout the seven training sessions was not different (P = 0.82) between CON 
(2855 ± 268 kJ) and BFR (2779 ± 667 kJ).  
mRNA expression 
There was a main effect of time for VEGF mRNA (P = 0.005) (Fig. 6.2a). Post hoc tests 
revealed that VEGF mRNA increased 3 h post-exercise compared to rest in training session 1, 
4 and 7 (P < 0.05). VEGF mRNA 3 h post-exercise was lower in training session 7 than session 
4 (P = 0.03). There was however, no difference between CON and BFR (interaction effect P = 
0.82; main effect of group P = 0.83).  
There was a main effect of time for PGC-1α mRNA (P = 0.001) (Fig. 6.2b). PGC-1α mRNA 
increased 3 h post-exercise compared to rest in training session 1, 4 and 7 (P < 0.01). PGC-1α 
mRNA 3 h post-exercise was lower following training session 7 than 4 (P = 0.007) and tended 
to be lower following training session 7 than 1 (P = 0.09). There was however, no difference 
between CON and BFR (interaction effect P = 0.57; main effect of group P = 0.25). 
There was a main effect of time for HIF-1α mRNA (P < 0.001) (Fig. 6.2c). HIF-1α mRNA 
expression increased 3 hours post-exercise compared to rest following training session 1, 4 and 
7 (P < 0.01). There was a trend for resting HIF-1α mRNA to be higher on day 15 compared 
with day 8 (P = 0.07). There was however, no difference between CON and BFR (interaction 
effect P = 0.40; main effect of group P = 0.70). 
There was no main effect of time (P = 0.10) or interaction effect (P = 0.14) for eNOS mRNA, 
however, there was a main effect of group (P = 0.03) (Fig. 6.2d). Post hoc tests revealed that 
eNOS mRNA was significantly higher in BFR pre (P < 0.001) and 3 h post (P = 0.03) training 
session 7 than CON; all participants in BFR had higher resting eNOS mRNA on day 15 
compared to day 1, whereas all participants in CON had lower resting eNOS mRNA on day 15 
compared to day 1.  
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Figure 6.2. mRNA expression of VEGF (A), PGC-1α (B), HIF-1α (C) and eNOS (D) pre and 
3 hours post-training sessions 1, 4 and 7 in control (CON) (open circles) and blood flow 
restriction (BFR) (closed circles). Values are expressed as fold changes relative to pre-training 
values. Data are mean ± SD. aP < 0.05 vs CON, bP < 0.05 vs pre, cP < 0.05 vs 4th 3 hr, dP < 
0.10 vs 1st 3 hr pre, eP < 0.10 vs 4th pre.    
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Protein content 
VEGF protein content (Fig. 6.3A) was unchanged with training (main effect of time P = 0.26) 
and was not different between CON and BFR (interaction effect P = 0.29; main effect of group 
P = 0.28). There was a near-significant trend for an increase in COXII (Fig. 6.3B), COXIV 
(Fig. 6.3C) and CS protein content (Fig. 6.3D) with training (main effect of time; P = 0.09, P 
= 0.06, P = 0.06, respectively), however there was no difference between CON and BFR 
(interaction effect and main effect of group P > 0.10).  A Western blot at the correct molecular 
weight could not be attained for PGC-1α (described in detail in Chapter 8), therefore PGC-1α 
protein content was not assessed.  
 
Figure 6.3. Protein content of VEGF (A), COXII (B), COXIV (C) and CS (D) in control (CON) 
(open circles) and blood flow restriction (BFR) (closed circles) training interventions. Values 
are expressed as fold changes relative to pre-training values. Data are mean ± SD. 
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CS activity 
CS activity (Fig. 6.4) was unchanged with training (main effect of time P = 0.42) and was not 
different between CON and BFR (interaction effect P = 0.58; main effect of group P = 0.61).  
 
 
 
 
 
 
 
 
 
Figure 6.4. Citrate synthase (CS) activity in control (CON) (open circles) and blood flow 
restriction (BFR) (closed circles) training interventions. Markers with thick dashed lines 
represent means and thin dotted lines represent individual responses. 
 
Performance variables 
Absolute V̇O2max, relative V̇O2max, MAP and GET (Table 6.2) all increased with training, 
however, there were no differences between CON and BFR for any of the variables.  
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Table 6.2.  Performance variables before and after control (CON) and blood-flow restriction (BFR) training interventions. 
 CON  BFR    
 
Parameter 
 
Pre 
 
Post 
 
Percentage 
change 
 
 
Pre 
 
Post 
 
Percentage 
change 
ANOVA 
interaction  
P value 
ANOVA 
main effect 
of time P 
value 
ANOVA main 
effect of 
condition  
P value 
Body Mass (kg) 88.7 ± 6.8 88.8 ± 7.0 0.1  81.1 ± 12.6 80.8 ± 12.2 -0.4 0.63 0.74 0.24 
V̇O2max (l.min-1) 3.70 ± 0.16 3.79 ± 0.16  2.5  3.50 ± 0.64  3.61 ± 0.62  3.3 0.80 0.04 0.63 
V̇O2max (ml.min-1.kg-1)   40.3 ± 2.0  41.3 ± 2.1  2.4  44.0 ± 9.5  45.4 ± 9.5 3.3 0.61 0.03 0.52 
MAP (W) 327 ± 25  337 ± 20  3.0  326 ± 64  338 ± 58  3.6 0.72 0.004 0.99 
GET (W) 102 ± 20 110 ± 16 8.0  111 ± 32 124 ± 34 11.9 0.36 0.003 0.52 
Values are mean ± SD. Abbreviations: GET, gas exchange threshold; MAP, maximal aerobic power; V̇̇ O2max, maximal oxygen uptake.  
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Training HR & RPE 
There was a main effect of time on mean HR during exercise (P = 0.002). Mean HR during 
exercise was significantly reduced from training session 1 by training session 4 (P < 0.02) but 
did not significantly decrease further after training session 4 (P > 0.10) (Fig. 6.5a). There was 
no difference between CON and BFR (interaction effect P = 0.28; main effect of group P = 
0.14). There was no main effect of time (P = 0.16) or interaction effect (P = 0.831) of mean 
HR during the recovery intervals, however there was a significant effect of group (P = 0.049) 
(Fig. 6.5b). Post hoc tests revealed that mean HR during the recovery intervals was 
significantly higher in BFR than CON during training session 4 (P = 0.02) and 7 (P = 0.04) 
and tended to be higher in BFR than CON during training session 2 (P = 0.08) and 6 (P = 0.06). 
 
Figure 6.5. HR during exercise (A) and recovery (B) during control (CON) (open circles) and 
blood flow restriction (BFR) (closed circles) training interventions. Data are mean ± SD. aP < 
0.05 vs CON, bP < 0.10 vs CON, cP < 0.05 vs 1, dP < 0.10 vs 1, eP < 0.05 vs 2,  fP < 0.10 vs 2. 
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There was a main effect of time for RPE (P = 0.01). RPE was significantly reduced from 
training session 1 by training session 3 (P < 0.05) but did not significantly decrease further 
until training session 7 (Fig. 6.6). There was no difference between CON and BFR (interaction 
effect P = 0.14; main effect of group P = 0.76). 
 
 
 
 
 
 
 
 
Figure 6.6. RPE during control (CON) (open circles) and blood flow restriction (BFR) (closed 
circles) training interventions. Data are mean ± SD. cP < 0.05 vs 1, dP < 0.10 vs 1, eP < 0.05 vs 
2,  fP < 0.10 vs 2, gP < 0.05 vs 3, hP < 0.10 vs 3,  iP < 0.10 vs 5. 
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6.4 DISCUSSION 
This study has confirmed previous findings by demonstrating that the transient increases in 
PGC-1α mRNA following single HIIT bouts are progressively attenuated over a two-week 
training period. These findings have been extended by demonstrating that similar responses 
occur in VEGF and HIF-1α mRNA. The addition of post-exercise BFR, however, did not 
enhance or better maintain these transient responses. In contrast, resting eNOS mRNA 
expression was increased only in BFR, suggesting that post-exercise BFR elicited an enhanced 
shear stress stimulus. There was no increase in mitochondrial protein content or CS activity 
following two weeks of HIIT with or without BFR.  
Consistent with previous observations (Perry et al. 2010), the present investigation 
demonstrated an increased acute transcriptional response of PGC1-α 3 h following single HIIT 
sessions that was progressively attenuated during two weeks of training as individuals became 
accustomed to the specific HIIT session. This study has further demonstrated that a similar 
‘sawtooth’ response to HIIT also occurs in VEGF and HIF-1α mRNA expression. Although 
peaking after one week, similar to PGC-1α, VEGF mRNA expression 3 h post-exercise was 
also significantly attenuated after two weeks of training. This is consistent with previous 
findings that have observed attenuated transient increases in VEGF mRNA following 4-8 
weeks of training (Richardson et al. 2000; Hoier et al. 2012).  
BFR applied during exercise and at rest has been shown to elicit multiple adaptive signals, i.e. 
increased shear stress, reduced muscle oxygenation and increased markers of oxidative stress 
(Christiansen et al. 2018; Gundermann et al. 2012; Karabulut et al. 2011), all of which are 
considered key stimuli of exercise-induced angiogenesis (Egginton, 2009) and/or 
mitochondrial biogenesis (Hood, 2009; Ljubicic et al. 2010). It was hypothesised that post-
exercise BFR could also elicit similar signals and therefore would increase and better maintain 
the transient increases in transcription of key angiogenic and mitochondrial biogenic genes. 
However, in agreement with previous research investigating post-exercise BFR within a SIT 
protocol (Taylor et al. 2016a), there was no difference in VEGF or PGC-1α mRNA at rest or 
3 h after training between CON and BFR. This suggests that post-exercise BFR is not a 
sufficient stimulus to enhance transcription of these genes. These findings are in contrast to 
BFR applied during low-load resistance-type or low intensity endurance-type exercise, which 
has been shown to enhance the acute expression of both PGC-1α and VEGF mRNA 
(Christiansen et al. 2018; Ferguson et al. 2018; Larkin et al. 2012). The exercise protocols in 
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the aforementioned studies undertaken alone did not elicit increases in VEGF mRNA and only 
elicited modest increases in PGC-1α mRNA expression of ~2-fold, compared to the 5-fold 
increase following SIT in Taylor et al. (2016a) and an initial increase of 9-fold in CON in the 
present study. Therefore, it seems likely that when combined with standard intensity training 
protocols, which are already potent stimuli of these genes, there is reduced capacity of BFR 
protocols to further increase the transcriptional response. 
Furthermore, there was no difference in HIF-1α mRNA between CON and BFR. This is not 
consistent with Taylor et al. (2016a) who observed an increase in HIF-1α mRNA expression 3 
hours post SIT only when combined with post-exercise BFR, or with the findings from Chapter 
5 which demonstrated post-exercise BFR reduced muscle oxygenation by 11-20% during the 
recovery intervals of SIT. The increase in HIF-1α mRNA in the present study was, however, 
greater in both groups than that reported in the BFR group in Taylor et al. (2016a) (2.2 fold vs 
1.5 fold). It is therefore possible that the increase in HIF-1α mRNA arising from training 
masked any effect of the BFR. Of note, in CON the magnitude of transient increases in HIF-
1α mRNA decreased as training progressed but were maintained in BFR. Therefore, a BFR 
mediated hypoxic stimulus could have manifested with continued training. Moreover, the acute 
increase in HIF-1α mRNA expression can take longer to manifest, with one study 
demonstrating an increase in HIF-1α mRNA only after 6 hours post-exercise (Lundby et al. 
2006), therefore the 3 h post biopsy may have missed the true peak in the transcriptional 
expression. 
There was an increase in resting eNOS mRNA expression only in BFR. Indeed, at day 15 all 
participants in BFR had higher resting eNOS mRNA than at day 1, whereas in CON eNOS 
mRNA had decreased in all participants. eNOS expression is raised in response to increased 
levels of shear stress (Baum et al. 2004; Egginton et al. 2016) and therefore this finding 
suggests BFR increased the shear stress stimulus. This could have been elicited through two 
mechanisms: firstly, due to an increase in retrograde blood flow distal to the cuff arising from 
vessel compression (Credeur et al. 2010) and secondly through reactive hyperaemia upon cuff 
deflation (Gundermann et al. 2012). Although capillary growth was not assessed in the present 
study, given the importance of shear stress in exercise-induced angiogenesis (Egginton, 2009) 
and that eNOS is an important mediator of angiogenesis (Baum et al. 2004; Williams et al. 
2006), tentatively it could be hypothesised that BFR elicited an increased angiogenic response. 
In support of this a previous study also observed an increase in resting eNOS mRNA following 
4 weeks of passive knee extensor training in humans (Hoier et al. 2010), which increases shear 
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stress in the absence of alterations to either EMG activity or muscle oxygen uptake (Hellesten 
et al. 2008). Alongside the increase in eNOS mRNA, they also observed an increase in 
proliferating endothelial cells and capillary contacts. Further analysis of samples from the 
present study for proliferating endothelial cells would clearly help to confirm this hypothesis.  
Despite the increases in VEGF mRNA expression in both groups, there was no change in 
skeletal muscle VEGF protein content during either CON or BFR. Previous studies have also 
not observed an increase in VEGF protein following a period of training after either continuous 
or HIIT (Hoier et al. 2012; 2013; Gliemann et al. 2015) even when there was an increase in 
capillarisation (Hoier et al. 2012), and varied responses have also been reported following an 
acute exercise bout (Gavin et al. 2004; Rullman et al. 2007; Hoier et al. 2013b). The importance 
of increased VEGF protein content for inducing angiogenesis is therefore not well-understood. 
For muscle-derived VEGF protein to promote angiogenesis secretion into the interstitial fluid 
is however required (Olfert et al. 2016). Indeed, increases in VEGF concentration in interstitial 
fluid have consistently been observed during and after exercise (Hoffner et al. 2003; Hoier et 
al. 2012; 2013b). The transient increases in muscle VEGF transcription observed in the present 
study may therefore have had a primary purpose to replenish lost stores rather than increase 
basal VEGF protein content (Hoier & Hellsten, 2014). Nevertheless, we did observe an 
increase in VEGF protein content in four participants in BFR and two participants in CON, 
suggesting VEGF protein content can be increased in the early stages of exercise training in 
some individuals. 
Although GET increased in both groups, neither content of mitochondrial proteins CS, COXII 
and COXIV or CS activity, a biomarker of mitochondrial content (Larsen et al. 2012), were 
significantly increased following 2 weeks of HIIT with or without post-exercise BFR. The lack 
of change in CS activity is consistent with some studies (Cochran et al. 2014; Granata et al. 
2016), but is in contrast to the majority of studies which have demonstrated large increases in 
CS activity of 20-30% in untrained individuals following a range of exercise modalities 
(Burgomaster et al. 2008; Granata et al. 2018; Gurd et al. 2010; Perry et al. 2008; 2010; Spina 
et al. 1996). The reason for this discrepancy could be attributable to methodological 
differences, including the assay method. Perry et al. (2010) utilised a very similar HIIT protocol 
to that of the present study and reported an increase of 17% in CS activity after just three 
training sessions. Given that training volume appears to be an important stimulus of CS activity 
(Bishop et al. 2014; Granata et al. 2018), this could perhaps be a factor. However, the volume 
of training was only minimally different to that of Perry et al. (2010) (10 x 3 min intervals vs 
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10 x 4 min intervals). Due to difficulty in controlling between the two conditions in the present 
study, in contrast to Perry et al. (2010), we selected not to increase the training intensity 
throughout the two weeks. This lack of progression could have failed to have induced a 
sufficient continued stimulus to increase mitochondrial content.  
Previous studies have demonstrated that the addition of post-exercise BFR during classic SIT 
enhanced V̇O2max by up to ~6% in trained individuals (Chapter 4; Taylor et al. 2016a). In 
contrast, in the present study post-exercise BFR did not augment the increase in V̇O2max 
following HIIT. This discrepancy could be attributable to the shorter length of the present 
investigation at only 2 weeks long, compared to 4 weeks in the aforementioned studies. It seems 
plausible that this length of intervention may have been too short for any additional training 
effect of BFR to manifest. Moreover, this may have been exacerbated by the relatively 
untrained participants in the present study, meaning the exercise stimulus undertaken alone was 
a greater stimulus. Indeed, in contrast to the increase of ~2.5% in V̇O2max after two weeks in 
the present study, 4 weeks of SIT failed to elicit any increase in V̇O2max in the trained 
populations (Chapter 4; Taylor et al. 2016a).  
The findings of the present study must be interpreted within the limitations of the current 
participant number of 11 (BFR n = 6 and CON n = 5). The observed powers for the majority 
of interaction effects and group effects were only ~0.2 and therefore, there is currently a high 
chance of type II errors in some of the outcomes. Clearly further participants are required to 
make firm conclusions of the effectiveness of the intervention. A further limitation of the study 
is the lack of measurement of the protein content of eNOS and PGC-1α (PGC-1α protein was 
not assessed due to technical difficulties in attaining a valid blot as described later in Chapter 
8) and assessment of capillary growth (i.e. proliferating endothelial cells). This means 
implications can only be made from the responses at the transcriptional level. Moreover, there 
was only an assessment of markers of mitochondrial content (CS activity and the content of 
mitochondrial proteins) and not mitochondrial function. Previous investigations have 
demonstrated that an increase in mitochondrial function can occur in the absence of changes to 
mitochondrial content (Granata et al. 2016; Groennebaek et al. 2018). Therefore, it is possible 
that the interventions in the present investigation could have elicited mitochondrial adaptations 
that resulted in increased mitochondrial function.  
In conclusion the present study demonstrated a ‘sawtooth’ pattern in the transcriptional 
response of PGC-1α, VEGF and HIF-1α to two weeks of HIIT. These transient increases 3 h 
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post-exercise in PGC-1α and VEGF mRNA were attenuated following the two-week training 
period. The addition of post-exercise BFR did not enhance or maintain these transcriptional 
responses. However, BFR may have elicited an increased shear stress mediated angiogenic 
stimulus, with an increase in resting eNOS mRNA expression observed after two weeks of 
HIIT only with post-exercise BFR. This hypothesis could be confirmed through the assessment 
of proliferating endothelial cells. Despite the potent increase in PGC-1α mRNA expression, CS 
activity and mitochondrial protein content were not changed following two weeks of HIIT, 
with or without post-exercise BFR.   
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CHAPTER 7 
GENERAL DISCUSSION 
 
 
 
7.1 SUMMARY 
The studies described in this thesis have investigated the efficacy of combining post-exercise 
BFR with interval training as a potential training tool for endurance trained athletes. The main 
purpose of this thesis was to assess if this model of BFR could, in the absence of a reduction 
in training intensity, be utilised to overcome the blunted adaptive response observed in trained 
individuals. This was addressed with particular reference to augmenting angiogenesis and 
mitochondrial biogenesis and whether ultimately endurance performance could be enhanced, 
in particular within the severe-intensity exercise domain.  
 
The main findings of the thesis are summarised below. 
 
1. There was a very strong correlation between critical power (CP) and indices of skeletal 
muscle capillarity in trained individuals, in particular capillary contacts with type I 
fibres (r = 0.94). This implies that skeletal muscle capillarity is an important 
determinant of CP. On the other hand, Wʹ was not related to skeletal muscle capillarity 
(Chapter 3).  
 
2. Four weeks of ‘classic’ SIT (4-7 x 30 s maximal bouts) increased CP by ~3.5% in 
trained individuals, but the addition of post-exercise BFR did not enhance this further. 
However, consistent with previous observations the addition of post-exercise BFR was 
potent in increasing V̇O2max (increase of 5.9%), with no change following SIT alone 
(Chapter 4). 
  
3. Skeletal muscle capillarity did not increase following four weeks of SIT in trained 
individuals with or without post-exercise BFR. Tentatively, post-exercise BFR could 
elicit an enhanced angiogenic response when undertaken with a greater training 
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duration and/or volume, as suggested by a trend (P = 0.06) for an increase in 
proliferating endothelial cells after four weeks of SIT only with post-exercise BFR 
(Chapter 4).  
 
4. The addition of post-exercise BFR to two weeks of lower intensity, higher volume HIIT 
did not enhance VEGF mRNA expression or protein content. However, a greater 
angiogenic stimulus from post-exercise BFR may be elicited by increased shear stress, 
implicated by an increase in resting eNOS mRNA after two weeks of HIIT only when 
combined with post-exercise BFR (Chapter 6). Furthermore, post-exercise BFR 
reduced skeletal muscle oxygenation during SIT restriction periods (Chapter 5) and 
could therefore enhance hypoxia mediated signalling. 
 
5. Post-exercise BFR did not enhance or maintain the attenuating acute transcriptional 
response of PGC-1α during two weeks of HIIT (Chapter 6). Moreover, post-exercise 
BFR did not elicit increases in markers of oxidative capacity after 4 weeks of SIT in 
trained individuals (Chapter 4) or mitochondrial content after 2 weeks of HIIT in 
recreationally active individuals (Chapter 6). 
 
7.2 CRITICAL POWER 
This thesis has extended our current knowledge of the physiological underpinnings of CP, the 
asymptote of the power-duration relationship, and by extension high-intensity endurance 
performance. The primary purpose of Chapter 3 was to assess the relationship between skeletal 
muscle morphology and the parameters of the power-duration relationship in endurance trained 
individuals, specifically indices of skeletal muscle capillarity and proportion and CSA of type 
I and type II muscle fibres.   
The key novel finding was the very strong positive correlations between CP and indices of 
skeletal muscle capillarity in trained individuals. In particular capillary contacts around type I 
fibres, which demonstrated a correlation coefficient of r = 0.94. This extends a previous 
observation of a significant correlation between capillary to fibre ratio and time to task failure 
during performance times of ~2-20 min (Iaia et al. 2011), which would be expected to span the 
duration of the severe-intensity domain. Although correlation does not directly establish 
causation, these very strong correlations imply that skeletal muscle capillarity is likely an 
important determinant of CP.  
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Specifically, the results suggest that the number of capillaries as opposed to diffusion distance 
per se are important for CP, given that only capillary to fibre ratios and capillary contacts were 
strongly correlated with CP and no significant correlation was observed with capillary density. 
This is perhaps not surprising given that oxygen extraction is determined primarily by the 
number of red blood cells in contact with contracting muscle fibres (Federspiel & Popel, 1986; 
Roca et al. 1992; Wagner, 1992). This assertion is also supported by previous observations 
demonstrating that an increase in capillary density following short-term immobilization did not 
enhance muscle diffusion capacity (Hepple et al. 2000).  
Chapter 3 also confirmed previous findings in recreationally active individuals (Vanhatalo et 
al. 2016), demonstrating a positive correlation between the proportion of type I fibres and CP 
in endurance trained individuals. Furthermore, it was observed that the CSA of type I fibres 
was also positively correlated with CP. 
A high skeletal muscle capillary supply enhances skeletal muscle oxygen extraction (Roca et 
al. 1992; Wagner, 1992) and type I fibres possess characteristics to facilitate high rates of 
oxidative phosphorylation including a higher mitochondrial content and increased fatigue 
resistance compared to type II fibres (Saltin et al. 1997; Schiaffino & Reggiani, 2011). 
Therefore, the positive correlations between these parameters and CP adds support to a 
previous body of literature implicating CP as a parameter of aerobic function. For example, 
previous investigations have demonstrated CP to be sensitive to changes in oxygen delivery, 
decreasing under conditions of systemic hypoxia (Dekerle et al. 2012) and BFR (Broxterman 
et al. 2015), and to be negatively correlated with the fundamental time constant of the oxygen 
uptake response to constant-load submaximal exercise (Murgatroyd et al. 2011).  Moreover, 
CP has been observed to increase following training interventions also known to increase 
skeletal muscle capillarisation and mitochondrial biogenesis (Gesser & Wilson, 2007; Jenkins 
& Quigley, 1992; Poole et al. 1990).  
Chapter 4 was the first investigation to demonstrate that SIT enhances CP. Previous 
investigations have demonstrated HIIT to increase CP by 10-15% following 4-7 weeks 
(Gaesser & Wilson, 1988; Poole et al. 1990; Vanhatalo et al. 2008). Whilst the enhancements 
of CP of ~3.5% observed in Chapter 4 are lower than the aforementioned studies, this is not 
surprising given the reduced training volume (total of just 8 sessions) and endurance trained 
status of the participants (V̇O2max of ~63ml.min-1.kg-1). Moreover, the gains of ~3.5% are 
greater than the smallest worthwhile change in power for well-trained individuals of 1% (Paton 
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& Hopkins, 2001). Together CP and Wʹ, the curvature constant of the power-duration 
relationship, describe cycling performance within the severe intensity domain (Monod & 
Scherrer, 1965). Therefore, with the absence of a decrease in Wʹ, Chapter 4 demonstrates SIT 
to be an effective training protocol for endurance athletes competing within the severe-intensity 
domain.  
Chapter 4 also demonstrated that despite the very strong correlations between CP and indices 
of skeletal muscle capillarity (Chapter 3), CP was enhanced without any concomitant increases 
in skeletal muscle capillary supply or mitochondrial protein content. Therefore, the 
improvements in CP could be attributable to factors classically related to the so-called 
anaerobic capacity of skeletal muscle, such as increases in skeletal muscle buffering capacity 
and monocarboxylate transporter proteins. Such skeletal muscle adaptations have been 
demonstrated to increase following HIIT in trained individuals (Bickham et al. 2006; Weston 
et al. 1996) and would enhance the ability for the removal of fatigue inducing metabolites. 
Since CP represents the highest sustainable power output in the absence of a progressive loss 
of muscle metabolic homeostasis, it therefore seems possible that these adaptations could be 
another determinant of CP. Furthermore, despite the fact that changes in CP were observed 
with training in the absence of any increase in capillary supply in Chapter 4, capillary supply 
is also likely to be important to CP by enhancing the removal of fatigue inducing metabolites 
such as H+ and K+ (Joyner & Coyle, 2008). Indeed, positive correlations between capillary 
supply and K+ accumulation and muscle pH recovery have previously been observed (Iaia et 
al. 2011). Clearly the importance of these ‘anaerobic’ adaptations to CP requires further 
investigation.  
CP and Wʹ often change in opposite directions in response to multiple interventions (Poole et 
al. 2016), therefore it was not surprising that in contrast to CP, Wʹ was not correlated to skeletal 
muscle capillary supply (Chapter 3). Moreover, consistent with previous observations in 
recreationally active individuals (Vanhatalo et al. 2016) Wʹ was not correlated with type II fibre 
proportion or CSA (Chapter 3), despite Wʹ being associated with characteristics also associated 
with type II fibres, including the VO2 slow component (Murgatroyd et al. 2011; Vanhatalo et 
al. 2011b) and greater end-exercise muscle metabolic perturbations (creatine and lactate) 
(Vanhatalo et al. 2016). In the absence of these correlations, this suggests that Wʹ is more 
closely related to other physiological events, for example there may be a neuromuscular 
contribution to the mechanistic underpinning of Wʹ (Kordi et al. 2018).    
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7.3 ANGIOGENIC POTENTIAL OF POST-EXERCISE BFR 
As discussed above, Chapter 3 implies that a high skeletal muscle capillary supply may be a 
key determinant of CP, and thus performance in the severe intensity domain. This finding 
highlights the importance of optimising the angiogenic potential of training protocols for 
endurance athletes. As outlined in the literature review (Chapter 2) it was suggested that post-
exercise BFR could increase the extent of shear stress, metabolic stress and level of hypoxia 
induced by training, all of which are key stimuli of exercise-induced angiogenesis (Egginton, 
2009). Therefore, it was hypothesised that post-exercise BFR would increase skeletal muscle 
capillarity.  
Using a between groups experimental design, Chapter 4 assessed the potential of the addition 
of post-exercise BFR during a typical SIT programme (4 weeks of 4-7 repeated 30 s maximal 
sprints) to enhance skeletal muscle capillarity in a group of trained cyclists, with a V̇O2max of a 
minimum of around 60 ml.min-1.kg-1. However, there was no increase in any index of skeletal 
muscle capillarity following 4 weeks of SIT with or without post-exercise BFR. This 
observation is in contrast to previous findings in a group of sedentary males (V̇O2max of 41.9 
ml.min-1.kg-1), where SIT was demonstrated to be a potent angiogenic stimulus, eliciting 
increases in indices of skeletal muscle capillarisation of 20-30% (Cocks et al. 2013). This 
disparity in findings suggests that in comparison to untrained individuals, SIT may not be a 
sufficient stimulus to elicit angiogenesis in endurance-trained individuals, who possess 
baseline skeletal muscle capillary supplies around double that of their sedentary counterparts 
(Andersen & Henriksson, 1977; Jensen et al. 2004a).  However, the acute angiogenic stimulus 
of SIT with and without post-exercise BFR has been demonstrated in trained individuals, with 
the observation that VEGF, VEGFR-2 and PGC-1α mRNA increased 3 hours after a single 
training session (Taylor et al. 2016a).  Therefore, as discussed in Chapter 4, given that current 
evidence supports the importance of training volume over training intensity for stimulating 
angiogenesis in already trained individuals (Gliemann et al. 2015; Hoier et al. 2013a), it seems 
likely that the training volume of the 4 weeks of SIT, which was just 8 sessions in total, may 
have been too low to elicit an increase in capillary supply in the trained population.  
Nonetheless, there was still a suggestion of an enhanced angiogenic stimulus from the addition 
of post-exercise BFR in Chapter 4. To further investigate the angiogenic stimulus, proliferating 
endothelial cells were assessed by determining the co-localisation of the proliferation marker 
Ki-67 in CD31 positive endothelial cells. As a marker of capillary growth that would be 
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expected to proceed any measurable changes in skeletal muscle capillary supply (Jensen et al. 
2004a; Hoier et al. 2010), this may have been more sensitive given the short intervention. There 
was a near significant interaction effect (P = 0.06), indicating an increase in Ki-67 positive 
endothelial cells in the BFR group only, with an increase in proliferating endothelial cells in 7 
out of 9 participants in BFR, whereas only one participant demonstrated an increase in CON. 
This trend tentatively suggests that the addition of post-exercise BFR may have elicited an 
angiogenic stimulus which could have manifested had training been continued for a greater 
duration or had been undertaken with a higher training volume. In support of this suggestion, 
preliminary data on 5 participants from a follow-up study currently being conducted 
demonstrates an increase in capillary to fibre ratio and capillary contacts around type I fibres 
of 13.7% and 11.5%, respectively, following six weeks of the same SIT combined with post-
exercise BFR training in trained cyclists.  
Angiogenic signalling from post-exercise BFR 
The angiogenic potential of post-exercise BFR was further explored in Chapter 6 during the 
first two weeks of a HIIT protocol. In a thorough approach, muscle biopsies were obtained pre 
and 3 hours post the first, middle and final training sessions across a two-week period. This 
allowed the investigation of whether post-exercise BFR would not only enhance the initial 
transient angiogenic transcriptional response following a single session, but also whether post-
exercise BFR could better maintain the attenuated transient mRNA expressions expected at the 
end of the training period (Hoier et al. 2012; Richardson et al. 2000) and subsequently increase 
VEGF translation during the two week period. With a view to increase the training volume 
from Chapter 4 to enhance the angiogenic stimulus, post-exercise BFR was combined with a 
lower intensity, higher volume HIIT protocol. In a between groups design individuals 
undertook 7 training sessions, over a 14-day period, each involving 10 repetitions of 3 min 
cycling bouts at an intensity of 60%Δ of the GET and MAP interspersed with 3 min recovery 
periods. In the BFR group, this permitted a total of 10 applications of BFR (2 min at ~160 
mmHg) and reperfusions compared with only 4 or 5 (2 min at ~120 mmHg) in the first two 
weeks of the SIT protocol in Chapter 4. Indeed, Taylor et al. (2016) previously established that 
the addition of post-exercise BFR to SIT did not enhance the increase in VEGF or VEGFR-2 
mRNA 3 hours following a single training session.  
HIIT elicited transient increases in VEGF transcription following single sessions that were 
attenuated after two weeks, however, there was no difference in VEGF mRNA at any timepoint 
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between the control and BFR group. This is consistent with the findings of Taylor et al. (2016), 
suggesting that post-exercise BFR is not a sufficient stimulus to increase VEGF transcription. 
Moreover, there was no increase in VEGF protein content following HIIT with or without post-
exercise BFR. VEGF is well regarded as the most central pro-angiogenic factor in skeletal 
muscle (Neufeld, et al. 1999; Olfert et al. 2010; Wagner et al. 2006; Olfert et al. 2016) and is 
critical for exercise-induced angiogenesis (Olfert et al. 2010; Delavar et al. 2014). Therefore, 
the lack of change in the protein content of VEGF may suggest a failure to alter the angiogenic 
stimulus of the training intervention.  
Nevertheless, the importance of increased baseline VEGF protein content for eliciting 
angiogenesis is not currently well established (Hoier & Hellesten, 2014). In contrast, for 
muscle-derived VEGF protein to promote angiogenesis, VEGF secretion into the extracellular 
space is known to be required (Olfert et al. 2016). The concentration of VEGF in interstitial 
fluid appears to parallel the proliferative effect on endothelial cells (Hoffner et al. 2003; Hoier 
et al. 2013a; Hoier & Hellsten, 2014) and therefore, the magnitude of VEGF secretion may be 
more important for the magnitude of angiogenesis. Whilst in healthy individuals, training does 
not appear to alter the exercise-induced increase in muscle interstitial VEGF (Hoier et al. 2012; 
Olfer et al. 2016), this can vary between exercise training protocols (Hoier et al. 2013a). 
Therefore, in the absence of immunohistochemical analysis of VEGF localisation and analysis 
of interstitial fluid for VEGF concentration, the full effect of the training intervention on VEGF 
signalling cannot be confirmed.    
A reduction in muscle oxygenation elicits an accumulation of the oxygen-sensing subunit HIF-
1α protein content and translocation into the nucleus (Ameln et al. 2005), where it binds to 
DNA and activates the expression of multiple target genes, one of which is VEGF (Forsythe et 
al. 1996; Ke & Costa, 2006). The finding that post-exercise BFR during SIT increased HIF-1α 
mRNA (Taylor et al. 2016a) therefore, provided preliminary evidence that BFR decreases 
muscle oxygenation which may lead to enhanced downstream hypoxia mediated angiogenic 
signalling. In support of this Chapter 5 established the muscle oxygenation response using 
NIRS during SIT with and without BFR. During the recovery periods post-exercise BFR 
reduced TOI, an overall indication of muscle oxygenation, by 20% and 11% in the RF and VL 
muscles, respectively, and increased HHb, which is considered to reflect the imbalance 
between muscle oxygen delivery and utilisation (DeLorey et al. 2003; Grassi et al. 2003) by 
176% and 44% in the RF and VL respectively.  
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Unexpectedly, in contrast to SIT, post-exercise BFR did not enhance the increases in HIF-1α 
mRNA following a single HIIT session, with a similar mean increase of ~2.2-fold in both the 
control and BFR group (Chapter 6). This was even in despite of an increased cuff pressure of 
~160 mmHg, which as demonstrated by Chapter 5, would be expected to increase HHb further.  
In contrast to HIIT, Taylor et al. (2016) reported SIT alone did not increase HIF-1α mRNA, 
and the increase in HIF-1α mRNA expression following SIT combined with post-exercise BFR 
was still lower (1.5-fold) than that observed with HIIT alone in Chapter 6. Therefore, post-
exercise BFR may only increase HIF-1α transcription when this is not elicited by the exercise 
stimulus alone. Perhaps in support of this was the observation that in the control group in 
Chapter 6 the magnitude of transient increases in HIF-1α mRNA decreased as training 
progressed but was maintained in BFR. It is also important to note, that HIF-1α protein levels 
can be increased in response to a single exercise bout in the absence of any change in HIF-1α 
mRNA expression (Ameln et al. 2005), with HIF-1α protein levels largely regulated at the 
post-translational level (Semenza, 2000). Therefore, increased HIF-1α signalling with BFR in 
Chapter 6 cannot be ruled out in the absence of the analysis of HIF-1α protein content. 
Arguably the finding of greatest interest in Chapter 6 was the observation that resting eNOS 
mRNA was increased following 2 weeks of HIIT only when combined with post-exercise BFR. 
Since eNOS expression is raised under conditions of increased shear stress (Baum et al. 2004; 
Egginton et al. 2016), this observation suggests that the addition of post-exercise BFR may 
have elicited an increased shear stress stimulus. Given that shear stress can be potent at eliciting 
angiogenesis (Rivilis et al. 2002; Williams et al. 2006; Zhou et al. 1998) and eNOS appears to 
be critical to shear stress-stimulated angiogenesis (Baum et al. 2004 Milkiewicz et al. 2005), 
tentatively, this suggests that the addition of post-exercise BFR may have elicited an increased 
shear stress-mediated angiogenic stimulus. Although, no measure of capillary growth was 
measured in Chapter 6 to confirm this, a previous investigation provides some support of the 
above hypothesis. Four weeks of passive knee extension training in humans, which increases 
shear stress in the absence of an increase in muscle activation or metabolic activity (Hellesten 
et al. 2008), was similarly demonstrated to increase resting eNOS mRNA expression and also 
increased proliferating endothelial cells and capillary contacts after 2 weeks (Hoier et al. 2010).  
The potential of post-exercise BFR to increase the shear stress stimulus during HIIT could have 
implications for training prescription. HIIT forms an important part of the training regime of 
endurance athletes, with strong evidence demonstrating that the inclusion of HIIT is required 
to optimise adaptations and performance (Laursen et al. 2002; 2005; Lindsay et al. 1996; 
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Westgarth-Taylor et al. 1997; Weston et al. 1997). Moreover, during a tapering phase HIIT 
can be a key training method when athletes reduce training load through a decrease in their 
training volume (Mujika, 2010; Spilsbury et al. 2015). However, as mentioned above current 
evidence suggests that training volume as opposed to training intensity is a greater stimulus for 
angiogenesis in already trained individuals, at least in the short term. Studies have 
demonstrated a greater proliferative effect arising from continuous moderate intensity exercise 
than intense interval training (Hoier et al. 2013a) and a reduction in skeletal muscle VEGF 
protein content when trained runners increased bouts of intense exercise at the expense of total 
training volume (Gliemann et al. 2015). Gliemann (2016) proposed that one reason for a 
reduction in the angiogenic stimulus with a reduced training volume was the reduction in the 
shear stress stimulus. Shear stress is a product of both magnitude and duration, but although 
high levels of shear stress are elicited during intense intervals, it seems likely that this is 
outweighed by the prolonged stimulus continuous moderate intensity exercise elicits 
(Gliemann, 2016). Therefore, if post-exercise BFR does increase shear stress, either during the 
restriction periods with an increase in retrograde blood flow while vessels are under 
compression (Credeur et al. 2010) or through reactive hyperaemia following the cuff deflations 
(Gundermann et al. 2012), it could falsely increase this aspect of ‘the volume stimulus’ of 
training helping to maintain the angiogenic stimulus. 
PGC-1α can also play a role in mediating exercise-induced angiogenesis (Chinsomboon et al. 
2009; Geng et al. 2010) and is upregulated in response to multiple stimuli, including ROS and 
increased metabolic stress (Olesen et al. 2010), which were both hypothesised to be increased 
by post-exercise BFR. However, the addition of post-exercise BFR to either SIT (Taylor et al. 
2016a) or HIIT (Chapter 6) did not enhance the transient increases in PGC-1α mRNA.   
In conclusion, although Chapter 4 did not demonstrate an increase in skeletal muscle capillarity 
following SIT combined with post-exercise BFR, the angiogenic potential of post-exercise 
BFR was still suggested by the trend towards enhanced proliferating endothelial cells (Chapter 
4), an increase in resting eNOS mRNA (Chapter 6) and reduced muscle oxygenation (Chapter 
5) with the addition of post-exercise BFR. Therefore, the effect of post-exercise BFR protocols 
during lower intensity, higher volume HIIT on skeletal muscle capillarity warrants further 
investigation.  
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7.4 MITOCHONDRIAL BIOGENIC POTENTIAL OF POST-EXERCISE BFR 
In addition to enhancing angiogenesis, it was also hypothesised that post-exercise BFR would 
augment the mitochondrial biogenic stimulus to interval training. It was postulated that as 
observed with BFR applied during exercise, that post-exercise BFR could also increase 
metabolic stress (Suga et al. 2009; 2012; Takano et al. 2005; Takarada et al. 2000) and 
production of ROS (Christiansen et al. 2018) and increase downstream signalling of PGC-1α, 
which is considered as the ‘master regulator’ of mitochondrial biogenesis (Wu et al. 1999; 
Puigserver & Spiegelman, 2003). 
Consistent with previous observations (Perry et al. 2010), in Chapter 6 the acute increase in 
PGC-1α mRNA expression following single HIIT sessions was progressively attenuated 
throughout two weeks of training. In contrast to the aforementioned hypothesis, however, as 
discussed above, post-exercise BFR did not enhance or better maintain the attenuating ‘saw-
tooth’ response of PGC-1α mRNA. This is in agreement with observations in SIT, with no 
difference in PGC-1α mRNA also demonstrated following a single SIT session with and 
without post-exercise BFR (Taylor et al. 2016a).  These findings suggest that in contrast to the 
addition of BFR applied during moderate-intensity (105% of lactate threshold) running interval 
training, which was demonstrated to enhance PGC-1α mRNA expression 3 hours post-exercise 
(Christiansen et al. 2018), that post-exercise BFR is not a sufficient stimulus to augment PGC-
1α transcription. It seems likely that there is a limited capacity to further elicit increases in 
PGC-1α mRNA when using BFR alongside training protocols undertaken at a standard training 
intensity. Indeed, in the study of Christiansen et al. (2018) the increase in PGC-1α mRNA 
expression following the exercise protocol undertaken alone was only ~2-fold compared to the 
potent 9-fold increase following the initial training session in the control group of Chapter 6. 
Unfortunately, due to methodological issues outlined in Chapter 8, analysis of PGC-1α protein 
content to assess the timecourse of the translational response was not possible. 
In accordance with the PGC-1α mRNA data, post-exercise BFR did not enhance the content of 
mitochondrial proteins COXII and COXIV following 4 weeks of SIT (Chapter 4) or 2 weeks 
of HIIT (Chapter 6), and also did not increase CS activity, a valid biomarker of mitochondrial 
content (Larsen et al. 2012) during 2 weeks of HIIT (Chapter 6). This thesis therefore, does not 
support the hypothesis that post-exercise BFR enhances mitochondrial biogenesis. 
Nevertheless, it is important to note that neither the SIT intervention in Chapter 4 or the HIIT 
intervention in Chapter 6 elicited increases in the markers of mitochondrial biogenesis assessed 
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without BFR. These findings are surprising given the potent PGC-1α mRNA responses 
observed following these training protocols (Chapter 6; Taylor et al. 2016a). SIT has 
consistently been demonstrated to increase markers of oxidative capacity, including increases 
in the protein content of COXII and COXIV (Burgomaster et al. 2007; Gibala et al. 2006). 
These studies have only been undertaken in untrained or recreationally active participants, 
however, therefore it seems likely that the lack of effect in Chapter 4 was attributable to the 
well-trained population that was tested. Perry et al. (2010) utilised a very similar HIIT protocol 
in participants of a similar fitness level to Chapter 6, and observed an increase in CS activity 
after just 3 training sessions. As discussed in Chapter 6 it is possible that the failure to progress 
the training intensity throughout the two weeks of training, as was undertaken in Perry et al. 
(2010), meant the training intervention did not elicit a sufficient continued stimulus to increase 
mitochondrial content. Therefore, it is possible that these factors prevented any adaptations of 
post-exercise BFR manifesting. Furthermore, it is also possible that the training interventions 
elicited increases in mitochondrial function which were not assessed in this thesis. Indeed, 
previous investigations have observed an increase in maximum coupled mitochondrial 
respiration through complex I and II as assessed by high-resolution respirometry following SIT 
and resistance training in the absence of changes to CS activity (Granata et al. 2016; 
Groennebaek et al. 2018). 
 
7.5 THE EFFECT OF POST-EXERCISE BFR ON ENDURANCE PERFORMANCE 
It was hypothesised that CP would be enhanced with the addition of post-exercise BFR. 
However, in Chapter 4 a similar increase in CP was observed following 4 weeks of SIT alone 
(3.6%) and SIT with post-exercise BFR (3.3%). The lack of increase in performance is 
consistent with Taylor et al. (2016) who observed no enhancement in 15 km time trial 
performance with the addition of post-exercise BFR to SIT. In addition to being an important 
performance parameter, CP was selected as the main performance measure in Chapter 4 as it 
was hypothesised to be sensitive to the peripheral adaptations that post-exercise BFR was 
postulated to elicit, i.e. angiogenesis and mitochondrial biogenesis. Therefore, given that post-
exercise BFR also failed to elicit increases in skeletal muscle capillarity and mitochondrial 
protein content, it is perhaps not surprising that no enhancement in CP was observed after this 
4-week intervention.  
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Moreover, the addition post-exercise BFR to SIT did not enhance Wʹ, the second parameter of 
the power-duration relationship, or mean power output (MPO) to 4 weeks of SIT (Chapter 4), 
parameters which may give more of an indication of the ‘anaerobic capacity’ (Smith & Hill, 
1991; Vanhatalo et al. 2016). BFR could have been hypothesised to have increased anaerobic 
capacity. For example, HIF-1α is known to stimulate increases in the activity of glycolytic 
enzymes (Semenza, 2009) and training in hypoxia can enhance mRNA expression and activity 
of glycolytic enzymes (Puype et al. 2013; Vogt et al. 2001; Zoll et al. 2006). Whilst not 
significantly different the percentage changes with post-exercise BFR were more favourable 
than SIT alone. Wʹ decreased by 10.4 and 3.0% and MPO increased by 0.8 and 3.1% following 
SIT alone and SIT with post-exercise BFR, respectively. Although it is important to note for 
Wʹ this pattern largely emerged from robust responses from just a few individuals.  
In contrast, chapter 4 did confirm previous findings (Taylor et al. 2016a) further demonstrating 
the potency of post-exercise BFR during SIT to enhance V̇O2max, with a 5.9% increase in 
trained individuals in just four weeks. Given that no increases in skeletal muscle capillarity or 
mitochondrial protein content were observed, this improvement seems more likely to be 
attributable to central adaptations, in particular cardiac output. Whilst SIT alone does not elicit 
increases in cardiac output (MacPherson et al. 2011), the addition of BFR could pose a greater 
challenge to the central cardiovascular system through the induction of the exercise pressor 
reflex (Alam & Smirk, 1937; Bull et al. 1937; Spranger et al. 2015), as evidenced by an 
increase in heart rate and systolic blood pressure with the addition of BFR during and after 
exercise (Chapter 6; Brandner et al. 2015; Poton & Polito, 2015; Renzi et al. 2010; Staunton 
et al. 2015; Takano et al. 2005). In addition to the reductions in stroke volume during BFR 
application (Renzi et al. 2010; Staunton et al. 2005; Takano et al. 2005), it seems plausible that 
the pressor reflex related stimulus could induce a central adaptive response, i.e. increased 
stroke volume and cardiac output. Having currently received little attention in the literature, 
these findings highlight that the central adaptive responses to BFR exercise require further 
investigation. 
 
7.6 LIMITATIONS 
The studies in this thesis were not without their limitations, many of which have been addressed 
in the discussion sections of the individual experimental chapters. One of the main limitations 
throughout this thesis was the lack of quantification of the level of BFR imposed in individuals. 
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A consistent absolute BFR cuff pressure was used for all participants in Chapters 4-6 as 
opposed to an individualised approach. Whilst this may make the application of findings into 
applied practice more practical for athletes who do not have access to the necessary equipment 
to measure the level of restriction, it has been demonstrated that there is large variation in the 
level of BFR imposed by a standard external cuff pressure between individuals (Hunt et al. 
2016; Loenneke et al. 2012). This variation will likely affect the extent of the physiological 
stimuli elicited including the level of the shear stress response, muscle oxygenation and muscle 
metabolite accumulation (Karabulut et al. 2011; Takarada et al. 2000). Indeed, Chapter 5 
demonstrated that by using a standard cuff pressure of 120 mmHg for post-exercise BFR during 
SIT the decrease in muscle oxygenation in the restriction periods varied between 11 and 43% 
across participants. It is therefore likely that this variation in physiological signals imposed 
may have impacted the extent of any adaptations elicited, with the possibility that in some 
participants the level of restriction was too low to elicit sufficient changes in some stimuli. 
Both the SIT and HIIT control interventions in Chapter 4 and 6 failed to elicit changes in 
skeletal muscle capillarity and the markers of mitochondrial biogenesis assessed. These 
training interventions may therefore have provided an insufficient stimulus to assess the effect 
of post-exercise BFR on these adaptations. Indeed, as discussed above in sections 7.3 and 7.4, 
the training volume of the SIT in Chapter 4 may have been too low to elicit adaptations in 
skeletal muscle capillarity and content of mitochondrial proteins and the failure to progress 
training in Chapter 6 may have prevented mitochondrial adaptations. Therefore, the potential 
of post-exercise BFR to elicit these adaptations cannot be ruled out.  
Furthermore, for Chapter 4 and 6 there were low samples sizes for the skeletal muscle analysis 
parameters. These low numbers are largely attributable to the invasive nature of the 
experiments, particularly in the case of Chapter 4 with the use of well-trained individuals 
wishing to adhere to strict training regimes. Nevertheless, the reduced participant numbers are 
likely to have decreased the chances of correctly accepting or rejecting some of the null 
hypotheses. Indeed, this is perhaps reflected in several parameters which displayed P values 
close to the critical value and low observed powers for interaction effects in Chapter 6. 
Moreover, these may have been exacerbated by the experimental designs, whereby in the 
experimental conditions the post-exercise BFR stimulus was introduced alongside a novel 
exercise stimulus. As alluded to above for some parameters the exercise intervention alone 
proved a potent stimulus and therefore, in some cases there may have been limited capacity to 
increase the initial response further. To overcome this future studies could look to precondition 
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individuals to a specific interval training program, before introducing a post-exercise BFR 
stimulus once an attenuated adaptive response would be expected.  
There are also limitations in the methods used for the assessment of mitochondrial adaptations. 
As aforementioned, no assessment was made of mitochondrial function. Adaptations to 
mitochondrial function can be dissociated from those of mitochondrial content (Granata et al. 
2016). Moreover, cross-sectional data from studies suggest that higher physical activity levels 
are associated with relatively larger values of mitochondrial function than mitochondrial 
content (Bishop et al. 2014) suggesting mitochondrial function may be more responsive to 
exercise training. Therefore, it seems plausible that the interventions may have increased 
mitochondrial function. Moreover, CS enzyme activity provides a more valid biomarker of 
mitochondrial content than the content of mitochondrial proteins assessed in Chapter 4 (Larsen 
et al. 2012). However, in this chapter, due to the large number of pre and post training visits, 
more than 24 hours rest prior to muscle biopsies was not possible in all participants. CS activity 
was therefore not assessed given that it can still be acutely elevated after 24 hours in response 
to a single exercise bout (Leek et al. 2001).  
 
7.7 CONCLUSIONS AND FUTURE DIRECTIONS 
This thesis has furthered our knowledge on the potential of post-exercise BFR as a possible 
training tool for endurance athletes. In contrast to the hypotheses it was demonstrated that 
combining post-exercise BFR with 4 weeks of SIT is not sufficient to elicit improvements in 
angiogenesis or mitochondrial biogenesis and does not enhance performance within the severe-
intensity domain. Nevertheless, whilst the findings of this thesis suggest that post-exercise BFR 
utilised during training protocols undertaken at a typical training intensity does not elicit 
mitochondrial biogenesis (at least in the form of increasing mitochondrial content), there were 
suggestions that post-exercise BFR could induce an enhanced angiogenic stimulus which may 
manifest when undertaken with greater training volumes and/or training durations. Indeed, this 
thesis was the first to observe that post-exercise BFR enhances resting eNOS mRNA, 
suggesting the potential for enhanced shear stress. Given that the findings also imply that 
skeletal muscle capillarity is a key determinant of CP, these suggestions clearly warrant further 
investigation. Future studies should look to establish whether the addition of post-exercise BFR 
during more than 4 weeks of SIT and higher volume HIIT protocols, such as that utilised in 
Chapter 6, enhances angiogenesis and high-intensity endurance performance.  
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Post-exercise BFR also has the potential to elicit further peripheral adaptations than that 
explored in this thesis, such as enhancing the regulation of ion gradients. For example, 
Christiansen et al. (2018) recently provided preliminary data to suggest BFR could enhance 
sodium and potassium ion regulation. They demonstrated that BFR undertaken during 
moderate-intensity running interval training augmented the acute increase in mRNA expression 
of the Na+, K+-ATPase complex ancillary protein FXYD1, which performs a role in the 
maintenance of transmembrane sodium and potassium ion gradients, which are critical to 
preserve skeletal muscle membrane excitability and thus to resist fatigue (McKenna et al. 
2008). Therefore, in addition to angiogenesis future research should also investigate the effect 
of post-exercise BFR upon these adaptations.  
Should future investigation support the preliminary findings of this thesis that suggest the 
potential for enhanced angiogenic signalling, by demonstrating post-exercise BFR can enhance 
capillary supply, post-exercise BFR could also have applications for sedentary and clinical 
populations. Indeed, not only is increased skeletal muscle capillarity linked with functional 
improvements, decreased capillarity is associated with reduced health outcomes, including 
reduced insulin sensitivity (Prior et al. 2014) and chronic diseases such as peripheral artery 
disease (Duscha et al. 2011) and diabetes (Kondo et al. 2015). Although the demanding 
protocols in the current thesis may not be suitable for sedentary individuals or individuals with 
functional limitations, post-exercise BFR could be trialled alongside reduced intensity 
protocols in a bid to enhance the angiogenic stimulus. It seems likely that this model of BFR 
may reduce the discomfort and perceived exertion in comparison to continuous BFR during 
exercise, with intermittent applications previously demonstrated to elicit lower perceived 
exertions (Neto et al. 2017), which may assist in adherence to BFR exercise. 
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CHAPTER 8 
SKELETAL MUSCLE ANALYSIS METHOD DEVELOPMENT 
 
 
8.1 IMMUNOHISTOCHEMICAL PROTOCOL OPTIMISATIONS 
Immunohistochemistry utilises the specific bond between antigens and antibodies for the 
identification of proteins with a fluoresce microscope to allow the visualisation of muscle tissue 
structure. Within the thesis this process was used to visualise myosin heavy chain (MHC) I and 
II, CD31 and Ki-67.  
Prior to analysis of experimental samples methods for CD31, MHCII and Ki-67 antibodies 
were optimised to minimise background staining and optimise positive staining. The MHC I 
and II antibodies had been previously optimised, however, due to use of a different secondary 
antibody some optimisation was also undertaken for the MHC II antibody. This previous MHC 
protocol was used as a starting protocol for all proteins, alongside antibody suppliers 
recommended dilutions.  
CD31 Optimisation 
CD31, also known as platelet endothelial cell adhesion molecule (PECAM-1), is a 
transmembrane glycoprotein located within the endothelium. Immunohistochemical staining 
of CD31 on cross-sectional muscle tissue sections allows a 2D quantification of skeletal muscle 
capillarity.  
CD31 Antibody: Rabbit monoclonal antibody (Abcam: ab76533)  
Initial primary antibody concentration of 1 in 250 and secondary antibody concentration of 1 
in 1000 was selected. As shown in Figure 8.1A these concentrations did not produce a clear 
expression of CD31 positive cells. To establish a positive expression of the primary antibody 
before proceeding further with the optimisation process both primary and secondary antibody 
concentration were increased together (Primary = 1 in 100, Secondary = 1 in 500). As shown 
in Figure 8.1B, the increased concentrations resulted in an identifiable positive stain.  
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Figure 8.1. CD31 staining. A) Primary antibody concentration 1 in 250 and secondary 1 in 
1000. B) Primary antibody 1 in 100 and secondary antibody 1 in 500. 
 
 
As there is a risk of over fixation, due to modification of amino-acids that form part of the 
epitope with the use of formaldehyde, two acetone fixing protocols, which have been used in 
previous literature analysing CD31, were tested against the formaldehyde fixing procedure 
used in the MHC protocol. The three fixative processes tested were: 
1. Incubation of samples in a 3.7% formaldehyde solution for 10 minutes. 
2. Immersion of slides in acetone at -20℃ for 5 min.  
3. Immersion of slides in acetone at -20℃ for 30 s before they were incubated in a 3.7% 
formaldehyde solution for 2 min.  
As displayed in Figure 8.2, neither acetone protocol enhanced the expression of CD31 positive 
cells and so the use of the formaldehyde solution was maintained.  
 
 
 
 
 
 
A B 
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Figure 8.2. CD31 (pink) & MHC I (green) staining. A) Fixed with acetone for 5 min. B) Fixed 
with acetone for 30 s and P-formaldehyde for 2 min. C) Fixed with P-formaldehyde for 10 min. 
 
Primary antibody concentration was then optimised. Concentrations tested were 1 in 100, 1 in 
250 and 1 in 500. Images are displayed in Figure 8.3 (due to an issue with inappropriate storage 
there was a higher amount of background/non-specific straining in parts). A concentration of 
1 in 100 resulted in the brightest stain. A further experiment was conducted at 1 in 50 in an 
attempt to reduce the high exposure time that was required (>2000 ms) but a higher amount of 
background staining was visible at this concentration.  
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Figure 8.3. CD31 staining (red). Primary antibody concentration: A) 1 in 100; B) 1 in 250; C) 
1 in 500.  
 
A higher concentration of seconday antibody (1 in 500 increased to 1 in 250) was then trialled 
but this did not produce a stronger expression of CD31 positive cells. Following optimisation 
of this antibody the images produced (Fig 8.3A) still did not produce a clear stain of all 
capillaries and some background staining was visible at the high required exposure time (~2000 
ms), therefore a second antibody was trialled.  
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C 
130 
 
Second CD31 Antibody: Mouse monoclonal antibody (Abcam: ab119339)  
Initially the new antibody was stained alongside the previous antibody on serial sections using 
the same optimised protocol. The results from this experiment are displayed in Figure 8.4. 
Whilst the staining of the capillaries was clearer and more numerous with the new antibody, 
there was significant background staining of the muscle fibres. Therefore, the incubation of the 
primary antibody was reduced from overnight to 1 hour. This eradicated the background 
staining of the muscle fibres (Fig. 8.4C).  
 
Figure 8.4. A) CD31 (green) new primary antibody incubated overnight, exposure time = 878 
ms B) CD31 (red) original primary antibody incubated overnight, exposure time = 1584 ms C) 
CD31 (green) new primary antibody incubated for 1 hour, exposure time = 623 ms. 
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The primary antibody concentration was then optimised (Figure 8.5). The concentrations tested 
were; 1 in 50, 1 in 100 and 1 in 250. A primary antibody concentration of 1 in 250 produced a 
stain with a lower expression that 1 in 100, however an increased concentration of 1 in 50 did 
not enhance the positive stain.  
 
Figure 8.5. CD31 staining (green). Primary antibody concentration: A) 1 in 50 B) 1 in 100 C) 
1 in 250. 
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Finally the secondary antibody concentration was optimised with concentrations of 1 in 250, 1 
in 500 and 1 in 1000 tested (Figure 8.6). A concentration of 1 in 1000 produced a low positive 
expression, but there was no observable difference between 1 in 500 and 1 in 250.  
 
Figure 8.6. CD31 staining (green). Secondary antibody concentration: A) 1 in 250 B) 1 in 500 
C) 1 in 1000. 
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Myosin heavy chain II optimisation 
MHCII antibody: Rabbit polyclonal antibody (Abcam: ab91506) 
The primary antiobdy concentration was optimised with concentrations of 1 in 1000 and 1 in 
2000 trialled (Figure 8.7). A concentration of 1 in 1000 produced a much brighter stain than 1 
in 2000.  
 
Figure 8.7. MHC II staining (red). Primary antibody concentration: A) 1 in 1000 B) 1 in 2000   
 
Secondary antibody concentrations of 1 in 250, 1 in 500 and 1 in 1000 were then trialled (Figure 
8.8). A concentration of 1 in 1000 produced a low positive expression but an increase to 1 in 
250 did not make fibres easier to classify than 1 in 500. 
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Figure 8.8. MHC II staining (red). Secondary antibody concentration: A) 1 in 250 B) 1 in 500 
C) 1 in 1000.    
 
Controls were undertaken with no primary antibodies (Figure 8.9) to ensure specificity of 
secondrary antibodies.  
 
 
 
 
 
 
Figure 8.9. No primary antibody controls: A) Alexa Fluor 488 Mouse antibody B) Alexa Fluor 
594 Rabbit antibody. Exposure time ~600ms.   
A B 
A B 
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Ki-67 antibody optimisation 
Ki-67 detects a proliferation-associated nuclear antigen, and its co-localisation within 
endothelial cells can be used to identify and quantify proliferating endothelial cells (Hoier et 
al. 2010; Jensen et al. 2004a).  
Ki-67 Antibody: Rabbit monoclonal antibody (Abcam: ab92742)  
Due to the infrequency of Ki-67 positive cells, the size of Ki-67 positive staining and level of 
expression positive staining is not generally visible when printed, therefore, images are not 
displayed in this section. 
Initially the primary antibody concentation was optimised. Concentrations tested were: 1 in 
100, 1 in 250 and 1 in 500, these were incubated for 1 hour. The concentrations of 1 in 100 and 
1 in 250 were similar, but images were weak in expression. Following this a primary antibody 
concentration of 1 in 250 was used but primary antibody incubation was continued over night.  
There was no additional background staining evident so an overnight incubation was continued. 
A higher secondary antibody concentration of 1 in 250 was then trialled. This did not enhance 
the expression of positive staining so a concentration of 1 in 500 was maintained. Due to the 
higher required exposure time (up to 1000 ms) an additional no primary antibody control was 
performed to confirm seconday antibody speficity at this exposure. After optimisation the 
signal to noise ratio for some samples remained low. As a result a serial section with a no 
primary antibody control was stained for all samples concomitantly to confirm if visible 
staining was Ki-67 positive.  
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8.2 IHC OPTIMISED PROTOCOL 
Sectioning 
Preparation 
The Cryostat was set to an initial working temperature of -25°C and specimen temperature of 
-20°C. Samples were removed from the -80°C freezer and were left to equilibrate to the 
temperature for at least 1 hour.  
Cryosectioning 
Single sections of 8 μm were sectioned and added to a polysine microscope slide. Cross-
sectional orientation was examined under a light microscope, using the assumption of 
circularity. Microtome height and angle were adjusted as required until a cross-sectional 
orientation was achieved. 6 or 8 slides were collected (with 18-21 sections per slide) with serial 
sections depending upon the size and number of mounted samples available. Slides were stored 
at -80°C until analysis. 
Staining 
Reagents 
1 x PBS (1% Tween-20) 
• 2 PBS Tablets 
• 0.4 g of Tween-20 
• 400 ml of dH2O 
3.7% formaldehyde fixing solution 
• 1 ml of 37% formaldehyde 
• 9 ml of 1 x PBS (1% Tween-20) 
Blocking solution 
• 1 g of BSA 
• 2.5 ml of goat serum 
• 100 μl of Triton X-100 
• 46.4 ml of PBS 
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Immunostaining Protocol 
1. Upon removal from -80°C freezer samples were left to dry and slides were circled 
with a PAP-pen 2-3 times. 
2. Muscle samples were fixed within a 3.7% formaldehyde solution, for 10 minutes at 
room temperature. 
3. Slides were washed for 3 min five times with PBS.  
4. Samples were then blocked for 60 minutes at room temperature. 
5. Slides were washed for 3 min five times with PBS. 
6. Samples were incubated with primary antibodies in blocking solution at room 
temperature for 60 minutes.  
Slide 1 = CD31 (anti-mouse monoclonal) at a concentration of 1:100  
    MHC II (anti-rabbit monoclonal) at a concentration of 1:1000 
Slide 2 = MHC I (anti-mouse monoclonal) at a concentration if 1:500 
Slide 3 = CD31 (anti-mouse monoclonal) at a concentration of 1:100 
Slide 4 =  Blocking solution alone 
7. Slides were washed for 3 min five times within PBS.  
8. Slides 3 and 4 underwent a secondary primary antibody incubation at room 
temperature overnight and were wached for 3 min five times with PBS. 
Slide 3 = Ki-67 (anit-rabbit monoclonal) at a concentration of 1 in 250 
Slide 4 = Blocking solution alone  
9. Samples were incubated with secondary antibodies in blocking solution in the dark 
at room temperature for 2 hours. 
Slide 1, 3 & 4  = Alexa Fluor 488 at a concentration of 1:500 
= Alexa Fluor 594 at a concentration of 1:500 
Slide 2  = Alexa Fluor 488 at a concentration of 1:500 
10. Slides were washed for 3 min five times with PBS in the dark.  
11. 1-2 drops of fluoromount aqueous mounting medium was applied to each slide and 
a cover slip was placed over the samples.   
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8.3 WESTERN BLOT PROTOCOL OPTIMISATIONS 
Western blotting combines the process of gel electrophoresis with the specifity of antibody-
antigen detection. This allows the quantification of the content of a specific protein in a sample. 
Within this thesis western blotting was used for the quantification of mitochondrial enzymes 
CS, COXII and COXIV and signalling proteins VEGF and PGC-1α 
CS, COXII and COXIV 
CS antibody: Rabbit monoclonal antibody (Abcam: ab129095) 
COXII antibody: Mouse monoclonal antibody (Abcam: ab110258) 
COX IV antibody: Mouse monoclonal antibody (Abcam: ab33985) 
These proteins have regulary been measured in the literature. As a result an initial protocol 
based from previous publications was trialled. The initial trials of these proteins are displayed 
in Figure 8.10. 15ug and 30ug of protein loading was trialled. There was a strong blot when 
only 15ug of protein was loaded. With clear positive bands and lack of non-specific bands no 
further optimisation was undertaken upon these protocols.  
 
 
 
 
 
 
 
 
Figure 8.10. Western blots for (left to right) CS, COXII and COXIV with 15 ug loaded on the 
left-hand lanes and 30 ug loaded on the right-hand lanes.    
 
 
~26 kDa 
~17 kDa 
~45 kDa 
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VEGF 
VEGF antibody: Rabbit monoclonal antibody (ab52917) 
Initially two different protein loading concentrations: 30 µg and 60 µg and two blocking 
protocols: 5% milk and 5% BSA both in TBST were tested (Figure 8.11). Loading of 60 µg 
produced a clearer band near the correct molecular weight. BSA was an ineffective blocking 
solution so milk was used, but there was still non specific bands with this blocking protocol.  
 
 
 
 
 
 
 
Figure 8.11. Western blots for VEGF top) blocked in 5% BSA, bottom) blocked in 5% milk. 
Left-hand lane 60 µg protein loaded and right-hand lane 30 µg protein loaded    
 
Next lower primary antibody concentrations were trialled to try to reduce the non-specific 
bands. The concentrations trialled were 1 in 1000, 1 in 2000 and 1 in 4000 (Figure 8.12). This 
trial was run with an new vial of antibody. There was not a single clear positive band at any 
concentration. This experiment was repeated on different samples and produced the same result. 
As a result a new antibody was trialled.  
 
 
 
 
 
~25 kDa 
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Figure 8.12. Western blots for VEGF at a primary antibody concentration of (left to right) 1 in 
1000, 1 in 2000 and 1 in 4000.    
 
Second VEGF antibody: Mouse monoclonal antibody (Santa-Cruz: sc-7269) 
Initial protein loading centrations of 30 µg and 60 µg were triallled (Fig. 8.13A). There were 
two faint bands around the correct molecular weights for the VEGF monomer and dimer. Given 
the bands were faint the exposure time was increased in the next trial from initial exposure of 
10 s for a total of 1200 s to an initial exposure time of 30 s for a total of 3600 s and a reduced 
concentration of milk was used in the blocking solution (2%). A higher primary antibody 
concentration was also trialled (1 in 500) (Fig.8.13B). The increase in exposure time resulted 
in a clear positive band which was not enhanced with a primary antibody concentration of 1 in 
500.  
 
 
 
 
 
 
 
Figure 8.13. Western blots for VEGF. A) left hand lane 30 µg, right hand lane 60 µg. Exposure: 
initial time of 10 s for total of 12000 s. B) left-hand lane primary antibody concentration of 1 
in 500 and right-hand lane 1 in 1000. Exposure: initial time 30 s for 3600 s.     
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PGC-1α 
PGC-1α antibody: Mouse monoclonal antibody (Merck: 4C1.3) 
Initially two different protein loading concentrations were trialled: 30 µg and 60 µg, with an 
initial primary antibody concentration of 1 in 1000 (Fig. 8.14A). A clear band at a high 
molecular weight was visible, although there was some background staining. A lower primary 
antibody concentration (1 in 2000) was trialled and both primary and secondary antibodies 
were diluted in 5% milk (increased from 3%) to try and reduce non-specific bands (Fig. 8.14B).  
 
 
 
 
 
 
 
Figure 8.14. Western blots for PGC-1α A) left hand lane 60 µg, right hand lane 30 µg, with 
antibodies diluted at 1 in 1000 in 3% milk. B) left-hand lane primary antibody concentration 
of 1 in 1000 and right-hand lane 1 in 2000 with antibodies diluted in 5% milk. 
 
A higher concentration of milk reduced the non-specific bands. The clear band produced was 
higher than the estimated molecular weight (~150 vs ~113 kDa), however, with no other bands 
near the estimated molecular weight it seemed possible that this could be a positive band. To 
confirm this a positive control was run alongside the sample to check if they occurred at the 
same molecular weight. As demonstarted in Figure 8.15A, however, the band for the muscle 
sample was occuring above that of the main band of the positive control, although there was 
still a weaker band of the control at a similar molecular weight. A further experiment was run 
against another PGC-1α antibody (Abcam) to identify if it was an issue with the antibody or 
positive control (Figure 8.15B).  
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Figure 8.15. Western blot for PGC-1α A) left lane muscle sample, right lane positive control. 
B) left lane current Merck monoclonal antibody, right lane Abcam polyclonal antibody. 
 
The abcam antibody produced multiple bands; a weak one was evident at the same molecular 
weight as that produced by the merck antibody, but there was a clearer band at the antibodies 
stated molecular weight (~100 kDa) and further larger bands at lower molecular weights, so 
the ‘correct’ band was also not clear for this antibody. 
A further experiment was run on experimental samples using the Merck antibody to see if the 
changes were as would be expected (Fig. 8.16A), alongside another high molecular weight 
protein (mTOR ~289 kDa) to confirm if higher weight proteins in the muscle samples were 
running through the gels correctly (Fig 8.16B). mTOR came out at the correct molecular weight 
suggesting that there was no issue with the running protocol. The experimental samples also 
decreased across the training period which based upon previous literature (e.g. Perry et al. 2010) 
would be unexpected.  
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Figure 8.16. A) Western blot for PGC-1α on experimental samples across the training period 
from Chapter 6. B) Western blot for mTOR (~289 kDa). 
 
A final experiement was run using muscle sampes which had not boiled prior to gel loading. 
This produced a similar single clear band again at a molecular weight of ~150 kDa.  
Therefore, following this series of trials being unable to produce a valid positive band for PGC-
1α protein at the correct molecular weight, the muscle samples from Chapter 6 were not 
analysed for PGC-1α protein.  
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8.4 WESTERN BLOT OPTIMISED PROTOCOL 
Sample preperation 
1. Muscle samples were weighed and 100 µl of lysis buffer was added per 10 mg of 
protein. 
2. Samples were blitzed in a tissue lyser twice for 2 min at 20 Hz and were centrifuged 
at 12000 g for 10 min. 
3. The supernatant was transferred to a fresh eppendorf tube. 
4. Samples were diluted 1 in 10 in dH2O and protein concentrations were determined 
by Pierce 660 protein assay.  
5. Samples were prepared to the desired concentraion of protein with 4 x LDS sample 
buffer (2.5 µl per 10 µl), 0.1% β-mercaptoethanol (0.5 µl per 10 µl) and the 
remaining volume of dH2O. Samples were then boiled for 5 minutes at 95°C and 
were frozen at -20°C until analysis.  
Gel Running 
1. Samples were loaded onto TGX gels. CS, COXII and COXIV = 15 µg and VEGF 
= 60 µg. 5 µl of pre-stained ladder was loaded at intervals across the gels.  
2. Running buffer was added to the tank and the gels were run at a constant voltage of 
100 v for 80 min. 
Transfer  
1. Gels were removed from casing and were incubated in transfer buffer for 5 min. 
2. Transfer sandwiches were made with scoth pad, filter paper, TGX gel, PDVF 
membrane, filter paper and scoth pad. A roller was used to remove any air bubbles. 
3. The remaining transfer buffer was added to the tank and the transfer was run at a 
constant voltage of 30 v for 90 min. 
Immuno-Blot 
1. Membranes were removed from the transfer sandwich and were washed for 5 min 
in TBST. 
2. Membranes were blocked in 5% milk in TBST for 1 hour at room temperature on 
a rocker. 
3. Membranes were washed for 5 min three times in TBST. 
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4. Membranes were cut at the appropriate molecular weight for the proteins of interest 
and incubated overnight at 4°C on a rocker at ~60 rpm at dilutions displayed in the 
table. GAPDH was used as a control protein. 
 
Table 8.1. Molecular weights and primary antibody solutions for the proteins of interest. 
 
5. Membranes were washed for 5 min three times in TBST. 
6. Membranes were then incubated in the appropriate secondary antibody (anti-mouse 
horesradish peroxidase-conjugated secondary antiboy (Dako) or anti-rabbit 
horseradish peroxidase-conjugated secondary antibody (Bio-Rad)) at a 
concentration of 1 in 10 000 for 60 min at room temperature.  
7. Membranes were washed 5 min three times in TBST. 
8. Membranes were then incubated in a 1:1 solution of enhanced chemiluminescence 
substrate (ClarityMax, Bio-rad) for 5 min in the dark. 
9. Membranes were then visualised using image analysis with exposure times listed in 
the table below.  
 
Table 8.2. Exposure times for the proteins of interest. 
Protein Exposure time 
CS 10 s for total of 1200 s (total images = 60) 
COXII 10 s for total of 1200 s (total images = 60) 
COXIV 10 s for total of 1200 s (total images = 60) 
GAPDH 10 s for total of 1200 s (total images = 60) 
VEGF 30 s for total of 3600 s (total images = 60) 
 
Protein Mol. weight Primary antibody solution 
CS ~45 kDa 1 in1000 in 3% Milk 
COXII ~26 kDa 1 in 1000 in 3% Milk 
COXIV ~17 kDa 1 in 1000 in 3% Milk 
GAPDH  ~38 kDa 1in 10 000 in 3% Milk 
VEGF ~25 kDa 1 in 1000 in 2% Milk 
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